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Abstract 
Biophysical properties of the PrP-repeat sequences from the brush-tailed possum (i.e. a 
marsupial) are reported. The results of several methods (FTIR, fluorescence, FRET, 
ESI MS, CD, ED, UV Nis absorption spectroscopy) have been integrated to provide 
information on the conformation, and conformational changes,_ of n1arsupial PrP-repeat 
(Msp) peptide under various conditions (peptide length, pH and presence of copper 
ions), and the copper-binding properties (binding strength, stoichiometry, and binding 
sites). Similarities and differences between the properties of marsupial and mammalian 
PrP repeats, which have significantly different repeats sequences, were also analyzed. 
The conformation of Msp peptides was studied mainly by FTIR spectroscopy, which 
showed that in the absence of copper ions Msp peptides are disordered throughout pH 
6.0-9.0. The presence of disordered structure was also evident in CD spectra. Although 
they are disordered, inter-residue distance data obtained from FRET experiments 
combined with MD simulations showed the peptides are loosely folded, and not 
staggered or fully extended. The simulations also indicated that the peptide does not 
adopt only one conformation. Copper binding to longer peptides induced the formation 
of a more hydrogen-bonded structure, as shown by the shift of the IR amide I band 
toward lower frequency and changes in CD spectra. 
Copper-binding strength was measured primarily by fluorescence titration spectroscopy. 
The shape of the saturation curve indicates that copper binds very tightly to Msp 
peptides with free imino terminus. Under the experimental conditions, acetylation of 
the N-terminus abolishes the binding ability of the peptides or suggests far weaker 
binding. ED was also employed to investigate copper binding to a rather high 
molecular weight Msp peptide. However, the binding strengths obtained from ED do 
not agree with the fluorimetry results. 
Amidation of the C-terminus does not affect the binding strength but greatly influence 
the stoichiometry. In the absence of this group, one copper ion binds to more than one 
molecule of peptide, which suggests multimerisation. However, this multimerisation 
was not detected when stoichiometry was measured using ESI MS and ED, the last two 
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methods using peptide concentrations 10-20 times higher than the fluorescence method. 
Fluorimetry experiments also showed that the stoichiometry as well as the copper-
binding affinity depended greatly on the peptide concentration. 
FTIR spectra, fluorimetry, and ESI MS data show that the N-terminally free Msp 
peptides (PHPGGSNWGQ)n = 1, 2, 3, 4 binds copper ion through the imino end group of 
Pro as the anchoring site. The amide nitrogen and the Nrr atom of the His2 also 
participate in copper binding. At higher peptide concentration and pH higher than 8 · 
copper binding to the N-terminally capped Msp peptides was detected by FTIR. The 
data suggest that the copper-anchoring site in these peptides is the Nrr atom of the His2 . 
The amide nitrogens of the Gly4 and Gly5 complete the copper-coordination sphere. 
Mutation of the Pro3 into Gly3 (1PHGGGSNWGQ10) increases the ability of the N-
terminally capped peptide to bind copper, suggesting that the NH group of the amide 
backbone of the Gly3 found naturally in the human PrP octarepeat (1PHGGGWGQ8), is 
also a copper-binding site. 
This thesis . also proposes a possible interaction, which stabilizes the loosely folded 
structure in PrP-repeat peptides, as cation-n or n-n interactions between Trp and His 
residues. The influence of cation-n or n-n interactions on the conformational stability 
of PrP-repeat peptides needs to be investigated further. 
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Chapter I 
Introduction 
Prion protein (PrP) is a cell surface glycoprotein, tethered to the membrane via a GPI 
anchor at the C-terminus, which is normally present in a soluble form (PrPc). It is 
expressed primarily in the central nervous system (Prusiner, 1998), or in nervous tissues 
in peripheral organs (Ford et al., 2002). Although the physiological function of PrPc is 
currently unclear, its pathogenic form has been associated with several 
neurodegenerative disorders that affect humans and other mammals. The diseases are 
characterized by an accumulation of an amyloid aggregate in the brain, in which an 
alternative conformer of PrP (PrP8c) is observed to be the major component (Prusiner, 
1998). The difference between the two isoforms resides in their secondary structural 
content; PrPc is rich in a-helix whereas PrP8c has a high B-sheet content (Pan et al., 
1993). The formation of infectious "prion" has been ascribed to a conformational 
change in which the helix-rich structure rearranges into a high B-sheet form, which then 
aggregates. The relationship between the conformational change and the development 
of the diseases themselves is still debated. Nonetheless, the PrP phenomenon has been 
classified as one of the conformational diseases (Cohen and Prusiner, 1998; Sunde and 
Blake, 1998), and its properties have been intensively investigated using structural 
(Donne et al., 1997; Riek et al., 1997; Lopez Garcia et al., 2000; Zahn et al., 2000) and 
biophysical approaches (Baldwin et al., 1995; Cohen and Prusiner, 1998). 
1.1. 3-D structure of PrP 
Solution NMR structures. Although relatively short (,--253 residues, mammalian), the 
sequence of PrP is unusual because it contains a number of regions with quite different 
amino acid compositions (Wopfner et al., 1999) and apparent structure. Figure 1.1 
shows NMR structures of several full-length mammalians PrPs. 
The figure shows that the C-terminal region (residues 126-231) adopts a loosely folded 
structure containing three a-helices and two short B-strands, while the N-terminal 
region (residues 23-125), including the PGH-rich tandem repeats region (residues 51-
91 ), is largely unstructured (Donne et al., 1997; Riek et al., 1997; Lopez Garcia et al. , 
2000; Zahn et al., 2000) with a high degree of backbone flexibility (Viles et al. , 2001). 
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Figure 1.1: Solution NMR structure of full-length mammalian PrP. The NMR structure 
of syrian hamster (ShaPrP), murine (MuPrP), human (HuPrP), and bovine (BoPrP) 
show three helices ( a 1, a 2, and a 3) and two stretches of B-strands within the C-terminal 
region (126-231), while the N-terminal region (23-125) is unstructured. These figures 
are taken from the sources stated above with some modification in size and colour. 
XRD structure. A crystal structure of PrPc (Figure 1.2) in dimer form has also been 
published. The dimer results from the three-dimensional swapping of the monomeric 
forms involving the C-terminal helix 3 and rearrangement of the disulfide bond. As 
many familial prion disease mutations map to the regions directly involved in helix 
swapping, it has been suggested that oligomerization through 3-D domain-swapping 
may constitute an important step on the pathway of the PrPc - PrPsc conversion (Knaus 
et al., 2001). 
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Figure source: Knaus et al. (2001) 
Figure 1.2: Crystal structure of PrPc (residues 119-12~) showing the dimer form. The 
stereo figure is taken from Knaus et al. (2001) with some changes in size and colour so 
that the two peptide chains are in black and grey. The position of ball-and-stick 
structures, representing the interchain disulfide bridges, are not clear in the figure, so 
they are marked with arrows. 1 
1.2. Copper binding and the proposed functions of PrP 
Although the function of PrP is still a matter of debate, recent work has shown the 
ability of the protein to bind copper ions through its PGH-rich tandem repeats region 
(Homs_haw et al., 1995a; Viles et al., 1999; Aronoff-Spencer et al., 2000; Bonomo et al., 
2000; Whittal et al., 2000; Bums et al., 2002; Luczkowski et al., 2002; Qin et al., 2002). 
Endocytosis of PrPc from the cell surface has been shown to be rapidly and reversibly 
stimulated by copper ions (Pauly and Harris, 1998). This suggests that PrP is a 
recycling receptor for uptake of copper ions from the extracellular milieu. Other 
evidence that supports this hypothesis is that substitution and deletion mutation in the 
octarepeat region, which resulted in diminution of copper-binding ability, abolished the 
endocytosis, while a disease-associated mutation, addition of nine octarepeats, resulted 
in PrP failing to undergo copper-mediated endocytosis (Sumudhu et al., 2001). 
Different lines of evidence suggest PrPc has a role in regulating the activity of the 
enzyme Cu,Zn-SOD activity by influencing copper incorporation into the enzyme 
molecule (Brown and Besinger, 1998). PrPc itself may have an enzymic function, as it 
exhibited SOD activity in vivo (Wong et al., 2000), following the binding of copper to 
the octarepeat region of the molecule during protein folding (Brown et al., 1999). It was 
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also shown that the octarepeats region of PrP protects the cell against oxidative stress 
and copper toxicity (Wong et al., 2000). This supports the suggestion that the 
octarepeats region of PrP may represent a functional domain of the native protein 
(Brown et al., 1998). It has also been suggested that PrP, through its octapeptide repeat 
region, can function to take away copper ions in the Cu(I) redox-inactive state and in so 
doing prevent the formation of copper-induced generation of reactive oxygen species 
(Shiraishi et al., 2000). 
1.3. Repeats region of PrP 
As noted above, some findings suggest a PrP role in copper metabolism (Brown and 
Besinger, 1998; Pauly and Harris, 1998; Brown et al., 1999; Wong et al., 2000) 
associated with binding to the N--terminal region, primarily the octapeptide tandem 
\ 
repeat region (Brown et al., 1997; Brown and Besinger, 1998; Brown et al., 1999; 
Shiraishi et al., 2000; Wong et al., 2000). Although the region comprising the 
octapeptide tandem repeat is not essential for mediating pathogenesis and prion 
replication, it modulates the extent of these events and of disease presentation (Flechsig 
et al., 2000). Copper ion itself has been suggested to have a role in the disease (Quaglio 
et al., 2001). Also, noting again, disease-associated mutation of the octarepeat region 
abolishes copper-induced endocytosis of PrP (Sumudhu et al., 2001). These findings 
make the repeats region another interesting part of PrP for separate study. In addition, 
the nature of the repeat sequence, which is known as a "low-complexity" sequence, 
makes this region very challenging for study. 
1.4. PrP repeats as a segment with low-complexity sequence 
The sequence of the repeats region of PrP is rich in Pro, Gly and His. This repetitive 
sequence is described as having low-complexity or non-random amino acid composition 
(Wootton, 1994). These types of sequence are abundant in natural proteins, and are 
often found in the unstructured domains of protein with unknown function. In fact they 
contribute 25% of the residues in the SwissProt database (Wootton, 1994). However, 
they have been little studied. This has been due to an assumption that they are less 
important than folded don1ains, and because methods to study them are not well 
established. Indeed, the tandem repeat region of PrP is located in the N-terminus that is 
unstructured as shown by NMR. However, the lack of intrinsic structure is often 
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relieved only when the protein binds to its target molecule (Wright and Dyson, 1999). 
In the case of the tandem repeats of PrP, the segment may take on more ordered 
structure when it binds to copper ions or sugars ( the copper and sugar binding to PrP 
repeats will be discussed further in sections 1.5 and 1.6, respectively). 
Table 1.1: Sequence of the N-terminal tandem repeats of PrP. 
Species Sequence 
Human ) 1PQGGGGWGQ PHGGGWGQ PHGGGWGQ PHGGGWGQ 
PHGGGWGQ91 
Chicken 47PRQPGY PHNPGY PHNPGY PHNPGY PHNPGY PHNPGY PQNPGY 
PHNPGY94 
Possum 61 PQGGGTNWGQ PHPGGSNWGQ PHPGGSSWGQ PHGGSNWGQ~N 
Wallaby PQGGGTNWGQ PHPGGSSWGQ PHAGGSNWGQ PHGGSNWGQ 
Table 1.1 shows that the human repeats region contains 5 tandemly repeated sequences. 
There are 2_ variants: the major one is PHGGGWGQ ( 4 of 5), while the minor one is 
PQGGGGWGQ. The major one PHGGGWGQ is regarded as the consensus octarepeat 
sequence as it also dominates in similar repeats sequence in other mammals (Wopfner et 
al., 1999; Van Rheede et al., 2003). 
The chicken repeats region contains 8 tandemly repeated sequences of 6 residues (Table 
1.1). There are 3 variants: 6 of 8 are PHNPGY, one PQNPGY, and one PRQPGY. The 
sequence "PHNPGY" is the dominant one in other avian sequences, and is considered 
the prototype. Note that, similarly to mammalian, the second residue of the chicken 
prototype hexarepeat is His. 
The PrP-repeats region of the brush-tailed possum, the only published marsupial 
sequence (Windl et al., 1995), contains 4 times tandemly repeated units of 10 or 9 
residues (Table 1. 1). There are 4 variants in the sequence: one PQGGGTNWGQ, one 
PHPGGSNWGQ, one PHPGGSSWGQ, and one PHGGSNWGQ. Recently, another 
marsupial PrP, which is from tamn1ar wallaby (Premzl and Gready, 2003, personal 
communication; not yet published) has been sequenced. It revealed similarly to 
possum; wallaby also has 4 repeats of 10 or 9 residues (Table 1.1 ). The first and fourth 
repeats of wallaby are the same as those of possum. The second repeat is similar to the 
third repeat of possum. The third repeat of wallaby, PHAGGSNWGQ, is unusual 
because no other PrP repeat has an Ala. 
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The motif P[H/Q].GG.WGQ is conserved among the mammalian and marsupial 
sequences. The second residue in marsupial and mammalian is dominantly His. 
- -
-·---- -
Marsupial has two additional residues, with polar amino acid side chains (Ser, Thr, or 
Asn). This is the feature that distinguishes marsupial from mammali'an PrP repeats. 
Also, the segment of three Gly (GGG) following the His residue is dominant only in 
mammals. In marsupial, it is Pro (2 of 4 in possum and 1 of 4 in wallaby) or Ala (none 
in possum and 1 of 4 in wallaby) being the third residue following His, resulting in the 
presence of PGG or AGG instead of the GGG segment. Although the presence of Ala 
instead of Gly is unusual,- a recent study indicates that a mutant peptide with tri-Ala 
instead of tri-Gly is still capable of binding of copper ions but with lower affinity 
(Luczkowski et al., 2003). 
1.5. Copper binding to PrP repeats 
Various biophysical methods have been applied to characterize peptides and proteins 
containing PrP repeats, in the presence and absence of copper. These include 
fluorescence spectroscopy (Hornshaw et al., 1995a; Smith et al., 1997; Stockel et al., 
1998; Jackson et al., 2001; Kramer et al., 2001), circular dichroism (CD) (Hornshaw et 
al., 1995a; Smith et al., 1997; Stockel et al., 1998; Viles et al., 1999; Aronoff-Spencer et 
al., 2000; Bonomo et al., 2000; Whittal et al., 2000; Luczkowski et al., 2002; Garnett 
and Viles, 2003), electron paramagnetic resonance spectroscopy (EPR) (Viles et al., 
1999; Aronoff-Spencer et al., 2000; Cereghetti et al., 2001; Luczkowski et al., 2002), 
electron spin resonance spectroscopy (ESR) (Bonomo et al., 2000), NMR spectroscopy 
(Viles et al., 1999; Yoshida et al., 2000; Janek et al., 2001; Luczkowski et al., 2002), 
mass spectrometry (Hornshaw et al., 1995b; Whittal et al., 2000; Kramer et al., 2001; 
Qin et al., 2002), voltammetry (Bonomo et al., 2000), potentiometry (Luczkowski et al., 
2002), Raman spectroscopy (Miura et al., 1996; Miura et al., 1999), equilibrium dialysis 
(ED) (Miura et al., 1996; Brown et al., 1997; Stockel et al., 1998; Miura et al., 1999), 
r 
infrared spectroscopy (FTIR) (Gustiananda et al., 2002), ana x-ray difraction (Bums et 
,._,_ 
al., 2002). 
These have used a range of synthetic and cloned peptides containing different numbers 
of repeats with either consensus (Hornshaw et al., 1995a; Hornshaw et al., 1995b; Miura 
et al., 1996; Smith et al., 1997; Miura et al., 1999; Bonomo et al., 2000; Yoshida et al., 
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2000; Bums et al., 2002; Gustiananda et al., 2002; Luczkowski et al., 2002) or actual 
sequences (Brown et al., 1997; Stockel et al., 1998; Viles et al., 1999; Aronoff-Spencer 
et al., 2000; Whittal et al., 2000; Cereghetti et al., 2001; Jackson et al., 2001; Kramer et 
al., 2001; Bums et al., 2002; Qin et al., 2002; Garnett and Viles, 2003) from mammals 
or chicken, or full-length mammalian protein (Stockel et al., 1998; Viles et al., 1999; 
Cereghetti et al., 2001; Kramer et al., 2001; Qin et al., 2002). There is also one 
publication using marsupial consensus-repeat peptide (Gustiananda et al., 2002). 
1.5.1. Structure of PrP repeats in the absence and presence of copper ion 
There are some discrepancies in the reported structure of repeat regions of PrP and the 
effect of copper ion addition on the structure, as summarized in Table 1.2. In the 
i 
absence of copper, CD (Hornshaw et al., 1995a; Viles et al., 1999; Bonomo et al., 2000; 
Whittal et al., 2000), Raman (Hornshaw et al., 1995a; Miura et al., 1996; Viles et al., 
1999; Bonomo et al., 2000; Whittal et al., 2000), and FTIR spectroscopy (Gustiananda 
et al., 2002) have shown that the repeat region is unstructured. This result is consistent 
with the NMR structure of full-length PrP (see previous section), which shows the 
repeat region is unstructured (Donne et al., 1997; Riek et al., 1997; Lopez Garcia et al., 
2000; Zahn et al., 2000). However, another CD study reports the presence of non-
random structure similar to the poly-L-proline type II left handed helix (Smith et al. , 
199_7). An NMR study of cyclic and linear peptides containing a consensus octarepeat 
sequence suggests certain residues within the repeats adopt loop and P-tum structure 
(Figure 1.3) (Yoshida et al., 2000). It has been suggested that the inconsistency within 
the CD results is due to the high proportion of Trp, which can contribute to CD spectra 
in the far UV region (Whittal et al., 2000). However, the fact that peptides used in both 
CD experiments (Smith et al., 1997; Whittal et al., 2000) have similar number of Trps 
argues against this explanation. 
Copper binding to octarepeat peptides has been reported to induce the formation of a-
helix structure, as probed by Raman spectroscopy (Miura et al. , 1996) and infrared 
spectroscopy (Gustiananda et al., 2002), in disagreement with one CD study which 
suggests no structural changes upon addition of copper (Hornshaw et al., 1995a). Yet, 
other CD experiments suggest the presence of turns and structured loop resulting from 
copper addition to repeat peptides (Hornshaw et al., 1995a; Viles et al., 1999; Bonomo 
et al., 2000; Whittal et al., 2000). 
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Table 1.2: Structure of PrP repeats in the presence and absence of copper. 
Author Peptide Methods No copper Plus copper 
Hornshaw et al., 1995a Sc CD unstructured unstructured 
Smith et al., 1997 Sa CD PP II helix Not done 
Viles et al., 1999 Sa (capNC) CD unstructured Tums & structured loop 
Whittal et al., 2000 Sa CD unstructured Tums & structured loop 
Bonomo et al., 2000 Sc (capNC) CD unstructured Tums & structured loop 
Yoshida et al., 2000 Sc (cyclic) NMR Loop and ~-tum Not done 
Miura et al., 1996 Sc Raman unstructured a-helix 
Sc: synthetic peptide of consensus sequence; Sa: synthetic peptide of actual sequence; 
capNC: peptides are blocked at the N-terminus with an acetyl group and at the C-
terminus with an amide. 1 
The discrepancy in CD results is suggested to be due to the type of buffer used in the 
experiments (Viles et al., 1999). It is suggested that the use of Tris HCl buffer in the 
experiment of Hornshaw (1995a) will prevent copper binding to the peptides, as buffer 
components will compete successfully for copper ion. 
. ' Figure source: Yoshida et al. (2000) ·- _ 
Figure 1.3: Solution NMR structure of PrP-octarepeat peptide according to Yoshida et 
al. (2000). Octarepeat peptide (1 PHGGQWGQ8; note the numbering of residue is 
different from that in the figure) adopts a loop (2HGGGW6 segment) and P-tum 
(5GWGQ8 segment) conformation. ~.-
The discrepancy between CD and Raman ( or FTIR) results may be due to several 
reasons such as peptide concentration and sample preparation method. In Raman and 
FTIR spectroscopy, peptide concentrations are in the mM range, while in CD 
spectroscopy they are in the µM range, i.e. 3 orders of magnitude lower. It may be that 
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in the presence of copper, there is a different copper-complex structure for different 
concentrations of peptide and copper. During sample preparation, in order to avoid 
copper precipitation as copper hydroxide at pH higher than 6.0 (Brown et al., 1997), 
samples for Raman (Miura et al., 1996) and FTIR (Gustiananda et al., 2002) study are 
prepared in the following way. The peptide solution is brought to pH around 9.0 
(H.Takeuchi, personal communication) (Miura et al., .1996) or 12.0 (Gustiananda et al., 
2002), copper solution is added, and then the pH of the solution is brought to the desired 
value by adding HCI. It is possible that complex prepared in this way will have 
different structure compared with complex where copper ion is added to neutral or 
slightly acidic peptide solution and the pH is increased by adding base solution later. 
The reason for this is probably due to differences in the copper-binding mode. High pH 
(basic) promotes more binding to the peptide backbone (pKa > 15 (Creighton, 1983)) 
while low pH (neutral or slightly acidic) enables the binding only to the His residue 
(pKa 6.2 (Creighton, 1983)). 
Top vlows Side views 
l2J (lt 
Figure source: Jackson et al.(2001) 
Figure 1.4: Copper-binding n1odes in PrP-octarepeat peptide according to Jackson et al. 
(2001). Copper-binding modes presented as five energetically identical space-filled 
n1odels in top and side views. In this model, copper ion (yellow, center) is proposed to 
coordinate four His side chains (blue), based on the assumption that the tight binding 
sites (femtomolar Kci) should be constructed from four imidazole ring side chains of His 
residues. Green and gray represent the backbone atoms and the remaining side chain, 
respectively. The diversity of the conformations suggests that copper binding will not 
induce one single fixed conformation although it does induce more compact structure. 
Although most studies show copper binding induces some structural changes to become 
more compact, it does not force the peptide to adopt a single fixed conformation. A 
diversity of molecular models of the complex have been suggested (Figure 1.4) 
(Jackson et al., 2001). The formation of more ordered structure upon addition of copper 
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could be crucial for protection of the N-terminus of PrP against accidental proteolysis 
(Whittal et al., 2000). However, since the functions of the repeat region and the whole 
PrP protein itself are still unclear, it is not known whether the copper complex needs to 
have a defined conformation that will interact with some other molecule specifically, or 
have diverse conformations that will allow it to carry out different tasks and interact 
with several different molecular machineries inside and outside the cell. It is also 
unclear whether or not copper binding to the repeat region induces structural changes in 
the rest of the protein. So far results are available only from short synthetic peptides 
and it is difficult to apply them to full-length PrP. Stockel et al. (1998) observed Trp 
fluorescence quenching upon copper addition to ShaPrP29-231. However, it is not 
possible to draw conclusions about changes in the tertiary structure environment of Trp 
residues in the folded domain as it is not possible to say whether only some or all the 
r 
quenching is due to copper binding to the repeats. 
1.5.2. Dissociation constant (Ki) of copper binding to PrP repeats 
The reported Kct range for copper binding to synthetic or recombinant peptides, both 
consensus sequence (Hornshaw et al., 1995a) and actual sequence (Brown et al., 1997; 
Viles et al., 1999; Whittal et al., 2000; Kramer et al., 2001; Garnett and Viles, 2003) is 
in the µM range (Table 1.3). This is in good agreement with the binding to full-length 
protein (Stockel et al., 1998) but differs from one binding study, which reported a Kt 
value in the fM range (Jackson et al., 2001). 
Jackson et al. (2001) argue that the µM range of Kct implies copper interaction with PrP 
repeats is extremely weak. They expect that given the octapeptide repeat region has 
five His side chains, its interaction with copper should be comparable with the 
interaction of copper with simple 1nolecules such as four independent imidazole groups 
(Kct is 30 fM) or malonate (Kct is 10 nM). The femtomolar Kt value is obtained from 
Trp fluorescence quenching and Gly competition experiments. According to Jackson et 
al. (2001), the Gly competition will abolish weak binding and weaken tight binding 
between copper ion and the peptide, so that the Kct of the tight site, which is 10-14 M 
after the competitive buffering effect of Gly is taken into account, can be measured 
accurately (Jackson et al., 2001). This femtomolar Kct, however, should be contrasted 
with other findings. 
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It can be argued that the Ki for copper binding to the peptide should not be compared 
with the binding to simple molecules because the binding to simple molecules will not 
be hindered by steric effects, as likely for peptides. Thus, even though the PrP 
octarepeat peptides may have four or more His residues, it is unlikely that the affinity 
will be in the same order of magnitude as those with small ligands. Furthermore, the 
physiological concentration of total copper in plasma is 18.6 µM (quoted in Kramer et 
al., 2001). 65% is bound to ceruloplasmin in a nonexchangeable way and around 8.3 
µM is bound in an exchangeable way to various proteins and amino acids. In the 
cerebrospinal fluid, copper concentration ranges from 0.5 to 2.5 µM, while in 
specialized areas such as synapses it is around 15 µM (Kramer et al., 2001). Thus, the 
fM copper-binding affinity is not necessary to be considered as physiologically relevant. 
Also, the use of Gly as a competitor to elucidate the tight binding site in copper binding 
study has been challenged (Garnett and Viles, 2003). The CD experiment shows that 
Gly competes strongly with copper ion, indicating that the affinity of the copper for 
PrP-repeat peptide is less than that of copper for Gly, for which the Kd is 12 nM. 
Together, these results suggest that the fM Ki value of copper binding to PrP-repeat 
peptides may be an error. 
One speculation about the µM affinity for copper is that PrP may be similar to the 
glucose transporter whose Kd value is within glucose concentration in the blood and is 
exceptionally sensitive in that range. Thus, PrP may act as a cuprostat, which activates 
cellular machinery in response to changes in ambient copper concentration (Bums et al., 
2002). 
Although there is good general agreement (except Jackson et al. (2001)) among values 
measured for Ki's in the µM range, the precise values differ significantly. The 
disagreement in the Kd values (Table 1.3) is due not only to variation in the 
experimental conditions (pH, buffer co1nponent, and temperature), peptide sequence, 
and whether or not they are terminally capped (some peptides were N- and C-terminally 
capped (Viles et al., 1999; Garnett and Viles, 2003), while others remained uncapped), 
but also because copper binding to PrP repeats is not a simple system. A number of 
problems are encountered, originating from experimental (technical) factors as well as 
the nature of the repeat itself. 
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Table 1.3: Dissociation constants of copper binding to PrP repeats 
Author Methods Peptide Peptide pH Kct (µM) 
Cone (µM) 
Hornshaw et al., 1995a Fluorescence Sc mammalian: (PHGGGWGQ)4 0.215 PBS pH 7.4 6.7 
Sc avian: (NPGYPH)4 1.148 PBS pH 7.4 4.5 
Brown et al., 1997 ED Ra HuPrP23_9s 2.7 NEM pH 7.4 5.9 
Stockel et al., 1998 ED Rfl SHaPrP29-231 2.5 MES pH 6.0 14 
Fluorescence Rfl SHaPrP29-231 1.68 MES pH 6.0 14 
Viles et al., 1999 CD Sa (capNC) SHaPrP51 _75 : PQGGGTWGQ(PHGGGWGQ)2 34 No buffer pH 7.5 6.0 
Whittal et al., 2000 ESIMS Sa ShaPrP73_91: WGQ(PHGGGWGQ)2 10 AmOAcpH6.0 2.2; 69 
Sa ShaPrPs7-91: WGQ(PHGGGWGQ)4 10 A.In OAc pH 6.0 0.7; 6.3; ~200 
Am OAcpH 7.4 0.2; 0.7; 2.5; 12 
Sa ShaPrP57_98: WGQ(PHGGGWGQ)4GGGTHNQ 10 A.In OAc pH 6.0 1.0; 6.0; 70 
A.In OAc pH 7.4 1.7; 0.5; <0.1 ; <0.1; 4.3 
Sa ShaPrP23_9g 10 A.In OAc pH 6.0 1.5; 2.8; 55 
Am OAc pH 7.4 2.2; 0.5; <0.1; <0.1; ~5 
Kramer et al., 2001 Fluorescence Sa: HuPrP 60-9 1: (PHGGGWGQ)4 0.17 MOPS pH7.2 
-d; [5.5] 
Sa: HuPrP60-109: (PHGGGWGQ)4GGGTHSQWNKPSKPKTNM 0.145 MOPS pH 7.2 8.8; [2.5] 
Ra: HuPrP23_9g 0.125 MOPSpH7.2 1.4; [2.2] 
Ra: HuPrP23_112 0.120 MOPS pH 7.2 2.4; [2.2] 
Rfl: MurPrP23_231 0.0-85 MOPS pH7.2 1.8; [2.2] 
Jackson et al., 2001 Fluorescence Sa HuPrP52_98 : QG(GGGWGQPH)4GGGWGQGGGTHSQ 5 MOPS pH 8.0 3.2; 8 fJv1 
Garnett & Viles, 2003 CD Sa (capNC) HuPrPss-91: GQ(PHGGGWGQ)4 10 NEMpH7.5 Between 10 and 0.0 1 
Sc: synthetic peptide of consensus sequence; Sa: synthetic peptide of actual sequence; Ra: recombinant peptide of actual sequence; Rfl: recombinant of 
full-length protein; capNC: peptides are blocked at the N-tenninus with an acetyl group and at the C-terminus with an ainide. PBS: phosphate buffer 
saline, NEM: N-ethyhnorpholine, MES: 2-(N-inorpholino)ethanesulphonic acid, Am Oac: ammonium acetate, MOPS: 3-(N-
inorpholino)propanesulphonic acid. Values in brackets [] show dissociation constant for cooperative sites (Kramer et al., 2001). -d means that Ki 
values for individual sites are not available as all sites bind copper ion cooperatively. The sequence of :Ki values reported by Whittal et al. (2000) is for 
the first, the second, the third, etc. copper binding to the peptide. 
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The experimental (technical) factors are described as follows .· (1) The type of buffers 
used in the binding study. It is reported that some buffers such as Tris form complexes 
with copper ions and, thus, will compete very successfully for copper ions, while N-
ethylmorpholine, phosphate, and acetate do not (Viles et al., 1999; Garnett and Viles, 
2003). (2) Although apo-peptide is soluble, its copper complex may not be as soluble, 
espescially at high concentration. 3) Cropper has a very low solubility at pH higher than 
6.0, where it precipitates as copper hydroxide. In one experiment, copper 10n was 
supplied as Cu(Gly)2 to overcome this problem (Brown et al., 1997). 4) It is reported 
that the solubility of 5 mM octarepeat peptide reduces significantly upon addition of 
copper ion (Viles et al., 1999). However, 10 times dilution to <0.5 mM will re dissolve 
the precipitating material. 
The influence of the nature of the repeat itself is illustrated as follows. First, the repeats 
region of PrP is a dynamic system with high backbone flexibility (Viles et al., 2001). 
Inconsistency in the reported structure of repeats in the literature leads to the conclusion 
that it does not adopt only one conformation, but more likely has a range of 
conformations, which will be dictated by its environment. As noted in section 1.5 .1 
solution NMR structures of octarepeat show loop and P-tum structure, which, the 
authors suggested, is in rapid equilibrium with random coil (Yoshida et al., 2000). 
Therefore, the initial conformation of the peptide just before it binds copper ion could 
be different from one condition to another, which is the case for experiments done in 
different laboratories with different peptide concentration, buffer components, pH and 
temperature. Thus, the initial conformational distribution of the repeat peptide could 
dictate its copper-binding properties. Second, copper binding to PrP repeats is 
completely different from a folded metalloprotein, where the site for metal binding is 
preorganized and dictated by the compact protein conformation. As PrP repeats adopt a 
range of conformations, there are no single preorganized sites for the first copper ions to 
bind. The sites for copper binding will likely vary depending on the experimental 
conditions (the copper-binding sites will be discussed further in section 1.5 .4). Thus, 
measured copper-binding affinities can be expected to vary. 
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1.5.3. Stoichiometry of copper binding to PrP repeats 
To some extent there is good agreement in the literature regarding the stoichiometry and 
cooperativity of copper-ion binding to the N-terminal segment of PrP, while results for 
binding to full-length protein still show apparent inconsistencies (Table 1.4). The 
reported stoichiometry for octarepeat peptide is 1: 1 copper per octarepeat at pH above 
7.0 (Hornshaw et al., 1995b; Brown et al., 1997; Miura et al., 1999; Viles et al. , 1999; 
Aronoff-Spencer et al., 2000; Whittal et al., 2000; Kramer et al. , 2001 ; Garnett and 
Viles, 2003) with some exceptions: Viles et al. (1999) reported stoichiometry of 1 :2, 
while NMR Jackson et al. (2001) reported 1:4 copper per octarepeat. However, recently 
Viles, now working independently, confirmed that the stoichiometry is indeed 1: 1 
(Garnett and Viles, 2003). 
Table 1.4 shows that the octapeptide region appears to bind up to five copper ions 
cooperatively. The Hill cooperative coefficient was reported to be 3.4 in PrP23_9g 
(Brown et al., 1997). A similar number was noted for PrPss-91 (3.3 copper ions bound 
cooperatively) (Viles et al., 1999; Garnett and Viles, 2003). Also, Whittal et al. (2000) 
reported results from ESI MS indicating the positive cooperativity of the binding of the 
second, third, and fourth copper ion to ShaPrPs7-98 and ShaPrP23_9g. Another ESI MS 
study revealed 3.7, 3.6, and 3.7 copper ions bind cooperatively to HuPrP60-l09, HuPrP23_ 
98, and HuPrP23_112 respectively (Kramer et al., 2001). 
As mentioned, there is disagreement as to the stoichiometry of copper binding to full-
length mammalian PrP. This could be due to differences in pH. ShaPrP29-23 1 was 
reported to bind only two copper ions at pH 6.0 (Stockel et al., 1998), which suggests 
two octarepeats are necessary to bind a single copper ion. However, it is also possible 
that one copper ion bound at the post-repeat region (Cereghetti et al. , 2001 ; Hasnain et 
al., 2001; Jackson et al., 2001; Jobling et al., 2001). Full-length mammalian PrP from a 
different species (MurPrP23_23 1) binds up to 5 copper ions at pH 7.4 (Kramer et al. , 
2001), which suggests each octarepeat binds one copper ion. The pH dependency of the 
copper-binding stoichiometry was confirmed by ESI MS (Whittal et al. , 2000). It is 
reported that a peptide containing four octarepeats binds two copper ions at pH 6.0 but 
four at pH 7 .4. 
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Table 1.4: Stoichio1netry of copper binding to PrP repeats 
Author Methods Peptide Peptide pH Nu1nber of Cooperativity 
Cone Copper botmd 
(µM) 
Homsha w et al., MALDI Sc 1nammalian: (PHGGGWGQ)3 10 Not specified 3 (1 Cu per repeat) Not specified 
1995b TOFMS Sc 1nainmalian: (PHGGGWGQ)4 10 Not specified 4 (1 Cu per repeat) Not specified 
Sc avian: (NPGYPH)3 10 Not specified 3 (1 Cu per repeat) Not specified 
Sc avian: (NPGYPH)4 10 Not specified 4 (1 Cu per repeat) Not specified 
Brown et al., 1997 ED Ra HuPrP23_9g 2.7 NEM pH 7.4 5. 6 ( 1 Cu/repeat+ 1. 6 Cu) 3.4 
Stockel et al., 1998 ED Rfl SHaPrP29-231 2.5 MESpH6.0 2 (1 /2 Cu per repeat) 0 
Viles et al., 1999 CD Sa (capNC) SHaPrP51 _75 : PQGGGTWGQ(PHGGGWGQ)z 34 No buffer pH 7.5 1 (1 /2 Cu per repeat) 0 
Sa (capNC) ShaPrP66-91: GQ(PHGGGWGQ)3 21 No buffer pH 7.5 3 (1 Cu per repeat) 2.4 
Sa (capNC) ShaPrP5s-91: GQ(PHGGGWGQ)4 , 33 No buffer pH 7.5 4 (1 Cu per repeat) 3.3 
Miura et al., 1999 Rainan Sf ( capN): PHGGG 20mM No buffer pH 8.2 1 Not specified 
Sc ( capN) 1na1nmalian: PHGGGWGQ 20mM No buffer pH 8.2 1 (1 Cu per repeat) Not specified 
Sc (capN) 1nammalian: (PHGGGWGQ)2 201nM No buffer pH 8.2 2 (1 Cu per repeat) Not specified 
Sc (capN) 1na1nmalian: (PHGGGWGQ)4 20mM No buffer pH 8.2 4 (1 Cu per repeat) Not specified 
Aronoff-Spencer et CD Sc mammalian ( capNC): PHGGGWGQ 398 NEM-pH 7.4 1 (1 Cu per repeat) Not specified 
al., 2000 Sa (capNC) HuPrP23_2s, 73_91: KKRPKPWGQ(PHGGGWGQ)2 333 NEM pH 7.4 2 (1 Cu per repeat) Not specified 
Sa (capNC) HuPrP23_zs, 57_91: KKRPKPWGQ(PHGGGWGQ)4 51 NEM pH 7.4 4 (1 Cu per repeat) Not specified 
EPR Sc mammalian ( capNC): PHGGGWGQ 1000 NEM pH 7.4 1 (1 Cu per repeat) Not specified 
Sa ( capNC) HuPrP23_2s, 73_91 : KKRPKPWGQ(PHGGGWGQ)2 500 NEMpH 7.4 2 (1 Cu per repeat) Not specified 
Sa ( capNC) HuPrP23_2s, 57_91: KKRPKPWGQ(PHGGGWGQ)4 250 NEM pH 7.4 4 (1 Cu per repeat) Not specified 
Whittal et al. , 2000 ESIMS Sa ShaPrP73_91: WGQ(PHGGGWGQ)z 10 AmOAcpH 6.0 2 (1 Cu per repeat) Not specified 
Sa ShaPrP57_91: WGQ(PHGGGWGQ)4 10 Am OAcpH 6.0 2 (1 /2 Cu per repeat) Not specified 
A.in OAc pH 7.4 4 (1 Cu per repeat) Not specified 
Sa ShaPrP57_93: WGQ(PHGGGWGQ)4GGGTHNQ 10 A.in OAc pH 6.0 3 (3/4 Cu per repeat) Not specified 
Am OAc pH 7.4 5 (1 Cu/repeat+ 1 Cu) 3 
Sa ShaPrP23-98 10 A.in OAc pH 6.0 3 (3/4 Cu per repeat) Not specified 
Am OAc pH 7.4 5 ( 1 Cu/repeat + 1 Cu) 3 
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Kramer et al., 2001 ESIMS Sa: HuPrP 60-91 : (PHGGGWGQ)4 20 NEM pH 7.4 4 (1 Cu per repeat 2.4 
Sa: HuPrP 60_109: (PHGGGWGQ)4GGGTHSQWNKPSKPKTNM 10 NEMpH 7.4 5 (1 Cu/repeat+ 1 Cu) 3.7 
Ra: HuPrP23_9g 10 NEM pH 7.4 6 (1 Cu/repeat + 2 Cu) 3.6 
Ra: HuPrP23_1 12 10 NEMpH 7.4 5 ( 1 Cu/repeat + 1 Cu) 3.7 
Ra: MurPrP121-231 13 NEM pH 7.4 1 Not specified 
Rfl: MurPrP23-231 10 NEM pH 7.4 5 ( 1 Cu/repeat + 1 Cu) 4.2 
Garnett & Viles, CD Sf ( capNC): HGG 50 NEMpH7.5 0.5 None 
2003 Sf(capNC): HGGG 50 NEMpH7.5 1 None 
Sf(capNC): HGGGW 50 NEMpH7.5 1 None 
Sa ( capNC) HuPrPg3_91 : QPHGGGWGQ 50 NEMpH7.5 1 (1 Cu per repeat) None 
Sa (capNC) HuPrP7o_g3 : GGGWGQPHGGGWGQP 50 NEMpH7.5 1 (1 Cu per repeat) None 
Sa (capNC) HuPrP73 _91: WGQ(PHGGGWGQ)2 50 NEMpH7.5 2 (1 Cu per repeat) Slight coop 
Sa (capNC) HuPrP66-91 : GQ(PHGGGWGQ)3 50 NEMpH7.5 3 (1 Cu per repeat) 2.4 
Sa (capNC) HuPrP5g_91: GQ(PHGGGWGQ)4 50 NEMpH7.5 4 (1 Cu per repeat) 3.3 
Sc: synthetic peptide of consensus sequence; Sa: synthetic peptide of actual sequence; Sf: synthetic peptide of fraginent octarepeat; Ra: reco1nbinant 
peptide of actual sequence; Rfl: recombinant full-length protein; capNC: peptides that are blocked at the N-terminus with an acetyl group and at the C-
tenninus with an amide group; capN: peptides that are blocked at the N-terminus with an acetyl group. 
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The pH dependency of the copper-binding stoichiometry is strongly linked to its 
binding sites. There is now much evidence to suggest that the imidazole side chain of 
the His residues is a major binding site for the copper ions (Viles et al., 1999; Bonomo 
et al., 2000; Qin et al., 2002). As protonation of the imidazole ring will inhibit copper 
binding to His, the stoichiometry of the binding will be pH-dependent. Raman 
spectroscopy provides one line of evidence for the differences in binding modes that 
eventually lead to differences in stoichiometry (Miura et al., 1999). It is reported that at 
pH 6.0, the copper-binding site of His switches from the nitrogen Nrr to the N1: to share a 
single copper ion between two His residues of different peptide chains. A review of 
copper-binding sites will be given in the following section. 
1.5.4. Copper coordination in PrP repeats 
How ligands coordinate in the complex is the key issue of all binding studies, as the 
coordination mode underpins the other properties of the complex such as the Ki and 
stoichiometry. Copper coordination in PrP repeats has been studied either directly or 
indirectly, or by a combination of both. Indirect study may be carried out by several 
approaches: measuring the effect of specific protein side chain modifications on metal 
binding, titrimetric determination of the pKas of the ligand groups involved, and 
correlation of protein-metal ion spectra with those of appropriate model systems. Direct 
study includes direct observation of the complex by X-ray crystallography, and NMR 
studies (Breslow, 1973). It is also possible to combine the experimental data with 
computational and n1olecular dynamics simulations to search for possible models of the 
complex. 
Several models of PrP repeats copper complexes has been reported in the literature. All 
models were deduced from spectroscopic properties of complexes in solution, 
sometimes combined with homology modelling using other protein with copper-binding 
sites (Stockel et al., 1998), with one exception where the model was from X-ray 
crystallography data (Bums et al., 2002). All models agree that the imidazole side chain 
of the His residues is the major binding site for copper ions. However, the other binding 
sites for a given copper ion may vary, and this could be due to differences in the peptide 
fragments used (Luczkowski et al., 2002). 
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Figure source: Stockel et al. (1998) 
Figure 1.5: Copper-binding mode in PrP-octarepeat peptide according to Stockel et al. 
(1998). One copper ion coordinates two N1 atoms of the imidazole ring of His2 residues 
and two oxygen atoms of the Gly4 carbonyl of the peptide backbone (note · the 
numbering of residue: 1PHGGGWGQ8). Figure was taken from Stockel et al., 1998, 
with some changes in size and colour. 
To account for stoichiometry of 2 copper ions bound in ShaPrP29_231 at pH 6.0, a model 
with square planar geometry was proposed (Figure 1.5). Copper ion is coordinated by 
two His residues and two oxygen main chain Gly carbonyl group, with each His and 
Gly coming from different repeats (Stockel et al., 1998). While His involvement is 
inferred from pH titration experiments, the involvement of Gly amide oxygens is not 
based on any spectroscopic evidence but rather on the proposed structure, which is 
based on sequence homology with sialidase enzyme, in which homologous residues 
form a loop structure. Hence, this suggestion has been contested and it may not be 
correct for pH > 4.0 or at physiological pH where backbone amide coordination is 
suggested to dominate (Viles et al., 1999). Although it comes from a different residue, 
the involvement of the oxygen amide from the Trp residue is indicated by EPR spectra 
at pH 7.45 (Aronoff-Spencer et al., 2000). Furthermore, the XRD structure of the 
copper PrP octarepeats complex clearly indicates the copper ion coordinates the oxygen 
amide of the Gly located on the C-terminal side of His (Bums et al., 2002). 
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Figure source: Viles et al. (1999) 
Figure 1.6: Copper-binding mode in PrP-octarepeat peptide according to Viles et al. 
(1999). (A) In 2 His peptide (PrP16-86), one copper ion coordinates N1 atom of 
imidazole ring of His77, Nrc atom of His85, nitrogen atom of His amide of peptide 
backbone, and water molecule. The complex geometry is square planar with all four 
ligands in equatorial position. (B) In 4 His peptide (PrP5g_91), similar copper-
coordination sphere is adopted. Note that each copper ion binds 2 His residues and both 
N1 and Nrc atoms of the imidazole ring of His participates in the binding forming the 
copper-bridging imidazolate. 
As noted earlier, Viles et al. (1999) argue for the involvement of the Gly carbonyl 
backbone in copper binding. A model is proposed based on 1 H NMR and copper ESR 
spectra of PrP76_86 (peptide has two His residues), which binds only one copper ion. In 
this model both His residues coordinate to the same copper ion along with nitrogen 
atoms from the backbone amide of the more C-terminal His residue. A water molecule 
is attached as a final ligand to make the four-coordinate square planar copper complex 
(Figure 1.6 (A)). A model (Figure 1.6 (B)) was also proposed for the copper complex 
of PrP 58-91, which contains four His residues and measured stoichiometry 1: 1 
copper/ octarepeat. In this model, four His residues in successive octarepeats form a 
bridged-copper complex, with the Nrc and N1 atom of the imidazole nitrogens from each 
His coordinating two adjacent copper ions (Cu-Nrc[His]N1-Cu). The amide nitrogen of 
His residue and oxygen atoms from four water molecules also participate in the binding. 
Viles et al. (1999) suggest the formation of a copper-bridging imidazolate in this 
structure (Figure 1.6.B) can also provide an explanation for the observed cooperativity 
of copper ion binding to PrP 58_91 . It is suggested that chelation of the first copper ion to 
the Nrc atom lowers the pKa of the N1H enabling the coordination of a second copper ion 
to the same His residue. Further, Viles et al. (1999) suggest that as the first copper ion 
coordinates two imidazoles, only two further imidazoles are needed to bind the next 
three copper ions. After the third copper binds, the fourth copper will have an entirely 
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preorganized site. However, it should be noted that this copper-bridging imidazolate in 
the copper complex of peptide containing 4-tandemly octarepeats failed to be detected 
by EPR (Aronoff-Spencer et al., 2000) and was only weakly observed by Raman spectra 
(Miura et al., 1999). 
There are also some weaknes·ses in the model of Viles et al. (1999). Copper binding to 
a His side chain will induce the ionization of a nearby amide group (Miura et al., 1999). 
It is less likely that copper will bind to the imidazole ring of His, which is the primary 
ligation site, and then to an a1nide nitrogen of the His residue located at the more C-
terminal side. This mode of binding results in a less compact arrangement of the 
primary ligation site (imidazole ring of His) and amide nitrogens, whereas, as Miura et 
al. (1999) suggest, metal chelation requires a compact arrangement (Miura et al., 1999). 
Viles et al. proposed this model to take account of the 1 :2 copper/octarepeat 
stoichiometry, which later on has been revised (Garnett and Viles, 2003). 
1636 crrc1 
{1605 cm·1 ) 
Figure source: Miura et al. (1999) 
Figure 1.7: Two tautomeric forms of the imidazole side chain of His in its copper-free 
and copper-complex form. The band frequency is for the C4=C5 bond vibration of the 
imidazole ring of His in copper-free and complex form (see figures). The values in 
brackets ( ) represent the same band frequency in 2H2O solvent. 
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Although there is enough experimental evidence to support ·His as a maJor copper-
binding site, the nitrogen atom that participates in the binding of copper ions is 
identified experimentally only by Raman spectroscopy. Note that the imidazole side 
chain has two tautomeric forms, dependent on which nitrogen atom binds the hydrogen. 
The tautomerism of the imidazole ring and its corresponding Raman frequency is shown 
in Figure 1. 7. Apart from .His coordination, Raman spectroscopy also shows that 
nitrogen atoms of deprotonated main-chain amides, rather than oxygen atoms of the 
HGGG segment, are the copper-binding sites (Figure 1.8) (Miura et al., 1996; Miura et 
al., 1999). This is in good agreement with the P,revious model of Viles et al. (Viles et 
al., 1999). 
Figure source: Miura et al. (1999) 
Figure 1.8: Copper-binding mode in PrP-octarepeat peptide according to Miura et al. 
(1999). At neutral and basic pH the 1PHGGG5 segment binds copper ion via the Nrr 
atom of the imidazole ring of His2, two nitrogen atoms of the amide backbone of Gly4 
and Gly5, which occupy three out of four tetragonal ligand positions. A water molecule 
(not shown) occupies the fourth position. 
As noted earlier, binding properties such as stoichiometry and ligand binding sites 
depend on the pH of the solution. Raman spectroscopy shows that at pH > 6.4, one 
copper ion binds to the imidazole Nrr atom of the His residue together with two 
deprotonated main chain amide nitrogens from the second and third Gly residues in the 
triglycine segment. At pH 6.o,· one copper ion binds two imidazole N1 atoms where 
each comes from different peptide chains (Miura et al., 1999). 
Also as mentioned previously, Raman spectroscopy detected the presence of a weak 
band due to a copper-bridging imidazolate in the copper complex of a 4-octapeptide 
repeat. This band suggested that some of the His residues are coordinating to copper 
ions via both N1: and Nrr atoms. - This result leads to the suggestion for two forms of 
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copper complex of 4-octapeptide tandem repeat at neutral and basic pH: the extended 
and the folded forms. In the extended form, copper ion binds the His Nn atom and 
deprotonated amide nitrogens of the second and third Gly residue, and the fourth ligand 
may be a water molecule. Copper complexes of 1-octarepeat and 2-octarepeat peptides 
also adopt this mode of binding. In the folded form, the fourth ligand may be a His N-r 
atom of another octapeptide unit to produce the Cu-N-r(His)Nn-Cu (copper-bridging 
imidazolate) structure. 
The next model (Figure 1.9) was proposed by Aronoff-Spencer et al. (2000). It includes 
the nitrogen atom of His and two amide nitrogens from the first and second Gly after the 
His residue, while the fourth ligand is the amide carbonyl oxygen of the Trp residue 
more C-terminal in the repeat (Figure 1.9). The involvement of the amide nitrogen of 
the first Gly residue is in contrast to the three models previously proposed by Stocket et 
al. (1998), Viles et al. (1999) and Miura et al. (1999) (see section above), but in good 
agreement with the XRD structure of the PrP copper-repeats complex (Bums et al., 
2002). However, the XRD structure indicates carbonyl oxygen comes from the second 
Gly residue rather than from Trp residue . 
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Figure source: Aronoff-Spencer et al., (2000) 
Figure 1.9: Copper-binding mode in PrP-octarepeat peptide according to Aronoff-
Spencer et al. (2000). The · dominant EPR-active binding modes of octarepeat 
(1PHGGGWGQ8) at pH > 7.0 shows that coordination in the equatorial plane arises 
from the Nn atom of the imidazole ring of His2, two nitrogen atoms each from the 
peptide backbone of Gly3 and Gly4 amides, and an oxygen atom from backbone 
carbonyl of the Trp6 residue. 
The crystal structure (Figure 1.10) also revealed that copper is coordinated by the His 
imidazoles, deprotonated amides from the next two Gly residues within the HGGGW 
segment, and one peptidic oxygen from Gly3, all in the equatorial position. The Trp 
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indole also participates through a hydrogen bond to the axially coordinated water 
molecule. This structure is consistent with the EPR signals. It is also suggested that the 
HGGGW segment provides a five-ligand coordination (pentacoordination) environment 
as often found for copper complexes. Therefore, with regard to the binding to multiple 
octarepeats, EPR demonstrates that the identified structure is maintained in the full PrP 
4-octarepeat domain (Bums et al., 2002). Thus, consistent with the previous study of 
Aronoff-Spencer et al. (2000) this study also does not detect the formation of a copper-
bridging imidazolate in multiple octarepeat peptides, but rather each individual 
octarepeat binds a single copper ion within the HGGGW unit. 
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Figure source: Bums et al. (2002) 
Figure 1.10: Copper-binding mode in PrP-octarepeat peptide according to Bums et al. 
(2002). The crystal structure of the copper-complex of 1 HGGGW5 segment of 
octarepeat shows copper pentacoordination in which 4 ligands are equatorially ligated 
and one water molecule is attached in the axial position. Four equatorial ligands are: Nrc 
atom of the imidazole ring of His 1, two peptidic nitrogen atoms each from Gly2 and 
Gly3, and one peptidic oxygen from Gly3. This model also shows that an axially-bound 
water molecule is hydrogen bonded to the nitrogen atom of the indole ring side chain of 
the 5Trp residue. This figure was taken from Bums et al. with some changes in size and 
colour. 
Another type of pentacoordination is reported to allow copper complexes of octarepeat 
peptide to adopt a ~-tum conformation (Bonomo et al., 2000). In this model, at neutral 
pH (Figure 1.11 a and c) the copper complex forms a square pyramid with one copper 
ion coordinating a water molecule, two peptidic nitrogen and one imidazole nitrogen all 
in equatorial position, while another peptidic nitrogen donor is linked at the apical 
position. At basic pH (Figure 1.11 b and d), the complex geometry is octahedral with 
hexacoordination from three peptidic nitrogens and one imidazole nitrogen, all 
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occupying the equatorial plane, while the two apical position·s are filled with a water 
molecule and another peptidic nitrogen. 
Figure source: Bonomo et al. (2000) 
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Figure 1.11: Copper-binding mode in PrP-octarepeat peptide according to Bonomo et 
al. (2000). · a) and b) represent the binding mode in Ac-HGGG-NH2 peptide at neutral 
and basic pH, respectively. c) and d) represent copper-binding mode in Ac-
PHGGGWGQ-NH2 at neutral and basic pH, respectively. 
The involvement of the amine terminal group in copper binding has been indicated 
earlier in ESI MS experiments of Whittal et al. (2000). The role of this group in 
determining the copper-binding mode in octarepeat peptide was further investigated 
using potentiometry, NMR, and EPR methods (Luczkowski et al., 2002). Different 
binding modes were observed for the peptide with and without the free imino terminal 
group. In the absence of the imino terminal group of Pro due to acetylation, at pH::::: 7.0, 
the copper ion binds 3 nitrogen ligands: the imidazole side chain of His2, the amide 
nitrogen of Gly3 and Gly4 (note the residue numbering: 1PHGGGWGQ8) (Figure 1.12) 
(Luczkowski et al., 2002). In the presence of imino Pro, the copper ion binds to the 
nitrogen atom of the imidazole ring of His2, the imino groups of Pro 1 at the N-terminus, 
and the amide nitrogen of the Gly3 residue. The involvement of the amide nitrogen of 
the Gly4 is detected only at higher pH. Protection of the N-terminal Pro nitrogen forces 
the copper ion to coordinate with the amide nitrogen on the C-terminal side of the His 
residue (i.e. third Gly) (Luczkowski et al., 2002). 
The specificity of the HGGGW segment in binding of copper ions has been 
demonstrated (Garnett and Viles, 2003; Luczkowski et al., 2003). The replacement of 
the GGG segment with AAA (in peptide HAAA W) reduces the copper-binding 
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stoichiometry, as found by CD, the complex formed is Cu(HAAA W)2 because of the 
reduction of potential for backbone coordination (Garnett and Viles, 2003). However, 
this result disagrees with EPR and potentiometry experiments of Luczkowski et al. 
(2003), which show that replacement of GGG with AAA or KKK does not change the 
coordination geometry or stoichiometry, but only reduces the stability of the complex. 
The formation of a Cu(HAAA W)2 complex with such stoichiometry implies that there is 
at least one amide coordination besides the imidazole coordination because, otherwise, 
the stoichiometry would be 1 :4, unless all other coordination is from water molecules. 
/ 
Figure source: Luczkowski et al. (2002) 
Figure 1.12: Copper-binding mode in PrP-octarepeat peptide according to Luczkowski 
et al. (2002). Copper-complex of octarepeat (Ac-1PHGGGWGQ8-NH2) has a distorted 
tetragonal geometry of coordination in which the Nrc atom of the imidazole ring of His2 
bound apically to the copper ion, along with subsequent peptidic nitrogens of Gly3 and 
Gly4 , which bound in the equatorial position. The copper ion bound three water 
molecules to complete the hexacoordinate complex. 
Which Gly residues are essential for a 1: 1 complex formation is the next question 
raised. The results with several segments of octarepeat peptides show that the 
stoichiometry is 1 :1 for Cu:HGGG but 1 :2 for HGG (Garnett and Viles, 2003). These 
data imply that the fourth Gly (note the numbering of the residue: 1HGGG4) is essential 
to maintain 1 :1 stoichiometry. The result of Garnett and Viles (2003), however, is 
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different from the X-ray crystallography data, which demonstrated copper can bind the 
HGG segment with 1: 1 stoichiometry, and that this segment is enough to make tetra 
coordination to copper (Bums et al., 2002). 
The large variation in copper coordination reported in the literature indicates that there 
is more than one stable copper-complex form that is feasible for octarepeat PrP. Thus, 
NMR structure studies would not be useful even if they could be done in the presence of 
the copper ion, and X-ray crystallography shows just one isolated form. As stated 
earlier, the nature of the repeat region is such that it does not provide one single fixed 
set of copper-binding sites. The sites and their .relative affinities are easily modified by 
the environment of the peptide, such as pH and the concentration ratio of copper and 
peptide. 
The effect · of pH on possible binding sites 1n the octarepeat peptide has been 
investigated by potentiometric titration. The results show that the more basic the 
solution, the more amide bond nitrogens participate in the binding (Luczkowski et al., 
2002). Higher ratios of copper ions over peptide (> 1) induce additional amide 
deprotonation and increase the number of amide bonds that participate in the binding, as 
demonstrated by Raman and visible absorption spectra (Miura et al., 1999). However, 
other experiments which varied the copper to peptide ratios at neutral pH, show that 
excess copper will not induce coordination from segments of octarepeat outside the 
HGGG segment. This implies the selectivity of the HGGG site (Bonomo et al., 2000). 
1.5.5. Copper binding to post-repeat region 
In addition to the N-terminal region of PrP, regions further towards the C-terminus have 
also been shown to interact with copper. Up to five copper ions bind to recombinant 
MuPrP23_231 (Kramer et al., 2001). It is proposed that 4 copper ions bind to the repeat 
region (there are 4 repeats) and 1 copper ion binds to the C-terminal side of the 
octarepeat (see Table 1.4). The C-terminal site is identified around His96 and possibly 
His111 by NMR and fluorescence in the presence of Gly (Jackson et al., 2001). This is 
confirmed by mass spectrometric foot printing (Qin et al., 2002) and XAFS (Hasnain et 
al., 2001). Cereghetti et al. (2Q01) also found a copper-binding site in the C-terminal 
folded region by EPR (Cereghetti et al., 2001). 
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1.6. Sugar binding to Pr P repeats 
Several experimental results pointed to glycosaminoglycans (GAGs) being 
physiological ligands of PrP (Shyng et al., 1995; Brimacombe et al. , 1999; Wong et al. , 
2001) and being likely to play a role in the cellular metabolism of both PrPc and PrPsc 
(Shyng et al. , 1995). The binding site in recombinant hamster PrPc for GAGs, in the 
form of low molecular weight heparin and heparan sulfate, has been identified and has 
recently been shown to encompass the N-terminal region, the pre-repeat region 
(residues 23-52), the central, hydrophobic, amyloidogenic sequence (residues 110-128) 
and the octapeptide-repeat region (residues 53-93) (Warner et al., 2002). 
As the octapeptide-repeat region is known to have both copper and GAG-binding 
capacities, the possibilities of concerted interaction between PrP, copper ions and 
heparin has also been investigated (Gonzalez-Iglesias et al., 2002; Warner et al., 2002). 
Warner et al. (2002) showed that copper ions enhanced the interaction between the 
octapeptide-repeat region and heparin and, furthermore, stabilized the oligomeric 
complexes resulting from PrP interaction with GAGs. In these complexes, PrP binds 
GAGs through His-bound copper in forming PrP - Cu(II) - GAG assemblies 
(Gonzalez-Iglesias et al., 2002). Recently it was shown that rPrP binding to GAGs is 
enhanced in the presence of Cu2+ and Zn2+, but not Ca2+ and Mn2+ (Pan et al. , 2002) . 
1.7. Review of low-complexity proteins and methods in general to study them 
Low-complexity sequences or non-random amino acid compositions such as that in 
octapeptide tandem repeats of PrP are common in natural proteins but have been little 
studied (Wootton, 1994; Wright and Dyson, 1999). This is partly because methods to 
study them are not well established. Difficulties with crystallization have meant that 
only a few X-ray diffraction (XRD) structures for these types of protein have been 
solved. These structures are also difficult to solve by NMR, because apart from 
structural disorder, the repetitive sequence, which lacks a unique nuclear Overhauser 
enhancement (NOE), makes the assignment ambiguous. This has required use of 
combinations of several low-resolution techniques, such as fluorescence titration 
spectrophotometry, CD, mass spectroscopy, UVN isible absorption spectroscopy, ED, 
EPR, potentiometry and voltammetry, Fourier transform infrared spectroscopy (FTIR), 
and fluorescence resonance energy transfer (FRET), to make studies of these proteins 
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feasible. Except EPR, potentiometry and voltammetry, this study has employed all the 
methods mentioned above to study the repeat system in marsupial PrP. Unlike the rest 
of the methods, the last two (FTIR and FRET) have not previously been used in PrP-
repeat studies, hence, their use in this thesis is novel. 
However, FTIR has long been used to probe conformation of proteins and peptides and 
conformational changes associated with ligand binding (Haris and Chapman, 1995; 
' Jung, 2000; Torreggiani et al., 2000; Torreggiani et al., 2000). The technique generates ' 
a low-resolution secondary structure. Compared with the 3-D structures obtained from 
high-resolution XRD and NMR, FTIR is less informative, but nevertheless, there are 
situations where FTIR is preferred to XRD and NMR in elucidating the structure and 
function of peptides and proteins, especially when the peptide has high backbone 
flexibility and conformational dynamics. 
FTIR is also more suitable than NMR for studying conformational changes upon 
binding of copper ions to proteins, such as in the case of copper binding to PrP repeats, 
because the copper ion is paran1agnetic and this will interfere with the NMR signal. 
Furthermore, the · interaction of copper with amino acid side chains can be detected. 
Thus, with thorough analysis of the spectrum, FTIR can be used to gain information 
about both conformational changes and ligand-binding sites in PrP-repeat peptides. 
FRET has potential for elucidating inter residue distances in PrP-repeat peptides. The 
technique itself is well established in conformational study of peptides and proteins 
(Stryer, 1978; Wu and Brand, 1994; Selvin, 1995) and has been applied to investigate 
structural characteristics of small and highly flexible peptides such as galanin (Kulinski 
et al., 1997). 
1.8. Copper-binding mode in Pr P from species other than mammalian 
The specific PrP sequence HGGGW is highly conserved across mammalian species of 
PrPs. However, this feature is absent from avian (Wopfner et al., 1999), reptile (turtle) 
(Simonic et al., 2000), and marsupial (brush-tailed possum (Windl et al., 1995) and 
tarnmar wallaby (Premzl and Greatly, personal communication)) PrPs (see Table 1. 1 
above). 
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A study with chicken hexarepeat peptide revealed that it does bind copper ion 
(Hornshaw et al., 1995a; Hornshaw et al., 1995b). Recently, it has been confirmed that 
chicken hexarepeat peptide binds copper ion but with different stoichiometry, and 
certainly different mode of binding, to that of mammalian octarepeat (Garnett and Viles, 
2003). Garnett and Viles (2003) suggest the stoichiometry is 1 copper ion per two 
hexarepeats (PHNPGY), which suggests two His residues from different peptide chains 
bind a single copper ion, as the amide nitrogen of Pro (the second residue after His) is 
not available for coordination to copper ion. 
The studies reported in this thesis are based on investigation of the properties of repeats 
from a marsupial PrP (brush-tailed possum). As shown in Table 1.1, marsupial repeats 
do not have the HGGGW segment, which is a feature of mammalian PrP repeats. It is 
suspected that marsupial repeats may have a different copper-binding mode and 
mechanism. Although the motif P[H/Q].GG.WGQ is conserved among the mammalian 
and. marsupial sequences, the marsupial repeat has a Pro inserted as its third residue 
( after H/Q), which cannot coordinate copper ion through its amide nitrogen. It is the 
aim of this study to characterize marsupial PrP repeats and their copper-binding 
properties. 
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2.1. Instrumentation 
Chapter II 
Materials and Methods 
Instruments that were used in these experiments are located in various departments and 
research schools within the Australian National University (ANU). 
2.1.1. UV Nis spectrophotometer 
A Varian Cary 1 Bio UVNis spectrophotometer located at the John Curtin School of 
Medical Research (JCSMR) ANU was used to measure the concentration of peptides 
based on Trp absorption at 280 nm [E2so = 5500 (Pace and Schmid, 1997)]. 
2.1.2. High-pressure liquid chromatography (HPLC) 
A Waters HPLC located at JCSMR ANU was used to check the purity of the peptides. 
The instrument was equipped with Waters 2487 dual A absorbance detector, Waters 515 
pump and Waters reverse phase C18 analytical column. 
2.1.3. Chromatography column 
A Biorad Econo Column (size of 0.5 x 5 cm) chromatography column was used to 
remove residual TF A from the peptides. The column was filled with Amberlite IR 45 
anion exchange resin (Muga et al., 1990). 
2.1.4. Fluorescence spectrophotometer 
A Perkin Elmer LS 50B Fluorescence spectrophotometer located in JCSJ\AR was used in 
the fluorescence titration experiments to determine the dissociation constant of copper-
Msp-peptide complexes as well as in the fluorescence resonance energy transfer (FRET) 
experiments to determine the distance between residues in the peptides. 
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2.1.5. Electrospray ionization mass spectrophotometer (ESI MS) 
A VG Quattro II triple quadrupole ESI MS from Fisons Instruments located in the 
Research School of Chemistry (RSC) ANU was used in experiments to determine the 
stoichiometry of copper binding to Msp peptides and to initially assess the binding of 
other metals. 
2.1.6. Fourier transform infrared spectrophotometer (FTIR) 
A Perkin Elmer Spectrum One FTIR spectrophotometer located in RSC ANU was used 
to probe the conformation and conformational changes of the peptide backbone upon 
copper binding and to determine the copper-binding sites. 
2.1.7. Circular dichroism spectrophotometer (CD) 
A Jobin-Yvon Model CD6 CD spectrophotometer located in RSC ANU was used to 
determine the conformation of the peptide backbone under particular conditions, such as 
in the presence of copper ions at different pHs. 
2.1.8. Equilibrium dialysis (ED) apparatus 
Forty dialysis chambers and a rotation device n1ade in the JCSMR workshop were used 
in experiments to study copper binding to Msp peptides. 
2.1.9. Inductively coupled plasma optical emission spectrophotometer (ICP OES) 
A Varian Vista Pro ICP OES located in the Geology Department, Faculty of Science 
ANU was used to determine the concentration of metals from equilibrium dialysis 
experiments. 
2.2. Materials 
2.2.1. Synthetic peptides 
Synthetic peptides were supplied by the Bion1olecular Resources Facility (BRF) 
JCSMR, ANU. 
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Table 2.1: Synthetic peptides used in the experiments. All peptides were terminated at 
the C-terminus with a Gly residue. 
Group Peptide Sequence Size 
Msp4 group Msp4 (PHPGGSNWGQ)4G 41 
Msp4cape (PHPGGSNWGQ)4G-NH2 41 
Msp4capNe Ac-(PHPGGSNW GQ)4 G-NH? 41 
Msp3 group Msp3 (PHPGGSNWGQ)3G 31 
Msp3cape (PHPGGSNWGQ)3G-NH? 31 
Msp3capNe Ac-(PHPGGSNWGQ)3G-NH2 31 
Msp2 group Msp2 (PHPGGSNWGQ)2G 21 
Msp2cape (PHPGGSNWGQ)2G-NH2 21 
Msp2capNe Ac-(PHPGGSNW GQ)2G-NH2 21 
Mspl group Mspl PHPGGSNWGQG 11 
Msplcape PHPGGSNWGQG-NH2 11 
MsplcapNe Ac-PHPGGSNWGQG-NH? 11 
Mspl MsplcapN Ac-PHPGGSNWGQG 11 
variant and Msp1H2A P APGGSNWGQG 11 
mutant Msp1N7A PHPGGSAWGQG 11 
MsplQlOA PHPGGSNWGAG 11 
Mspl Msp 1 His(l Me )cape PH[ 1:Me ]PGGSNW GQG-NH2 11 
His-methylated Msp 1 His(3 Me )cape PH[ rcMe ]PGGSNWGQG-NH2 11 
Modified MsplP3GcapNe Ac-PHGGGSNWGQG-NH2 11 
repeat Msp 1 strepcapN e Ac-PQGGGTNWGQG-NH2 11 
sequences Msp 4threpcapNe Ac-PHGGSNWGQG-NH2 10 
HulcapNe Ac-PHGGGWGQG-NH2 9 
Msp2F8capNe Ac-PHPGGSNFGQPHPGGSNWGQG-NH2 21 
Msp2Fl 8capNe Ac-PHPGGSNWGQPHPGGSNFGQG-NH2 21 
Msp3F8Fl Scape Ac-(PHPGGSNFGQ)?PHPGGSNWGQG-NH? 31 
Hu2F6cape Ac-PHGGGFGQPHGGGWGQG-NH2 17 
Hu2F14cape Ac-PHGGGWGQPHGGGFGQG-NH2 17 
Dansylated DansMspl Dans-PHPGGSNWGQG 11 
peptides DansMsp 1 cape Dans-PHPGGSNWGQG-NH2 11 
DansMsp2F8cape Dans-PHPGGSNFGQPHPGGSNWGQG-NH2 21 
DansMsp2F 18cape Dans-PHPGGSNWGQPHPGGSNFGQG-NH2 21 
DansMsp3F8Fl Scape Dans-(PHPGGSNFGQ)2PHPGGSNW GQG-NH2 31 
DansHulcape Dans-PHGGGWGQG-NH2 9 
DansHu2F6cape Dans-PHGGGFGQPHGGGWGQG-NH2 17 
DansHu2F l 4cape Dans-PHGGGWGQPHGGGFGQG-NH2 17 
capC is peptide with the terminal coo- group protected with an amide group; capN is 
peptide with the terminal NH group protected with an acetyl group; capNC is peptide 
with both terminal groups protected; Msp1H2A is Mspl with His2 replaced by Ala2; 
Msp1N7A is Mspl with Asn7 replaced by Ala7, MsplQl0A is Mspl with Gln10 
replaced by Ala10; Msp2F18capC is Msp2capC where Trp 18 is replaced with Phe18; 
Dans is the peptide with a dansyl group attached to the terminal imino group. 
2.2.1.1. Peptide synthesis 
Peptide synthesis was carried out using two instruments. In the initial stage of the 
research, the peptides were synthesized using the Applied Biosystems 430A Peptide 
Synthesizer and in the final stage the synthesis was carried out using the 
SYMPHONY/MULTIPLEX Multiple Peptide Synthesizer. Peptide syntheses on both 
instruments were performed using FMOC chemistry and the solid-phase peptide 
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synthesis technique. Cleavage of the peptide from the resin was performed in a mixture 
of 10 mL trifluoroacetic acid (TFA), 0.5 mL H2O, 0. 75 g phenol, 0.5 mL thioanisole, 
and 0.25 mL ethaneditiol. The crude peptide was purified by Bio-Rad HPLC on a C18 
column, using a 4-40% linear gradient of acetonitrile in 0.09% (v/v) TFA. The peptide 
was then freeze dried. When required, the N-or C-terminus or both N- and C-termini 
were protected by means of acetylation and amidation, respectively. 
For dansylated peptide, the dansyl group was attached to the imino end of the peptide 
before the oligomer was released from the resin. About 0.5 gram of deprotected resin 
was removed from the reaction vessel, reacted for 10 hr with 25 0 mg of dansyl chloride 
in methylene chloride containing 1 mL of triethylamine, and then washed thoroughly 
with methylene chloride and ethanol. The dansylated peptide was released from the 
resin by stirring for 20 hr with 20 mL of ethanol containing 4 mL of anhydrous (97 % ) 
hydrazine. _ Purification was carried out using HPLC. The peptide was then freeze 
dried. 
2.2.1.2. Peptide purification: the removal of residual trifluoroacetic acid (TFA) 
Synthetic peptides (Table 2.1) contained a small amount of TFA (the buffer used in 
HPLC purification). The removal of residual TF A is important for peptides to be used 
in the FTIR experiment because it has IR absorption overlapping the peptide spectrum. 
Thus, the peptide was additionally purified either by anion exchange resin ( amberlite 
IR-45) mini column chromatography (Muga et al., 1990) or by repeated lyophilization 
(after addition of sufficient amount of HCl). In the anion exchange method, the column 
was pre-equilibrated with Milli-Q water. The peptide was dissolved in 1 mL of Milli-Q 
water, transferred to the column, and eluted with Milli-Q water. Collected fractions 
were then freeze dried. 
2.2.1.3. Preparation of stock peptide solutions 
Typically, 1-5 mg of peptide was weighed out on an analytical balance into a 1.5 mL 
Eppendorf tube. The peptide was dissolved in Milli-Q water. The concentration of 
peptide was determined by measuring the Trp absorbance of peptide in the solution at 
280 nm, using UV Nis spectrophotometer. The concentration of the stock solution was 
then calculated using the Beer-Lambert relation 
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A=£xcxl (Equation 2.1) 
in which £ = molar absorbance coefficient, c = concentration of peptide, l = the cell 
length, A = absorbance. The molar absorbance coefficient (£) at 280 nm for each 
peptide was calculated using the equation (Pace and Schmid, 1997): 
£2so [M-1 cm-1] = 5500 x nTrp (Equation 2.2) 
in which nTrp is the number of Trp residue in the peptide. 
2.2.2. General buffer and reagent solution 
Amberlite IR-45, anion exchange resin analytical grade, was manufactured by Rohm 
Haas company. Buffer components, NaCl, Na2HPO4.2H2O, NaH2PO4.H2O, NaOH, 
HCl, KCl, KOH, NEM (N-ethylmorpholine), ammonia, ammonium formate, KH2PO4, 
sodium tetraborate, Tris, and formic acid were all analytical grade and purchased from 
Analar BDH. Metal salts; CuSO4.5H2O, CaCh.2H2O, ZnCh, MgSO4, and 
MnSO4.4H2O were all analytical grade and purchased from Analar BDH. CuCh.2H2O 
were analytical grade and purchased from Sigma. Amino acids Glycine and Tryptophan 
were both analytical grade and purchased from Analar BDH. Deuterium Oxide was 
purchased from Sigma. Milli-Q water was used as a solvent in all buffer and reagent 
solutions. The buffer and all reagent solutions were filtered prior to use, using the 0.45 
µm Whatman filter paper. 
2.2.2.1. Preparation of stock PBS (phosphate buffered saline) buffer 
100 mL PBS buffer (10 x) was prepared by dissolving 8 g NaCl, 1.25 g Na2HPO4.2H2O, 
and 0.3535 gram NaH2PO4.H2O in Milli-Q water. The pH was adjusted to 7.4 by 
addition of dilute HCl or NaOH solution. 
2.2.2.2. Preparation of stock NEM (N-ethylmorpholine) buffer 
100 mL of stock (10 x) NEM buffer was prepared by dissolving 3.2 mL NEM (MW -
115.2; d = 0.91 gram /mL) and 11.175 gram KCl in Milli-Q water. The solution was 
adjusted to pH 7.4 by addition of dilute HCl or KOH. The concentration of NEM in the 
working solution (1 x solution) was 25 mM and KCl was 150 mM. 
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2.2.2.3. Preparation of stock phosphate buffer solutions at pH 6.0, 7.4 and 8.0 
50 mL of stock (10 x) phosphate buffer was prepared according to Table 2.2. The 
concentration of phosphate in working solution (1 x solution) is 25 mM and ionic 
strength is O .1 M. 
Table 2.2: Preparation of 10 x phosphate buffer 
pH 2 MNa2HPO4 2 MNaH2PO4 5 MNaCl Milli-Q water Total Volume 
6.0 0.769 mL 5.481 mL 6.885 mL 36.865 mL 50mL 
7.4 5.062 mL 1.188 mL 4.450 mL 39.300 mL 50mL 
8.0 5.919 mL 0.331 mL 2.765 mL 40.985 mL 50mL 
2.2.2.4. Preparation of stock universal buffer solution pH 3.0-8.0 
Stock I universal buffer was prepared by dissolving 21.014 g of citric acid, 13.609 g of 
KH2PO4, 38.136 g of sodium tetraborate, 12.114 g of Tris, and 7.455 g ofKCl in Milli-
Q water and made up to 400 mL. 5 x stock buffer solutions (pH 3.0, 5.0, 6.5, 7.4, and 
8.0), were prepared by taking 25 mL stock I, adjusting to desired pH by adding 5 M 
NaOH or 5 M HCl, and adding Milli-Q water to 50 mL. The concentration of each 
component in the working solution (1 x solution) is 25 mM. 
2.2.2.5. Preparation of stock solutions of metal salts 
100 mL of 0.2 M of stocks of metal salts (CuSO4, CaCb, ZnCb, MgSO4, and MnSO4) 
were made in Milli-Q water. The following amounts of metal salts were weighed out 
using an analytical balance ( 4.994 g CuSO4.5H2O, 2.940 g CaCb.2H2O, 2. 726 g ZnCb, 
4.461 g MnSO4.4H2O and 2.407 g MgSO4). The sample was transferred to a 100 mL of 
volumetric flask, and made up with Milli-Q water. 
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Chapter III 
Fourier Transform Inf rared Spectroscopy 
Fourier transform infrared spectroscopy (FTIR) was used to probe the conformation of 
PrP-repeat peptides and follow their conformational changes associated with copper 
binding. The interaction of copper with amino acid side chains was also detected by 
FTIR. Thus, with thorough analysis of the FTIR spectrum, both conformational 
changes and copper-binding sites in PrP-repeat peptides can be revealed. 
3.1. Introduction 
Fourier transform infrared spectroscopy (FTIR) is an extremely useful tool to probe 
protein and peptide conformation in a wide range of environments (Haris and Chapman, 
1992; Haris and Chapman, 1995; Jung, 2000). The most useful band for infrared 
analysis of the protein secondary structure is the amide I band, which appears in the 
region between 1600-1700 cm-1 (Byler and Susi, 1986; Surewitz and Mantsch, 1988; 
Haris and Chapman, 1992; Haris and Chapman, 1995; Jung, 2000). This band arises 
\' 
primarily from the C=O stretching vibration of the amide backbone coupled weakly to ·_ 
th/;~··.plane NH bending, CCN deformation and CN stretching modes. 
1
· 
I , 
\ I , 
Table 3.1. General classification of amide I vibration of polypeptides in 2H2O. 
Wavenumber ( cm -1) Assignment Reference 
1649-1658 a-Helix (Byler and Susi, 1986; 
Surewitz and Mantsch, 1988; 
1640-1648 Random coil Haris and Chapman, 1995; 
1620-1635 and Intramolecular ~-sheets Arrondo and Goni, 1999; 
1672 (weak) Heimburg et al., 1999; Jung, 
1665-1690 Tums 2000) 
1614-1624 and Intermolecular antiparallel ~- (Ismail et al., 1992; Jackson 
1684 (weak) sheets in aggregated proteins et al., 1992; Panick et al., 
1999) 
The frequency region of the an1ide I band is characteristic for each type of secondary 
structure. The correlation between the positions of the amide I band and the type of 
secondary structure adopted by the polypeptide chain in solution has been extensively 
reported in the literature (Byler and Susi, 1986; Surewitz and Mantsch, 1988; Haris and 
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Chapman, 1995; Arrondo and Gani, 1999; Heimburg et al., 1999; Jung, 2000). For the 
purpose of spectral assignment in this chapter, the amide I band and its corresponding 
structure of peptides and proteins in 2H2O is presented in Table 3.1. However, there are 
some exceptions to this general assignment, especially the one related to a-helical 
structure. 
The absorption of a-helical structures is sensitive to their environment. The position of 
the amide I band of a-helical structure in a membrane protein can be different from ex-
helix in a soluble protein, or in a homopolypeptide or a short highly solvent-exposed 
peptide (Haris and Chapman, 1995). In membrane proteins the a-helix absorption 
occurs between 1656-1658 cm-1 while in a soluble protein it occurs between 1649-1658 
cm-1 (see Table 1). In a homopolypeptide, such as poly-L-lysine, a-helix absorption is 
located at 1638 cm-1. For a short solvent-exposed peptide, the band frequency of ex-
helical structure occurs at 1644 cm-1 (Haris and Chapman, 1995). It should also be 
noted that the position of the amide I band of polypeptides in 2H2O is 2-9 cm~1 lower 
than its value for protein in 1H2O. 
3.2. Aims 
The aims of this work are to probe the conformational changes in marsupial PrP-repeat 
peptides (Msp ), as a function of copper binding at different pHs and for different 
numbers of repeats. As shown in Table 3.2, much of this copper-binding study has used 
the synthetic peptide containing 1-4 copies of the second-repeat sequence 
(PHPGGSNWGQ) of marsupial (brush-tailed possum) PrP (Windl et al., 1995). 
However, the first-repeat sequence (PQGGGTNWGQ), where QG replaces HP, and the 
fourth-repeat sequence (PHGGSNWGQ), where Pis deleted, were also studied for their 
copper-binding properties. The study also compares the copper-binding properties of 
marsupial PrP repeats with those of human PrP octarepeat (PHGGGWGQ). 
Experiments using some mutant peptides of the second-repeat sequence, where the third 
Pro is replaced with Gly (PHGGGSNWGQ), the second His is replaced with Ala 
(P APGGSNWGQ), the seventh Asn is replaced with Ala (PHPGGSA WGQ), and the 
tenth Gln is replaced with Ala (PHPGGSNWGA), were carried out to obtain 
information about the copper-binding sites. . Copper binding to peptides with the His 
ring methylated (PH[lMe]PGGSNWGQ and PH[3Me]PGGSNWGQ) was studied to 
determine which tautomeric form (nitrogen atom of the imidazole ring of His) binds the 
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copper 10n. Copper titration of Msp 1 monitored by FTlR was used to obtain 
information about the number of copper ions bound in a single marsupial repeat. The 
possibility of other metal ( calcium, zinc, manganese, and magnesium) ions binding to 
Msp peptides was also investigated. 
3.3. Materials and methods 
3.3.1. Sample preparation 
The peptide (see Table 3.2) was additionally purified either by anion exchange resin, 
amberlite IR-45, mini column chromatography (Muga et al., 1990) or repeated 
lyophilization (after addition of sufficient amount of HCl) to remove residual TFA. In 
anion exchange method, the column was pre-equilibrated with Milli-Q water. The 
peptide was dissolved in 1 mL of Milli-Q water, transferred to the column, and eluted 
with Milli-Q water. Collected fractions were then freeze dried. UV/Vis spectrometry 
was used to .check the peptide concentration based on the Trp absorption at 280 nm (£2so 
= 5500) (Pace and Schmid, 1997). 
Table 3.2: Synthetic peptides used in the experiments. 
Group Peptide Sequence Size 
Msp4 group Msp4 (PHPGGSNWGQ)4G 41 
Msp4capC (PHPGGSNW GQ)4G-NH2 41 
Msp4capNC Ac-(PHPGGSNWGQ)4G-NH2 41 
Msp3 group Msp3 (PHPGGSNWGQ)3G 31 
Msp3capC (PHPGGSNWGQ)3G-NH2 31 
Msp3capNC Ac-(PHPGGSNW GQ)3 G-NH2 31 
Msp2 group Msp2 (PHPGGSNWGQ)2G 21 
Msp2capC (PHPGGSNWGQ)2G-NH2 21 
Msp2capNC Ac-(PHPGGSNW GQ)2G-NH2 21 
Mspl group Mspl PHPGGSNWGQG 11 
MsplcapC PHPGGSNWGQG-NH2 11 
MsplcapNC Ac-PHPGGSNW GQG-NH2 11 
Msp 1 variant MsplcapN Ac-PHPGGSNWGQG 11 
and mutant Msp1H2A P APGGSNWGQG 11 
Msp1N7A PHPGGSA WGQG 11 
MsplQl0A PHPGGSNWGAG 11 
Mspl Msp 1 His(l Me )capC PH[ 1Me ]PGGSNW GQG-NH2 11 
His-methylated Msp 1 His(3Me )capC PH[ nMe ]PGGSNW GQG-NH2 11 
Modified repeat MsplP3GcapNC Ac-PHGGGSNWGQG-NH2 11 
sequences Msp lstrepcapNC Ac-PQGGGTNW GQG-NH2 11 
Msp 4threpcapNC Ac-PHGGSNWGQG-NH2 10 
HulcapNC Ac-PHGGGWGQG-NH2 9 
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Copper ion binding to Msp peptides. In order to avoid copper precipitation as copper 
hydroxide at pH higher than 6.0, the sample was prepared according to the Takeuchi 
procedure (personal communication), with some modifications. The Msp peptide 
solution was brought to pH around 12.0 (by addition ofNaOH), and then CuCh solution 
was added. The pH was adjusted to the desired pH by addition of HCI. The solution 
was freeze dried and redissolved in 2H2O. In the final solution, the concentration of 
Msp peptide is 2. 5 mM and Cu Ch is 10 mM, unless otherwise stated. 
Other metal ions (Zn, Ca, Mn, Mg) binding to Msp peptides. The metal salts 
(ZnCh, CaCh, MnSO4, and MgCh) solution were added into the peptide solution and 
then, by adding HCl or NaOH solution, the mixture was brought to the desired pH. The 
solution was freeze dried and redissolved in 2H2O. In the final solution, the 
concentration of Msp peptide is 2.5 mM and metal ion is 10 mM, unless otherwise 
stated. 
3.3.2. Infrared spectroscopic measurement and analysis 
In these experiments, the FTIR spectra were recorded in 2H2O to avoid the overlapping 
band of the HOH bending motion of water in the amide I band region. The use of 2H2O 
also enabled use a longer path-length cell, which meant that the noise can be minimized 
and the signal to noise ratio increased, while using low concentration of peptides. 
Infrared spectra were recorded on a Perkin Elmer Spectrum One Fourier Transform 
Infrared Spectrometer. Samples were placed in a micro cell fitted with CaF2 windows 
and a 50 µm Teflon spacer. 200 scans were taken and signal averaged at a resolution of 
4 cm-1. Spectra were recorded at room temperature (25 °C) and the sample 
compartment was continuously purged with nitrogen gas to suppress water vapour 
absorbance in the spectral region of interest. Data were analysed using the Spectrum 
v.3.0 software from Perkin Elmer. Subtraction of the 2H2O spectrum from the sample 
spectrum was carried out digitally to give a straight baseline in the region 2000 - 1800 
cm-
1 (Haris et al., 1986). The resulting absorbance spectrum of the peptide was 
analyzed using the second derivative procedure with 19 data point Savitzky-Golay 
smoothing window (Haris et al., 1986). In the second derivative spectrum, the height of 
the bands is proportional to the _ square of the height of the original peak, but with 
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opposite sign (Susi and Byler, 1983; Susi and Byler, 1986). Thus, the original intensity 
or absorbance of particular peaks after the spectrum has undergone the second 
derivative procedure can be calculated. This method was used to quantify the intensity 
or absorbance of some peaks (1650 cm-1, 1593 cm-1, and 1563 cm-1) which occur in the 
spectra of Mspl and Mspl titrated with copper ions. Difference spectra were also 
generated, after normalization of the amide I band region to absorbance = 1. 
Normalized spectra were also used to monitor the increase and decrease of some peaks 
upon addition of copper at different pHs. 
3.4. Results and discussion 
In order to investigate the effect of pH and copper binding on the structure of the 
peptides, FTIR spectra were recorded at different pH values, ranging from pH 6.0-9.0, 
in the presence and absence of copper ions. Msp peptides with various numbers of 
repeats were used to investigate the effect of peptide length on its conformation and 
copper-binding properties. Experiments with Msp peptides where the C-terminus was 
capped, or both C- and N-termini were capped, were also carried out to investigate the 
effect of free N- and C-termini on copper binding. Copper binding to some mutant 
peptides was studied to identify binding sites in Msp peptides. The first and fourth-
repeat sequence of marsupial PrP, as well as human repeat sequence, were also 
investigated to identify the repeat segments and sequence most important for copper 
binding. 
3.4.1. FTIR spectra of Mspl group in the absence and the presence of copper ions 
3.4.1.1. Conformational analysis - amide I band at "'1650 cm-1 
The amide I band of Mspl at pH 6.0-9.0 appears at 1650-1644 cm-1 in the absorbance 
spectra (see Figure 3.1, left panel), and 1652-1648 cm-1 in the second derivative spectra 
(Figure 3.2, left panel). Both spectra show a gradual down shift of the position of the 
band with increasing pH. It is quite plausible that this downshift is due to pH-
dependent conformational changes, as Msp 1 is a small peptide whose structure could be 
easily modified by pH. 
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Mspl. According to the general assignment (see Table 3.1), the amide I band 
frequency of Msp 1 peptide falls within the range of frequency for a-helix structure. 
However, the fact that the amide II band* completely disappears immediately upon 
dissolution of sample in 2H20 supports the spectral assignment for random-coil 
structure. This assignment is in good agreement with other spectroscopy measurements 
undertaken during these studies, such as CD, fluorescence spectroscopy, and FRET. 
Furthermore, it also fits conclusions from the literature that suggested the structure of 
PrP-repeat peptides is random coil or disordered (Hornshaw et al., 1995a; Miura et al., 
1996; Miura et al., 1999; Viles et al., 1999; Bonomo et al., 2000; Whittal et al., 2000). 
MsplcapC. Protection of the C-terminus in MsplcapC peptide does not change the 
structure. The amide I band at pH 6.0-9.0 is observed at 1651-1646 cm-1 in absorbance 
spectra (Figure 3.3, left panel), and at 1655-1649 cm-1 in second derivative spectra 
(Figure 3.4, left panel); as above, this indicates the presence of random-coil structure. 
The gradual downshift of the peak upon increasing pH from 6.0 to 9.0 is also observed 
in the Msp 1 capC spectra. 
MsplcapNC. MsplcapNC peptides, where both C- and N-termini are protected, 
adopted a random coil structure throughout pH 6.0-9.0: this is suggested by the amide I 
band at 1650-1646 cm-1 in the absorbance spectra (Figure 3.5, left panel), and 1653-
1646 cm-1 in the second derivative spectra (Figure 3.6, left panel). As also observed in 
the spectra of Msp 1 and Msp 1 capC, there is a gradual red · shift in the spectra of 
MsplcapNC upon increasing pH from 6.0 to 9.0. 
*The amide II band arises fron1 the NH bending of the peptide backbone coupled with CN 
stretching. In 1H2O this band is located at 1550 cm-1. Upon dissolution of protein in 2H2O, the 
amide II band is observed at 1450 cm-1 as a result of 1H-2H exchanges where the N-1H group of 
the ainide backbone becomes N-2H. Polypeptides with highly solvent-exposed amide groups or 
having weak hydrogen bonding, such as random-coil structure, undergo 1H-2H exchange n1ore 
rapidly than polypeptide with defined conforn1ation where the NH backbone is usually buried 
inside the globular folded protein core. Therefore, the amide II band of random-coil structure 
disappears aln1ost instantly upon dissolution of polypeptide in 2H2O, while the more ordered 
protein requires a longer time (Haris and Chapman, 1995). 
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The Mspl group is a small peptide, with only 11 residues (PHPGGSNWGQG). The 
large red shift ( 4-7 cm-1 ), observed in these three peptides, indicates that the peptides are 
very flexible, and their structure can easily be modified by pH. However, pH variation 
does not result in a compact structure of the peptide as the amide I band position still 
indicates they are unstructured throughout pH 6.0-9.0. Nonetheless, the increase in 
intensity of the band at 1360 cm-1 upon increasing pH from 6.0 to 9.0 (Figure 3.2, 3.4, 
3.6; left panel), supports the suggestion that the structure of Mspl peptide is slightly 
modified by pH. This 1360 cm-1 band is the high-frequency component of the doublet 
1360 and 1340 cm-1, which is assigned as arising from Trp, and can be used as a marker 
of the environment around the Trp residue (Harada et al., 1986). The 1360 cm-1 band 
would increase in intensity when the Trp is in a more hydrophobic environment or 
surrounded by more aliphatic side chains. The noticeable increase of the 1360 cm-1 
band intensity upon increasing pH from 6.0 to 9.0 suggests that the Trp residue has 
moved into a more hydrophobic environment, probably getting closer to the Pro side 
chain or to the N-terminal part of the peptide. This suggestion would be in good 
agreement with FRET experiments (see Chapter V), where the distance between Trp 
and the N-terminal residue is slightly closer at pH 9.0 than at lower pH. 
Mspl +Cu. Addition of copper modified the IR spectra of Msp 1, with the most striking 
change being the appearance of a new band at r-.., 1560 cm-I. This band assignment will 
be made in a later section. However, with regard to the amide I band at pH 6.0-8.0, 
addition of copper does not change the band position as shown in the absorbance 
spectra (Figure 3.1, right panel). At pH 9.0, there is a 3 cm-1 shift toward lower 
frequency upon addition of copper; now the amide I absorption is at 1641 cm-1. The 
shift toward lower frequency is also reported in Raman spectra for copper interaction 
with human PrP octarepeat. This shift has been assigned as arising from an increase in 
helix content (Miura et al., 1996; Miura et al., 1999). However, in this FTIR spectrum 
the frequency of the amide I band in the range of 1651-1641 cm-I more likely indicates 
the presence of random-coil structure. 
MsplcapC+Cu. Copper ion also forms a complex with MsplcapC, as suggested by the 
appearance of the new band at r-..11560 cm-1 (Figure 3.3 right panel) . Concerning the 
amide I band, addition of copper to MsplcapC at pH 9.0 results in a 3 cm-1 shift from 
1646 cm-1 to 1643 cm-1 in absorbance spectra, while at pH range 6.0-8.0, the frequency 
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of the amide I band is unchanged. The position of amide I band of copper complex of 
MsplcapC at 1651-1643 cm-1 throughout pH 6.0-9.0 suggests the random-coil structure. 
MsplcapNC+Cu. Addition of copper ion to MsplcapNC peptide produces smaller 
spectral changes (Figures 3. 5 and 3. 6, right panels) compared with those for Msp 1 and 
MsplcapC. Regarding the amide I band, at pH 9.0, the position shifts from 1646 cm-1 
in free peptide to 1641 cm-1 in the copper complex. Second derivative spectra (Figure 
3. 6 right panel) show the amide I band of the copper complex of Msp 1 capN C at pH 6. 0-
8. 0 is around 1653-1650 cm-1 and at pH 9.0 it is at 1646 cm-1• Although the exact 
position of the amide I band in second derivative and absorbance spectra is slightly 
different, the same trend, which is a red shift upon increasing pH from 6.0 to 9.0, is 
observed. These data suggest that copper ion induces the formation of a more 
hydrogen-bonded structure in MsplcapNC at pH 9.0. However, the position of the 
amide I band suggests that the copper complex of Mp 1 capNC peptide adopts a random-
coil structure. The smaller spectral changes in Msp 1 capN C upon addition of copper 
could indicate that the binding of copper to the peptide is not so effective, and suggest a 
role for the imino group of Pro at the N-terminus in copper binding. 
As copper can coordinate 6 atoms to form a complex, a thorough analysis of the FTIR 
spectrum may reveal the other copper-binding sites in Msp peptides. The spectral 
regions where changes mostly occur are analyzed below. 
3.4.1.2. Assignment of the band at 1611-1617 cm-1 
Mspl and MsplcapC. Second derivative spectra of Msp 1 (Figure 3 .2 right panel) and 
MsplcapC (Figure 3.4 right panel) show the appearance of a new shoulder at 1611 cm-1 
upon addition of copper ions at pH 6.0. This shoulder gets stronger and becomes a 
discrete individual band at 1617 cm-1 as the pH increases from 6.0 to 8.0. A discrete 
band is not observed at pH 9.0. However, there is a very weak shoulder around 1620 
cm-
1
, which overlaps with the major amide I band that also shifts but toward lower 
frequency. As a result, the overlapping band cannot be fully resolved by the second 
derivative procedure. 
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Figure 3.1: FTIR normalized absorbance spectra of Msp 1 and copper complex of 
Mspl. The spectra of Mspl in 2H2O at 2.5 mM peptide concentration, in the absence 
(left) and the presence (right) of 10 mM CuCb at pH 6.0, 7.0, 8.0, and 9.0. 
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Figure 3.2: FTIR second derivative spectra of Msp 1 and copper con1plex of Msp 1. The 
spectra of Msp 1 in 2H2O at 2.5 mM peptide concentration in the absence (left) and the 
presence (right) of 10 mM CuCh, at pH 6.0, 7.0, 8.0, and 9.0. 
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Figure 3.3: FTIR normalized absorbance spectra of Msp 1 cape and copper complex of 
Msplcape. The spectra of Msplcape in 2H2O at 2.5 mM peptide concentration, in the 
absence (left) and the presence (right) of 10 mM eueb at pH 6.0, 7.0, 8.0, and 9.0. 
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Figure 3.4: FTIR second derivative spectra of Msp 1 cape and copper complex of 
Msplcape. The spectra of Msplcape in 2H2O at 2.5 mM peptide concentration, in the 
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46 
MsplcapNC. The small band around 1611-1617 cm-1 observe·d in copper complexes of 
Mspl and MsplcapC appears less obvious in second derivative spectra of MsplcapNC 
(Figure 3.6 right panel). This is consistent with the smaller spectral changes in general 
for copper addition to Msp 1 capN C peptide, compared with those for Msp 1 and 
Msp 1 capC. However, curvature at the base of the amide I band around 1611-1617 cm-1 
indicates the presence of a very weak shoulder: this is observed most clearly at pH 7.0 
and 8.0. 
The assignment of the weak band at 1611-1617 cm-1 is not straightforward: there are 
several possible origins as discussed below. 
Possible assignment - antiparallel ~-sheet. The appearance of the band at 1611-1617 
cm-1 could reflect peptide aggregation or self-association related to the formation of an 
intermolecular antiparallel ~-sheet structure (Ismail et al., 1992; Panick et al., 1999) (see 
Table 3.1). The weak component band that usually appears at 1684 cm-1 cannot be 
detected in the spectrum probably because the proportion of this type of structure is 
much smaller than the random-coil structure that is predominantly present. Msp 1 group 
is a relatively small peptide (11 residues), and it is very con1mon for a small peptide to 
aggregate to form an intermolecular antiparallel ~-sheet structure. 
Possible assignment - Trp ring. According to the literature, a band at 1618 cm-1 could 
arise from the vibration of the C-C bond of benzene and the C=C bond of pyrole in the 
Trp ring (Barth, 2000). In the absence of copper, this Trp band is observed with 
relatively high intensity, in the Raman spectra of human PrP repeats (Miura et al., 
1999). However, addition of copper does not change this Trp band (Miura et al., 1999) 
suggesting that the origin of this band is less likely due to the Trp residue. 
Possible assignment - deprotonated amide backbone. The band at 1611-1617 cm-1 
could also arise from the out-of-phase (antisymmetrically coupled) component of the 
C=O/C-N- stretching vibration of the deprotonated amide backbone. This band appears 
at 1610 cm-1 in the copper complex of glycylglycine at pH > 5 .0 (Tasumi, 1979). In 
that complex, the in-phase (symmetrically coupled) component appeared at 1428 cm-1. 
In the copper complex of Mspl and MsplcapC peptide at pH 6.0-8.0, the symmetric 
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component of C=O/C-N- vibration is observed at 1426-1427 cm-1. As mentioned 
earlier, the band at 1611-1617 cm-1 shifts to 1620 cm-1 at pH 9.0. The shifted 
phenomenon is also observed for the 1426-1427 cm-1 band, which is at pH 9.0 located at 
1417-1420 cm-1. The band at 1419 cm-1 is also observed in the copper complex of 
MsplcapNC at pH 9.0. The fact that there are two bands, one at 1611-1617 cm-1 and 
the other at 1426-1427 cm-1, that behave similarly (shift at pH 9.0) strongly suggests the 
presence of a deprotonated peptide group as a result of copper interaction with the 
peptide. This suggestion is in good agreement with the literature, where copper is 
reported to coordinate via the NH of the amide backbone (Miura et al., 1996; Miura et 
al., 1999; Aronoff-Spencer et al., 2000; Bums et al., 2002; Luczkowski et al., 2002). 
Thus, overall, the 1611-1617 cm-1 band could have more than one origin. Firstly, it 
could reflect an intermolecular antiparallel ~-sheet structure, which is associated with 
peptide aggregation. Secondly, it could originate from the C=O/C-N- stretching 
vibration of deprotonated amide backbone. 
3.4.1.3. Assignment of the -1590 cm-1 and --1560 cm-1 band 
The band at 1590 cm-1 is visible in the spectra of copper-free as well as copper-
complexed forms of Mspl peptide (see Figures 3.1 and 3.2). Some possible origins of 
this band are outlined below. 
Possible assignment - from terminal coo-. The band at 1590 cm-1 could arise from 
the antisymmetric vibration of coo-. This assignment is based on the second 
derivative spectra, which show that the intensity of the 1590 cm-1 band in Msp 1 is 
higher than that in MsplcapC peptide (see Figure 3.7), and also the difference spectra, 
which show a strong positive peak at 1590 cm-1 emerging as a result of Mspl-
MsplcapC subtraction (Figure 3.8). 
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Figure 3.8: FTIR absorption difference spectra for the peptide end groups and side 
chain residues. The spectra were normalized to absorbance = 1 before the subtraction 
procedure was carried out. A positive peak reflects the absorption of the first spectrum 
while a negative peak belongs to the second spectrum. The difference spectra show the 
positive peak at 1590 cm-1 is strongest in the difference spectra of Mspl-MsplcapC, 
suggesting it arises mainly from the coo- vibration of the C-terminus of the peptide. 
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The assignment of the 1590 cm-I band for the coo- vibration is supported by data from 
the literature. It has been reported that the ionized carboxyl group in 2H20 has strong 
absorption with the maximum at 1590 cm-I, and that this band results from the 
antisymmetric stretching of the coo- group (Chirgadze et al., 1975). The 
antisymmetric stretching of the coo- vibration of polylysine peptide was also observed 
at 1590 cm-I; the intensity of this band decreases as the chain length of poly lysine 
increases (Jackson et al., 1989). 
The chain length phenomenon is also observed in Msp peptides. The FTIR absorbance 
and second derivative spectra of the Msp2 group (21 residues) (Figures 3 .17-3 .22), 
Msp3 group (31 residues) (Figures 3.23-3.28), and Msp4 group (41 residues) (Figures 
3.29-3.34) peptides show that the intensity of the 1590 cm-I band is not as prominent as 
in the Mspl group (11 residues) (Figures 3.1-3.6). This supports the assignment of the 
1590 cm-I _ band in Msp 1 peptide as originating partly from the coo- vibration. 
However, it seems obvious that the band has at least 2 origins as it is still observed in 
the spectra of Msp 1 capC ( other origins of this band will be discussed in later sections). 
Addition of copper resulted in increase of the intensity of the band at 1590 cm-1 (see 
Figure 3.1 ), which, partly, indicates interaction between copper ions and the coo-
group. In this case, copper ion binds to only one of the oxygen atoms; therefore, the 
antisymmetric stretching vibration of coo- group could be expected to increase in 
intensity. The interaction of copper with the coo- group at the C-terminus of the 
peptide was reported for the copper complex of glycylglycine. The FTIR absorbance of 
this complex revealed bands at 1596 cm-I ( antisymmetric stretching) and 1385 cm-1 
(symmetric stretching) (Tasumi, 1979). In the spectra of the copper complex of Msp 1 
peptide, the symmetric component of the coo- stretching vibration is probably located 
at 1390 cm-I. Thus, the data suggest the possibility of the coo- group at the C-
tenninus of Mspl being one of copper-binding sites. However, binding to the coo-
group is not essential because in its absence binding still occurs as shown in 
fluorescence quenching experiments (Chapter 111) and FTIR spectra of Msp 1 capC 
(Figures 3.3-3.4 and 3.7). 
As already mentioned, amidation of the coo- group (in Msp 1 capC) does not abolish 
the 1590 cm-I band but only decreases its intensity. This suggests that other vibrations 
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also contribute to the absorbance in this region. In order to identify other groups that 
absorb at 1590 cm-1 and interact with copper ion, some mutant peptides were 
investigated and analyzed using FTIR difference spectra; these are discussed in the 
section below. 
Possible assignment - imino group of Pro. The difference spectrum of Msp 1 and 
MsplcapN (Figure 3.8) shows a positive peak at 1587 cm-1, suggesting the imino 
nitrogen of Pro at the N-terminus absorbs in this region. As has been shown in the 
previous section, addition of copper to Msp 1 capN does not produce as great spectral 
changes as for Msp 1 and Msp 1 capC. The smaller changes suggest the free imino group 
of Pro has a significant role in copper binding. The possibility that the imino nitrogen 
participates in copper binding has also been investigated using fluorescence titration 
spectrophotometry (see Chapter IV). It was found that upon addition of copper to 
Msp 1 capN _peptide · no quenching occurred, while addition of copper to Msp 1 and 
Msp 1 capC peptides resulted in large quenching. Together these data suggest the imino 
group of Pro is a copper-binding site in Msp 1 peptide. This suggestion fits data from 
the literature which suggest the amino group of the N-terminal residue facilitates the 
binding of copper ion to the human PrP octarepeat (Whittal et al., 2000; Luczkowski et 
al., 2002). It was reported that protection of the N-terminus by acetylation caused some 
reduction in the stoichiometry of binding (Whittal et al., 2000). The unprotected N-
terminal Pro-His segment is a quite specific sequence for interaction with copper ions 
(Luczkowski et al., 2002). The interaction of copper with the imino terminal Pro, 
however, would be physiologically irrelevant as this group is not present in the real 
protein. 
Possible assignment - imidazole ring of His. It is clear that the band at 1590 cm-1 has 
more than one origin. Apart from the coo-and imino groups, another possibility is the 
imidazole ring of His. This suggestion follows from the difference spectrum of Msp l-
Msp l H2A, which shows a positive band at 1590 cm-1 (Figure 3.8). It is also supported 
by the literature, which shows that the C4=C5 stretching vibration of the imidazole ring 
of His can contribute to absorption in this region, as observed in the FTIR spectra of 
carnosine in a KBR pellet (Torreggiani et al., 2000a; Torreggiani et al., 2000b ). Besides 
the band at 1590 cm-1, the difference spectrum of Mspl-MsplH2A also shows a small 
positive peak at 1564 cm-1, which might originate from the His residue. 
52 
t 
w 
0 
z 
<{ 
m 
0::: 
0 (f) 
m 
<{ 
di-histidine I 1/\ 
I~ 
__,,/ ~ • ----
di-histidine+Cu .1 ~ 
I~~ / -l 
I "· / ~ 
__ _...,..,.. 
1700 1600 
Wavenumber (cm-1) 
1500 
Figure 3.9: Effect of copper addition on the FTIR spectrum of the di-histidine peptide. 
Absorbance spectra of di-histidine at 40 mM peptide concentration recorded at pH 8.0, 
in the absence (top) and the presence (bottom) of 10 mM CuCb. 
The band at 1564 cm-1 deserves further comment as this band becomes quite strong in 
the spectra of copper complexes of Mspl group peptides (Figures 3.1-3.6, right panels), 
which most probably results from copper interaction with the His residue. This band is 
also observed in the spectrum of the copper complex of di-His peptide (Figure 3.9), 
which strongly supports the assignment for copper-bound His. Other evidence t4at this 
band is due to the His residue is its absence from the spectra of the copper complex of 
Msp1H2A (Figure 3.7). This assignment is in good agreement with reports in the 
literature which suggest that the His residue is a copper-binding site in human PrP 
octarepeat (Miura et al., 1996; Miura et al., 1999; Aronoff-Spencer et al., 2000). 
3.4.1.4. Tautomeric forms of His ring 
As has been pointed out earlier, the band at 1590 cm-1 could also arise from the His 
residue. The presence of two bands associated with His clearly indicates the presence 
of two tautomeric forms of His. Literature reports indicate that between pH 6.0-11.0 in 
2H20, free His would have IR absorbance at 1569 and 1575 cm-1 (Barth, 2000; 
Hasegawa et al., 2000), which is the C4=C5 stretching vibration of the imidazole ring of 
His. These two bands appear as a doublet, representing the two tautomeric forms: these 
differ depending on which N atom the proton is bound to (see Figure 3.10). In tautomer 
I, N1: is protonated, while in tautomer II the proton is attached to Nn. The 1569 cm-1 and 
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1575 cm-1 bands represent tautomer I and II, respectively. It is possible that the two 
bands, 1564 cm-1 and 1590 cm-1, observed in the difference spectrum of Msp l-
Msp 1 H2A (see Figure 3.8) represent these two tautomeric forms of His. 
Two tautomeric forms of His side chain 
Tautomer I 
1569 cm-1 
,.._,75% 
'c/ 
I 
CH2 
•• 
Tautomer II 
1575 cm-1 
,.._,25% 
Two tautomeric forms of copper-bound histidine in Msp 1 peptide 
'c/ 'c/ 
I I 
CH2 CH2 
Tautomer I 
1560-1565 cm-1 
Cu 
Tautomer II 
1592-1594 cm-1 
Figure 3.10: Structures of the two tautomeric forms of copper-free His (upper) and 
copper-bound Mspl peptide (lower). In the copper-free form, the reported IR frequency 
for the C4=C5 bond vibration of His in 2H20 is 1569 cm-1 (tautomer I) and 1575 cm-1 
(tautomer II) (Barth, 2000). According to the difference spectrum (Mspl-MsplH2A), 
the copper-free tautomer I in Mspl peptide could be located at 1564 cm-1 and tautomer 
II at 1590 cm-1. In the copper-bound form of Mspl peptides, the IR frequency for the 
C4=C5 vibration of tautomer I appears in the range between 1560-1565 cm-1 and 
tau tom er II in the range 15 92-15 94 cm-1. However, the frequency of these two 
tautomeric forms may vary. It appears that the frequency of tautomer I has been 
downshifted and tautomer II upshifted as a result of copper interaction. 
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It has also been reported in the literature that in 2H2O the two tautomeric forms are 
difficult to detect by Raman spectra (Miura et al., 1999). The proton attached to the N1 
or Nrc atoms of His undergoes 1H-2H exchanges readily in 2H2O solution. As a result, a 
singlet Raman band around 1570 cm-1 is observed for the C4=C5 stretching vibration 
that is now insensitive to tautomerism. Upon metal chelation the frequency up shift of 
the C4=C5 vibration still occurs in 2H2O solution. Thus, in the copper complex, the 
C4=C5 vibration was observed at 1584 cm-1• In H2O, the copper-free His is observed as 
a doublet at 1587 and 1574 cm-1, while in the copper complex it is observed at 1603 and 
1590 cm-1 (Miura et al., 1999). 
Methylated His peptides. In order to investigate further the two tautomeric forms of 
His, Mspl peptides with either N1 or Nrc methylated were synthesized. These peptides, 
MsplHis(lMe)capC (N1 methylated) and Msp1His(3Me)capC (Nrc methylated), were C-
terminally capped to eliminate the strong absorption of coo- at ,__, 1590 cm-1, which 
would complicate the spectral assignment. The N-terminus of the peptides was left 
uncapped to facilitate copper binding to the peptide. 
Copper complex of 'tMe-His peptide - ,..., 1560 cm-1 (Tautomer I). Copper addition to 
MsplHis(lMe)capC resulted in an increase in intensity of the band at 1564 cm-1 (see 
Figure 3.11). This result strongly supports the suggestion that tautomer I with copper 
bound to the Nrc atom of the imidazole ring will absorb at ,__,1560 cm-1• 
In the copper-free form of all Msp 1 peptides, the intensity of the 15 60 cm-1 band is very 
weak and not clearly visible in the spectrum (Figures 3.1-3.6, left panels). However, 
copper binding to Nrc has altered the environment around C4=C5 bond leading to an 
increase in band intensity. In FTIR only vibrations that produce changes in dipole 
moment can be detected. During the vibration, the absorption coefficient increases with 
the change of dipole moment. The change in dipole moment is often correlated with the 
polarity of the vibrating bonds. Thus, a change in environment that results in an altered 
bond polarity will lead to a change in band intensities (Barth, 2000). It is proposed that 
copper binding to Nrc has increased the polarity of the C4=C5 bond, so that the bond 
vibration produces larger changes in dipole moment, and consequently the IR intensity 
of the absorption is increased. 
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Figure 3.11: Copper binding to MsplHis(lMe)capC peptide. FTIR Absorbance (upper 
panel) and second derivative (lower panel) spectra of MsplHis(lMe)capC in 2H2O at 
2.5 mM peptide concentration, in the absence (left) and the presence (right) of 10 mM 
CuCh, at pH 6.0, 7.0, 8.0 and 9.0. The spectra clearly show the band at 1563 cm-1 
appears upon addition of copper, which indicates the formation of a Cu-Nn bond 
(tauton1er I). 
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Figure 3.12: Copper binding to MsplHis(3Me)capC peptide. FTIR Absorbance (upper 
panel) and second derivative (lower panel) spectra of MsplHis(3Me)capC in 2H2O at 
2.5 mM peptide concentration, in the absence (left) and the presence (right) of IO mM 
CuCb, at pH 6.0, 7.0, 8.0 and 9.0. The pron1inent band at 1595 cm-1 appears upon 
addition of copper, which indicates the formation of a Cu-N1: bond (tautomer II). 
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Copper complex of nMe-His peptide - ---1590 cm-1 (Tatitomer II). The FTIR 
spectrum of the copper complex of Msp1His(3Me)capC shows a very strong band at 
---1590 cm-1 (see Figure 3.12). The appearance of this band suggests that copper binding 
to the N-r atom of imidazole will produce an IR band at ,..__, 1590 cm-1. However, as even 
in the absence of a His residue, this band is still observed in the copper complex of 
Msp1H2A (see Figure 3.7), one could argue that the band at 1590 cm-1, which appears 
upon copper addition to Msp 1 His(3Me )capC, is in fact due to the imino group of Pro 
that absorbs at this region. Furthermore, fluorescence spectroscopy experiments 
(Chapter N) showed copper binding to Msp1His(3Me)capC occurs only at pH > 8.0 
with affinity much lower than the binding to MsplHis(lMe)capC and close to that for 
Msp1H2A, where His is replaced by Ala. 
However, the appearance of a band at 1602-1603 cm-1 in the copper complexes of some 
C- and N-terminally capped peptides: MsplP3GcapNC (PHGGGSNWGQG) (Figure 
3.13), Msp_4threpcapNC (PHGGSNWGQG) (Figure 3.15) and HulcapNC 
(PHGGGWGQG) (Figure 3.16) supports the assignment of the 1590 cm-1 band as 
originating from tautomer II of His. Although the frequency of this band is slightly 
higher than that observed in Msp 1 peptide (1590 cm-1 ), the appearance of this band in 
these capNC peptides suggests that it is not only copper-bound imino or coo- groups 
but also His. The absence of changes in intensity of this band in the copper complex of 
Msp_lstrepcapNC (Ac-PQGGGTNWGQ-NH2) also suggests that the origin of intensity 
changes of this band is copper interaction with the His residue. Together, these data 
suggest that the band in the region of 1590-1600 cm-1 is a copper-bound form of 
tautomer II of His. 
3.4.1.-S. Assignment of the band at 1500-1506 cm-1 
Mspl +Cu - His tautomer I. Another band appearing in the second derivative spectra 
of copper complexes of Msp 1 group peptides that can be attributed to binding sites of 
copper is at 1500-1506 cm-1 (Figures 3.2 and 3.4). It is suggested this band arises from 
Nrprotonated/Nn:-copper-ligated histidine. The same band is observed in the Raman 
spectra of copper complexes of human PrP octarepeats (Miura et al., 1999): these 
authors suggested that the band originates from copper ion binding to the Nn: atom of the 
imidazole ring of His. However, the vibration that produces the 1503 cm-1 band is not 
yet clarified (Miura et al., 1998). 
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MsplHis(lMe)capC +Cu. This band is also observed at 1508-1509 c1n-1 in second 
derivative spectra of copper complexes of MsplHis(lMe)capC (Figure 3.11), where 
copper is forced to bind to the Nrr atom. This band is not observed in copper complexes 
' 
of MsplHis(3Me)capC (Figure 3.12) where the Nrr atom is methylated and copper binds 
to the N1: atom. It is also evident from the spectra of MsplP3GcapNC (Figure 3.13) and 
HulcapNC (Figure 3.16) that increase in intensity of the band at 1560 cm-1 (1570-1577 
cm-
1 for Hul capNC) is concomitantly followed by increase of the band intensity at 
1503-1499 cm-1. These data may be compared with the spectra of Msp_ 4threpcapNC 
(Figure 3.15) where the bands at 1560 cm-1 and 1495 cm-1 are both weak. Overall these 
data strongly support the assignment of the band at 1502 cm-1 as originating from 
copper ion binding to the Nrr atom of the imidazole ring of His. 
3.4.1.6. Copper-binding sites in Mspl group peptides (PHPGGSNWGQG) 
The above FTIR assignments identified three nitrogen atoms as copper-binding sites in 
Mspl peptides: the nitrogen atom from the imino group of Pro at the N-terminus, the Nrr 
atom of the imidazole ring of His, and the nitrogen atom of the deprotonated amide 
backbone (the data do not indicate how many deprotonated amides). In Mspl peptide 
(PHPGGSNWGQG), the role of the free terminal imino group of Pro in binding copper 
ion is very significant, especially at pH 6.0 and 7.0; the absence of it results in 
effectively no binding. However, binding to this group has no physiological relevance, 
as in the real protein this group does not exist. 
The literature suggests that in the absence of the imino group, copper can bind to two 
nitrogen atoms from the deprotonated amide backbone of the third and fourth Gly 
residue, in addition to the His side chain (Luczkowski et al., 2002) in the sequence of 
1PHGGG5 found naturally in human PrP repeat (see Figure 1.10 in Chapter I). This 
report may explain why there is no binding between copper and MsplcapNC peptide 
(Ac-PHPGGSNWGQG-NH2), as the third residue in this peptide is Pro, which lacks on 
amide that can be deprotonated. The fourth residue in Msp 1 peptides that is capable of 
binding copper through its deprotonated amide is Gly: however, the deprotonation 
probably appears to require a rather high pH, so that copper binding in MsplcapNC 
occurs only at pH 8.0 and higher. 
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An X-ray diffraction report of a copper complex of a PHGGG fragment of human PrP 
repeat generated a model where copper ion coordinates via 3 nitrogen atoms and two 
oxygen atoms (see Figure 1.12 in Chapter I): one nitrogen atom of His, two nitrogen 
atoms of the deprotonated amide backbone of the third and fourth Gly residues, one 
oxygen atom from the amide carbonyl group of the fifth Gly, and the oxygen atom of a 
water molecule that forms a bridge with the Trp indole ring (Bums et al., 2002). 
Another model suggested one nitrogen atom of His and two nitrogen atoms of the amide 
backbone of the third and fourth Gly as copper-binding sites in PrP octarepeat (Aronoff-
Spencer et al., 2000) (see Figure 1.9 in Chapter I). These three models do not agree 
with the model proposed by Miura et al. (1999), where copper ion binds to the fourth 
and fifth Gly amides rather than the third and fourth Glys (Miura et al., 1999) (see 
Figure 1.8 in Chapter I). A model of copper complex of Msp 1 peptide is presented in 
Chapter VIII. In terms of which Gly residues are the copper-binding sites in Msp 1 
peptide, this model follows the model proposed by Luczkowski et al. (2002), Bums et 
al. (2002), and Aronoff-Spencer et al. (2000), rather than Miura et al. (1999), as these 
models can explain the lack of binding between copper ion and the N-terminally capped 
Mspl peptide at pH lower than 8.0. At pH 8.0 and higher, maybe the amide of Gly4 and 
Gly5 participate or backbone amides further along. It is also possible the amide side 
chains of Asn or Gln, which require higher pH for deprotonation, participate in copper 
binding. In order to check whether or not the presence of Gly as the third residue 
replacing Pro can facilitate copper binding, the peptide MsplP3GcapNC, where the 
third Pro is replaced with Gly, was analyzed. Several other marsupial PrP-repeat 
peptides with capNC and human PrP repeat capNC were also investigated. 
3.4.2. FTIR spectra of MsplP3GcapNC (Ac-PHGGGSNWGQG-NH2) 
FTIR spectra show that upon addition of copper to MsplP3GcapNC at pH 8.0, large 
changes occur in the amide I band region as well as other parts of the spectrum (Figure 
3.13). The amide I band shifts from 1645 cm-1 to 1641 cm-1 (4 cm-1 red shift), this 
position indicates random coil structure. 
A new band with relatively strong intensity is observed at 1621 cm-1 upon interaction of 
the peptide with copper ion. Concomitantly a 1419 cm-1 band also appears. These two 
bands have been attributed (see section 3.4.1.2) to the out-of-phase and in-phase 
stretching of the C=O/C-N- of the deprotonated amide group. Similar band frequencies 
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with relatively weak intensity were observed in the second derivative spectra of copper 
complexes of Mspl group (see Figures 3.2, 3.4, 3.6, right panels). The reason for the 
weak intensity is probably because the number of deprotonated main-chain amide 
groups in Mspl is less than in MsplP3GcapNC, as a result of the sequence difference. 
It is likely that in MsplP3GcapNC, the nitrogen of the amide backbone of the third Gly 
residue is deprotonated and coordinated to a copper ion. In Msp 1, the Pro residue does 
not have a deprotonated NH amide. 
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Figure 3.13: Copper binding to MsplP3GcapNC peptide. The normalized absorbance 
(upper panel) and second derivative (middle and bottom) spectra in 2H2O of 2.5 mM 
Msp 1P3GcapNC peptide (Ac-PHGGGSNWGQG-NH2) in the absence and presence of 
10 mM CuCh at pH 8.0. 
61 
Together these data suggest that in the absence of the NH-deprotonated amide backbone 
from the third residue, the N-terminal imino group of Pro is required to form the 
complex with copper. If the amide NH of the third residue is available, then copper can 
form the complex with the peptide without requiring the imino group. This suggestion 
fits the model proposed in the· literature (Luczkowski et al., 2002). 
However, the fluorescence titration experiment (see Chapter IV) does not confirm the 
binding of copper to MsplP3GcapNC peptide. Fluorescence quenching is not observed 
upon addition of copper to these capNC peptides, even when the third residue is Gly. 
One reason may be that addition of copper to the capNC peptides does not perturb the 
microenvironment around the Trp residue, even though copper is being bound. Another 
possible reason is the concentration difference between the FTIR and fluorimetry 
experiments. In FTIR, the peptide and copper concentrations are in the mM range, 
while in ·fluorimetry, they are in the µM range. Fluorescence experiments also do not 
confirm the FTIR observation of copper binding to Hul cap NC, although in this peptide, 
the Trp residue is 2 residues closer to His (anchoring site for copper). Furthermore, the 
XRD structure of copper-octarepeat complex shows the involven1ent of the indole ring 
of Trp in constructing the complex structure (Bums et al., 2002) (see Chapter I Figure 
1.10). 
The observed frequency of the copper complex of tautomer I in MsplP3GcapNC is 
relatively low (1556 cm-1) compared with the same vibration in Msp 1 peptide (1565 
cm-1), while the frequency of the copper-bound tautomer II appears at higher frequency 
(1602 cm-1) compared with this vibration in Mspl (1595 cm-1). The width of the 1556 
cm-1 band is also larger than for the 1565 cm-1 band. Application of the deconvolution 
procedure revealed three component bands at 1556, 1568, and 1586 cm-1 ( data not 
shown). While the origin of the bands at 1568 and 1586 cm-1 is currently unclear, the 
appearance of the band at 1556 and 1602 cm-1 in copper complexes of MsplP3GcapNC 
suggests the formation of complex via both the Nn and N1: atoms of the imidazole ring of 
His. In summary, these data suggest that the copper-binding sites in MsplP3GcapNC 
are: the nitrogen atom, which could be Nn and N1: of the imidazole ring of His, the 
deprotonated amide backbone of the third Gly, and probably the fourth and fifth Gly 
residues. 
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Figure 3.14: Copper binding to Msp _ 1 strepcapNC peptide. The normalized 
absorbance (upper panel) and second derivative (1niddle and botton1) spectra in 2H2O of 
2.5 mM Msp_lstrepcapNC peptide (Ac-PQGGGTNWGQG-NH2) in the absence and 
presence of 10 n1M CuCb at pH 8.0. 
3.4.3. FTIR spectra of Msp_lstrepcapNC (Ac-PQGGGTNWGQG-NH2) 
The first-repeat sequence of marsupial PrP was investigated. It was found that the 
peptide does not bind copper ion, as indicated by the lack of changes in the FTIR 
spectrum upon addition of copper (see Figure 3.14). During the sample preparation, the 
color of the peptide solution in the presence of copper at pH higher than 9.0 is violet 
with some blue precipitate. Upon addition of HCl to pH 8.5 the solution becomes 
colourless with son1e blue pale precipitate. It is possible that at pH higher than 9. 0, the 
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peptide forms a complex with copper through the nitrogen atoms of the deprotonated 
amide backbone, such as the formation of the biuret complex (Creighton, 1983). It 
appears that the lack of a His residue prevents the peptide from binding copper at 
neutral and slightly basic pH, even though the GGG segment is available. This 
experiment suggests that the His residue is an important copper-binding site: the GGG 
segment alone cannot bind a copper ion and the Gln residue seems unable to substitute 
for His in binding copper. 
The PQGGGTNWGQ repeat is found naturally as the first-repeat sequence of marsupial 
PrP (brush-tailed possum (Windl et al., 1995) and tammar wallaby (Premzl and Greatly, 
2003, personal communication)). Its lack of binding with copper indicates that this part 
of the repeat region does not participate in copper binding. 
3.4.4. FTIR spectra of Msp_ 4threpcapNC (Ac-PHGGSNWGQG-NH2) 
The fourth repeat of the marsupial PrP-repeats region was analyzed for its ability to 
bind copper ions. The peptide was both N- and C-terminally protected. The spectra 
(Figure 3.15) show that upon addition of copper, the amide I band does not change, 
suggesting the structure of the copper-complexed and copper-free forms of 
Msp _ 4threpcapNC is random coil. 
Upon addition of copper, the band at 1601 cm-1 increases in intensity and the band at 
1566 cm-1 emerges. The intensity of the 1601 cm-1 band is higher than the 1566 cm-1 
band: this indicates that the copper complex forms mainly via the N1 atom, rather than 
the Nn atom, of the imidazole ring of His. This is also suggested by the fact that the 
band at 1502 cm-1, which is a marker for copper binding to the Nn atom, appears only 
very weakly. 
The band at 1421 cm-1, which is assigned as the in-phase stretching of C=O/C-N- of the 
deprotonated amide backbone, emerges. However, its intensity is not as strong as that 
observed in the copper complex of MsplP3GcapNC. Furthermore, the out-of-phase 
component at 1615 cm-1 appears only weakly as a shoulder. This result suggests that, in 
Msp_ 4threpcapNC, participation of the NH of the amide backbone in copper binding is 
much less than that in MsplP3GcapNC. The difference between these two peptides is 
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the absence of the fifth residue Gly in Msp _ 4threpcapNC: this likely reduces the 
number of the an1ide backbone groups that participate in copper binding. 
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Figure 3.15: Copper binding to Msp_ 4threpcapNC peptide. The normalized 
absorbance (upper panel) and second derivative (middle and bottom) spectra in 2H2O of 
2.5 mM Msp_ 4threpcapNC peptide (Ac-PHGGSNWGQG-NH2) in the absence and 
presence of 10 mM CuCb at pH 8.0. 
These results suggest that copper-binding sites 1n Msp _ 4threpcapNC involve: the 
nitrogen atom of the imidazole ring of His, predominantly the N1 atom and only a small 
proportion of N n: atom, and the nitrogen atom of the deprotonated amide backbone from 
the third and fourth Gly residues . The nitrogen atom of the amide backbone of the fifth 
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Ser residue probably does not participate in binding. These data emphasize the role of 
the GGG segment in copper binding. 
The sequence of PHGGSNWGQ is found naturally as the fourth repeat in the marsupial 
PrP-repeat region. In the absence of the free imino group of Pro at the N-terminal end, 
this sequence is still capable of binding of copper ion strongly, suggesting that this part 
of the marsupial PrP repeats could naturally bind copper ion. 
3.4.5. FTIR spectra of HulcapNC (PHGGGWGQG) 
Addition of copper to Hul cap NC peptide does not induce formation of more hydrogen-
bonded structure as suggested by the amide I band position at 1644-1645 cm-1 (Figure 
3.16), which indicates a random-coil structure. However, the other parts of the 
spectrum show significant changes. 
Bands at 1619 and 1419 cm-1 emerge upon interaction with copper ion, reflecting 
copper binding to the deprotonated amide backbone. The suggestion that this · band 
arises from the deprotonated amide backbone is supported by the literature, which 
reported that the group participates in copper binding (Miura et al., 1996; Miura et al., 
1999; Aronoff-Spencer et al., 2000; Burns et al., 2002; Luczkowski et al., 2002). It is 
possible that the NH amide groups of the third, fourth and fifth Gly residues participate 
in copper binding as the peak intensities of the 1619 and 1419 cm-1 bands are quite high. 
The involvement of the third Gly residue in copper binding is in good agreement with 
son1e molecular models proposed in the literature (Aronoff-Spencer et al., 2000; Burns 
et al., 2002; Luczkowski et al., 2002). But it differs from model of Miura et al. (1999) 
in which the NH amide of the third Gly residue does not participate in copper binding 
(Miura et al., 1999). 
The FTIR spectra show a strong band at 1603 cm-1, suggesting the formation of a Cu-N1 
bond, and a medium intensity band at 1570 cm-1, suggesting the formation of a Cu-Nrr 
bond. These data indicate that the copper complex of HulcapNC at pH 8.0 forms 
mainly through the forn1ation of a Cu-N1 bond, with His, with only a small proportion 
with a Cu-Nrr bond. This result disagrees with the Raman results of Miura et al. (1999), 
who reported that the Nrr atom, rather than the N1 atom, of the imidazole ring of His 
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coordinates mainly with copper ion at pH 8.0. Miura et al. reported the binding of 
copper mainly to the N1 atom occurs at pH 6.0. At this pH, Miura et al. reported the 
amide backbone does not participate in the binding, so that copper coordinated to two 
N1 atoms from two different peptide chains. However, FTIR data of copper binding at 
pH 6. 0 is not avail ab le for comparison with Raman results of Miura et al. 
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Figure 3.16: Copper binding to HulcapNC peptide. The normalized absorbance (upper 
panel) and second derivative (middle and bottom) spectra in 2H2O of 2.5 mM 
HulcapNC peptide (Ac-PHGGGWGQG-NH2) in the absence and presence of 10 mM 
CuCh at pH 8.0 
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The difference between the FTIR result here and the Raman results of Miura et al. 
(1999) is probably due to the amount of copper ions in the solution. In the latter, the 
ratio of copper to peptide was 1: 1, while in this experiment the ratio is 4: 1. It is 
suggested that at high concentration, copper ion would mainly bind to the N-c atom of 
the imidazole ring of His, while at lower concentration it binds to the Nn atom. 
However, due to time constraints of this thesis, experiments to obtain the spectra of the 
Hul capNC peptide as a function of copper-ion concentration could not be done. 
3.4.6. Conformational analysis of multi-repeat peptides (Msp2 group, Msp3 
group, and Msp4 group) in the absence and presence of copper ions 
Compared with that of Msp 1, the spectra of longer peptides are more complex. This has 
allowed the interpretation possible only for the a1nide I band. The greater possibility of 
conformational heterogeneity within the complexes of longer peptides depending on 
stoichiometry of binding, and the fact that complex precipitates, are factors that 
complicate the spectrum. The latter is apparent for several peptides where residual TF A 
has not been removed completely, by the intensity ratio of the amide 1/TF A band 
(,--.,1672 cm-1), which is lower for a less soluble complex. 
3.4.6.1. Msp2 group peptides 
Amide I band analysis of the Msp2 group peptides reveals that on going from pH 6.0 to 
9.0 the maximum shifts from 1647 to 1645 cm-1 (Msp2 peptide, Figure 3.17, left panel), 
164 7 to 1644 cm-1 (Msp2capC, Figure 3 .19, left panel) and 1646 to 1645 cm-1 
(Msp2capNC, Figure 3.21, left panel). Other than the appearance of a peak at 1670 
cm-1, which is due to residual TFA, the second-derivative analysis (Figures 3.18, 3.20, 
and 3 .22, right panels) confirms what can be seen from the absorbance spectra. The 
amide I maximum at 164 7-1644 cm-1 for the copper-free form of the peptide in 
2H20 
can be attributed to random-coil structure. 
Msp2+Cu. Addition of copper to Msp2 at pH 6.0 and 7.0 results in no shift of the 
amide I band position as shown in the second derivative spectra (Figure 3 .18, right 
panel). At pH 8.0, there is only a I cm-1 shift toward lower frequency upon addition of 
copper. The amide I band of the copper complex at pH 6.0-8.0, which is in the region 
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of 1644-1643 cm-1, is assigned to random-coil structure. A larger shift, reflecting an 
increase in hydrogen bonding, is evidenced at pH 9.0 (9 cm-1), where the amide I band 
is now at 1635 cm-1. The assignment of the 1635 cm-1 band is complicated because 
absorbance in this region can arise from P-sheet and P-tum structure, as well as from 
solvent-exposed a-helices (Haris and Chapman, 1995). However, the fact that the 
amide I band is shifted toward lower frequency indicates an increase in ordered 
secondary structure, which could possibly be solvent-exposed a-helical structure, 
although the assignment of the 1635 cm-1 band is not straightforward. This assignment 
would be in good agreement with the Raman studies of Miura et al. (Miura et al., 1996; 
Miura et al., 1999), who detected an increase in helix content upon interaction of copper 
ions with a human PrP-octarepeat peptide (single and multi octarepeat: 
[PHGGGWGQ]n=l, 2, 4). The difference between results of Miura et al. and this FTIR 
result is that in these FTIR experiments helix structure is detected only in multi-repeat 
and not in single-repeat peptides, while Miura et al. detected it in both repeats. 
Msp2capC+Cu. The second derivative spectra of copper complexes of Msp2capC (see 
Figure 3.20, right panel) shows that at pH 6.0-8.0 the complex adopts a random-coil 
structure, as shown by the amide I band at 1645-1640 cm-1. At pH 9 .0, the amide I band 
of the complex is located at 1634 cm-1, again suggestive of solvent exposed a-helical 
structure. 
Msp2capNC+Cu. Addition of copper to Msp2capNC peptide at pH 6.0 produces only 
small changes in the second derivative spectra (Figure 3 .22, right panel): the amide I 
band maximum of the copper complex is at 1645 cm-1. This indicates a random-coil 
structure. Addition of copper to Msp2capNC at pH 7.0 results in the appearance of two 
components of the amide I band: 164 7 and 1639 cm-1. Two components of the amide I 
band are also observed at pH 8.0 (1649 and 1635 cm-1) and 9.0 (1649 and 1634 cm-1). 
At pH 7.0, the intensities of the two components are comparable, while at pH 8.0, the 
intensity of the lower-frequency component is higher. At pH 9.0, the higher-frequency 
component appears merely as a shoulder. The lower-frequency component of the amide 
I band, at '"'"'1636 cm-1, could be attributed to solvent exposed a-helical structure, as 
proposed above for the copper complex of Msp2 peptide. 
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Figure 3.17: FTIR normalized absorbance spectra of Msp2 and copper con1plex of 
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Figure 3.18: FTIR second derivative spectra of Msp2 and copper complex of Msp2. 
The spectra of Msp2 in 2H2O at 2.5 mM peptide concentration, in the absence (left) and 
presence (right) of 10 mM CuCh, at pH 6.0, 7.0, 8.0, and 9.0. 
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Figure 3.19: FTIR normalized absorbance spectra of Msp2capC and copper complex of 
Msp2capC. The spectra of Msp2capC in 2H2O at 2.5 mM peptide concentration, in the 
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Figure 3.20: FTIR second derivative spectra of Msp2capC and copper complex of 
Msp2capC. The spectra of Msp2capC in 2H2O at 2.5 mM peptide concentration, in the 
absence (left) and presence (right) of 10 mM CuCh, at pH 6.0, 7.0, 8.0, and 9.0. 
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Figure 3.22: FTIR second derivative spectra of Msp2capNC and copper complex of 
Msp2capNC. The spectra of Msp2capNC in 2H2O at 2.5 mM peptide concentration, 1n 
the absence (left) and presence (right) of 10 mM CuCh, at pH 6.0, 7.0, 8.0, and 9.0. 
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Preliminary conclusion. In general, copper complexes of Msp2 group peptides are 
less soluble than the copper-free peptides. Although the appearance of the TFA band in 
the IR spectra is unfortunate, the intensity of this band can give indirect information 
about the complex solubility. The intensity ratio of the amide 1/TF A band suggests that 
the copper complex of Msp2 group peptides is less soluble at pH 7.0-8.0 than at the 
other pHs (pH 6.0 and 9.0), as the intensity ratio is higher at these latter pHs. 
The peaks of the amide I band of copper complex of Msp2 group peptide splits into two 
components, each typical of random-coil and a-helix structure. Two explanations are 
possible for this peak splitting. The first one is that the FTIR spectra represent a 
distribution of complexed (,--.,1636 cm-1) and uncomplexed (,--.,1645 cm-) Msp2 
molecules, with the relative concentration of the former depleted by precipitation. This 
issue would be resolved by copper titration experiments. The second explanation is that 
there are two conformations of complexed peptide, on different regions of the Msp2 
molecule adopting mostly either random-coil or helical conformation. Interpretation of 
other regions of the spectra, as done for Msp 1 peptides, might allow discrimination of 
the two explanations, but unfortunately the other spectral regions are much more 
complicated in the multi-repeat peptides and it is difficult to draw conclusions. 
3.4.6.2. Msp3 group peptides 
There are no significant pH-induced changes in the structure of Msp3 group peptides in 
the absence of copper. In Msp3, the amide I band frequency between 1646-1643 cm-
1 
throughout the pH range studied suggests the presence of a random-coil structure (see 
Figures 3.23 and 3.24, left panel: note that the concentration of the peptide is 5 mM, 
which is twice that of the other peptides). This assignment is further supported by the 
fact that the amide II band disappears very rapidly upon dissolution of peptide in 
2H2O. 
Amidation of the C-terminus of Msp3 (Msp3capC) does not change the structure of the 
peptide: its structure is still random coil, as suggested by the position of the amide I 
band at1646-1644 cm-1 (see Figures 3.25 and 3.26, left panel) . The highest frequency 
belongs to the peptide at pH 6.0 and the lowest to the peptide at pH 9.0. Msp3capNC 
peptides also adopt a random-coil structure as suggested by the amide I band position at 
1645-1644 cm-1, which appears in the FTIR absorbance spectra (see Figures 3.27 and 
3.28, left panel). 
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Figure 3.23: FTIR normalized absorbance spectra of Msp3 and copper complex of 
Msp3. The spectra of Msp3 in 2H2O at 5 mM peptide concentration, in the absence 
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spectra at pH 9. 0 are not shown. 
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Figure 3.24: FTIR second derivative spectra of Msp3 and copper complex of Msp3. 
The spectra of Msp3 in 2H2O at 5 mM peptide concentration, in the absence (left) and 
presence (right) of 20 mM CuCh, at pH 6.0, 7.0, 8.0 and 9.0. 
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Figure 3.26: FTIR second derivative spectra of Msp3capC and copper complex of 
Msp3capC. The spectra of Msp3capC in 2H2O at 2.5 mM peptide concentration, in the 
absence (left) and presence (right) of 10 mM CuCh, at pH 6.0, 7.0, 8.0, and 9.0. 
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Figure 3.27: FTIR normalized absorbance spectra of Msp3capNC and copper complex 
of Msp3capNC. The spectra of Msp3capNC in 2H2O at 2.5 mM peptide concentration, 
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Figure 3.28: FTIR second derivative spectra of Msp3capNC and copper complex of 
Msp3capNC. The spectra of Msp3capNC in 2H2O at 2.5 mM peptide concentration, 1n 
the absence (left) and presence (right) of 10 mM CuCb, at pH 6.0, 7.0, 8.0, and 9.0. 
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In general, the copper complexes of Msp3 group peptides, as also the case for Msp2 
(section 3.4.6.2) and Msp4 (see later in section 3.4.6.3), are less soluble than their 
copper-free forms, as indicated by the formation of precipitate. From observations 
during sample preparation and judging from the intensity ratio of the amide I/TF A band, 
it appears the complex is more soluble at pH 9.0 than at the other pHs. The lower 
solubility of the complexes resulted in low peptide concentration left in the supernatant, 
which in turn lead to the low-resolution spectra (see Figures 3.23-3.28, right panel). 
However, spectral assignment is still possible for the amide I band. 
Msp3+Cu. Addition of copper ions at pH 6.0 and pH 7.0 to Msp3 peptide does not 
seem to change the position of the amide I band in second derivative spectra (Figure 
3 .24, right panel), although in the original absorbance spectra it changes the amide I 
band position slightly (3 cm-1 red shift) (see Figure 3.23, right panel). However, at pH 
8. 0 the amide I band frequency shifts significantly to lower frequency and now is 
located at 163 7 cm-1, reflecting solvent-exposed a-helical structure, similar to copper 
complex of Msp2 group peptides. The spectrun1 of the copper complex of Msp3 at pH 
9.0 is poor because of wet 2H20, which can absorb in the amide I region. 
Msp3capC+Cu. Upon addition of copper to Msp3capC peptides at pH 6.0 and 7.0, the 
position of the amide I band is relatively unchanged ( see Figures 3 .25 and 3 .26, right 
panel), suggesting the peptide is still random coil. Interaction of peptide with copper 
ion at pHs 8.0 and 9.0 produced a position for the amide I band at 1635 cm-1, again, 
reflecting a solvent exposed a-helical structure. 
Msp3capN C+Cu. Absorbance spectra show that addition of copper ions to 
Msp3capNC at pHs 6.0 and 7.0 does not change the position of the amide I band, which 
is at 1647-1644 cm-1 (Figure 3.27, right panel). However, the second derivative 
procedure applied to the copper-complex spectrum at pH 7 .0 reveals two amide I 
components at 1646 cm-1 and 1631 cm1 (see Figure 3.28, right panel). The higher 
frequency is ascribed to a random-coil structure, while the lower frequency is assigned 
to a solvent-exposed a-helical structure. The complex at pH 8.0 and 9.0 also adopts this 
latter structure: the amide I band position is at 1634-1632 cm-
1
. 
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Preliminary conclusion. The splitting of the amide I band is observed in the copper 
complex of Msp3 group peptides. As explained at the end of section 3.4.6.1, these two 
components could reflect either conformational heterogeneity within the same molecule 
or the presence of complexed and uncomplexed molecules. 
3.4.6.3. Msp4 group peptides 
Msp4+Cu. The structure of Msp4 throughout the pH range 6.0-9.0 is random-coil as 
suggested by the frequency of the amide I band at 1644-1641 cm-1 (Figures 3.29 and 
3.30, left panel). Addition of copper at pH 6.0 and 7.0 changes the amide I band only 
slightly (Figure 3 .29, right panel). However, the second derivative procedure reveals 
that in the copper complex at pH 6.0-7.0, the an1ide I band is composed of two 
component bands at 1650 cm-1 and 1637-1635 cm-1 (Figure 3.30, right panel). The band 
at 1650 cm-1 is attributed to a random-coil structure and the band at 1635-1639 cm-1 is 
assigned to a solvent-exposed a-helical structure, with the former being the major 
component. Two component bands (1650 cm-1 and 1634 cm-1) are also observed in the 
second derivative spectrum of the copper complex at pH 8.0, but with the solvent-
exposed a-helix now being the main structure. At pH 9.0, the structure of the copper 
complex is almost entirely a-helix as suggested by the band at 1634 cm-1• These results 
suggest a shift in the equilibrium between random-coil and a-helix structure as a 
function of pH. 
Large spectral changes that could also indicate a structural change upon copper binding 
to peptide are the intensity ratio of the 1360/1340 cm-1 doublet. As mentioned in 
section 3.4.1.1, the 1360/1340 cm-1 doublet is assigned as arising from Trp (Harada et 
al. , 1986), and can be used as a marker of the environment around the Trp residue. 
Thus, in the copper complex of Msp4, the higher intensity ratio of the 1360/1340 cm-
1 
doublet indicates the formation of more folded structure, in which the Trp residue 
becomes more buried. Ratio is highest at pH 9.0 indicative of almost complete 
complexation. 
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Figure 3.30: FTIR second derivative spectra of Msp4 and copper complex of Msp4. 
The spectra of Msp4 in 2H2O at 2.5 mM peptide concentration, in the absence (left) and 
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Figure 3.32: FTIR second derivative spectra of Msp4capC and copper complex of 
Msp4capC. The spectra of Msp4capC in 2H2O at 2.5 mM peptide concentration, in the 
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80 
1.2 1644 1642 
1645 "- / 1640 
1 0 
--.__...__ __ '\..I__,---
Msp4capNC 
w 0.8 
-- p,H 6 
(.) 
-- pH ? z 
<( 
--pHB (D 
a: 0.6 
-- pH 9 0 
(/) 
m 0.4 <.( 
0.2 
0.0 
f750 1700 1650 1600 
Wa,venurnbe r (cm·1) 
1550 
113::::, 1550 1633 
:'.::. _ __.::"\ \ __ !§ 3 3 
Msp4capNC +Cu 
-- pHG j 
-- pH 7 
-pH 8 h 
-- pH 9 h 
1500 1750 1700 1650 1600 
/ 
/ 
~ 55 ·1 
I 
1. 55D 1500 
Figure 3.33: FTIR normalized absorbance spectra of Msp4capNC and copper complex 
of Msp4capNC. The spectra of Msp4capNC in 2H2O at 2.5 mM peptide concentration, 
in the absence (left) and presence (right) of 10 mM CuCh, at pH 6.0, 7.0, 8.0, and 9.0. 
Large absorbance increases for pH 6.0 and 7.0 at lower wavenumber in right panel are 
due to HOD absorbance (wet 2H2O). 
N 
O'.'. 
w 
a:i 
~ 
::) 
z 
w 
~ 
~ 
w 
0 
:z 
<( 
a:i 
O'.'. 
0 
(f) 
a:i 
<( 
Msp4capNC pH 6 Msp4capNC+Cu pH 6 
pH 7 
.,.... 
0 
co 
"-I" 0) 
..- I.() 
-q-
.,.... 
(D (") 
l.{) ..- .,.... (") 
I.[) (") 
.,.... 
0) 
-q- I.() 
(") .,.... (") I.() 
t-- (") 
-tj- ..-
.,.... 
N 
.,.... (0 
s;j--
..-
r-- pH 9 
l.{) 
"-I" 
pH 9 .,.... (") 
(0 
.,.... 
en 
(") lO 
I.[) (0 
l.{) ..-
.,.... 
(") 0) 
(0 
(") ..-
l.{) N 
l.{) l.{) 
..... ..... -q-
t--
(0 
I.() 
(") 
'q-
(0 ..... 
N 
(") 
(0 
.,.... .,.... 
1750 1700 1650 1600 1550 1500 1450 1400 1350 1300 1750 1700 1650 1600 1550 1500 1450 1400 1350 1300 
Wavenumber (cm-1) Wavenu mber (cm-1) 
Figure 3.34: FTIR second derivative spectra of Msp4capNC and copper complex of 
Msp4capNC. The spectra of Msp4capNC in 2H2O at 2.5 mM peptide concentration, 1n 
the absence (left) and presence (right) of 10 mM CuCh, at pH 6.0, 7.0, 8.0, and 9.0. 
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Msp4capC+Cu. Absorbance and second derivative spectra (Figures 3.31 and 3.32, left 
panel, respectively) show that at pH 6.0-9.0 Msp4capC peptide adopts random-coil 
structure (the amide I band position at 1644-1641 cm-1). Copper addition at pH 6.0 and 
7.0 does not induce the formation of solvent-exposed a-helical structure as it does at pH 
8.0 and 9.0. The high intensity ratio of the 1360/1340 cm-1 doublet also indicates the 
formation of more folded stru·cture at pH 8.0 and 9.0, compared with pH 6.0 and 7.0. 
Msp4capNC+Cu. The amide I band position of Msp4capNC at pH 6.0-9.0 (se~ 
Figures 3.33 and 3.34, left panel) suggests that the peptide adopts random-coil structure. 
Copper ion induces the formation of solvent-exposed a-helical structure in Msp4capNC 
at pH 8.0 and 9.0 as indicated by the position of the amide I band at 1633 cm-1 in the 
absorbance (Figure 3.33, right panel) and second derivative spectra (Figure 3.34, right 
panel). The high intensity ratio of the 1360/1340 cm-1 doublets suggests the formation 
of a much more folded structure in the copper complex at pH 8.0-9.0. The absorbance 
spectra of Msp4capNC at pH 6.0 and 7.0 in the presence of copper are very poor and 
much noisier. However, the position of the amide I band (1652-1650 cm-1) and the low 
intensity ratio of the 1360/1340 cm-1 doublet indicate random-coil structure. 
Preliminary conclusion. As observed in the spectra of the previous two peptides, the 
spectra of the copper complex of Msp4 peptides also show two components of the 
amide I band (random-coil and a-helix structure), which reflect either the 
conformational heterogeneity within the same molecule or the presence of complexed 
and uncomplexed molecules. 
3.4.7. Copper-binding sites in multi-repeat (Msp2, Msp3, and Msp4 group) 
peptides. 
In the absence of stoichiometry data under similar experimental conditions, copper-
binding modes in multi-repeat peptides are difficult to predict. The role of the free 
imino group of Pro on binding of copper ion in multi-repeat peptides is evident from the 
lack of changes in the spectra of all capNC peptides, particularly at neutral pH and 
below. The appearance of the 1564 cm-1 band in copper-complex peptides indicates the 
coordination of the His side chain. The small shoulder at 1418 cm-1, which is the 
C=O/C-N- stretching of the deprotonated amide backbone, is also observed. Generally, 
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upon increasing pH to 9.0, this 1418 cm-1 band becomes stronger and appears as a 
discrete band. Overall, these data suggest that the possible copper-binding sites in the 
N-terminally uncapped multi-decarepeat peptides at neutral pH are the terminal imino 
group of Pro, the Nrr atom of the His side chain, and the nitrogen atom of the peptide 
backbone. The fact that the free imino terminal group of Pro is so important for copper 
binding indirectly suggests that the binding occurs only in the first repeat, where the 
imino group is the anchoring site. Therefore, in this case and assuming the 
stoichiometry is one copper ion per peptide molecule, the copper-coordination sphere in 
multi-repeat peptides will be the same as that for single-repeat peptide. However, we 
cannot eliminate the possibility that the subsequent repeat( s) would also bind copper 
ion, probably through the His side chain ( as an anchoring site) and amide nitrogen. 
Nonetheless, this binding will only occur at high pH, where copper coordination to the 
His side chain can be supported by the deprotonated amide nitrogen of the fourth and 
fifth Gly residues. 
The proposed binding mode described above could explain the phenomenon of the 
amide I band splitting reflecting the presence of conformational heterogeneity within 
the same peptide molecule. As copper binding in the multi-repeat peptides only occurs 
in the first repeat at low pH, this part of the peptide is likely a-helical but the C-terminal 
end still random coil. At higher pH, the complexes contain more a-helical content 
because subsequent repeat( s) bind copper ion via His and the amide backbone. 
3.4.8. Copper titration of Mspl at pH 8.0 
Figure 3.35 (A) shows the second derivative spectra obtained from copper-ion titration 
of Mspl, while (B) shows the plot of band intensity as a function of copper 
concentration. 
At 2.5 mM copper (1:1 ratio of copper to Mspl concentration), the band at ,..__,1617 cm-1 
starts to emerge. Addition of more copper increases the intensity of the ,..__,1617 cm-
1 
band, which, as discussed in section 3.4.1.2, has two origins: the intermolecular 
antiparallel ~-sheet structure and the deprotonated amide backbone. Above 5.0 mM 
copper concentration, the intensity of this band plateaus. 
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Figure 3.35: Copper titration of Mspl at pH 8.0. (A). FTIR second derivative spectra 
of Msp 1 in 2H20 at 2.5 mM peptide concentration, in the absence and presence of 
various amounts of CuCh, at pH 8.0. (B). Plot of absorbance versus copper 
concentration. The half height of the curve of absorbance at 15 62 cm-1 versus copper 
concentration indicates a ~ of 1. 7 mM. 
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The intensity of the 15 62 cm-1 band increases upon addition of copper and then starts to 
level out, while the intensity of the ,__, 1592 cm-1 band decreases, reaching its lowest value 
at 5 mM copper concentration, and then increases as more copper is added. The 
decrease of the band at,__, 1592 cm-1 could reflect a shift of the tautomeric form from II to 
I upon interaction with copper ion, while the increase indicates that this band has more 
than one vibrational origin. 
The band at 1562 cm-1 was taken as a marker band for copper binding to Msp 1 peptide. 
The intensity of this band was plot against the copper concentration. The shape of the 
curve (Figure 3.35 (B)) shows the binding is under equilibrium conditions, rather than 
stoichiometric conditions, from which we can only extract accurate information about 
the Kci but not stoichiometry. The half height of the maximum indicates a Kci value of 
1. 7 mM. This Kci value is 6 orders of magnitude greater than the value obtained from 
fluorescence titration spectroscopy (Chapter IV), which is in the nM range. The peptide 
concentrations employed in each method differ greatly: FTIR requires peptide in the 
mM range, while fluorescence measurements are made in the µM range. The result 
indicates the dependence of the Kci value on peptide concentration. 
3.4.9. Binding of other metals to Mspl and Msp4 
The possibility that other metals bind to Msp 1 and Msp4 has been investigated. As 
shown in Figure 3.36, addition of other metal ions (Zn2+, Ca2+, Mn2+, and Mg2+) at pH 
8.0 does not change the conformation of Mspl, as suggested by the frequency of the 
amide I band at ,__, 1652 cm-1, and lack of the 1617 cm-1 band. The possibility that Msp 1 
binds Zn2+ without inducing structural changes is suggested by changes in some bands. 
Upon addition of Zn2+, a weak band appears at 1572 cm-1, suggesting binding to the 
nitrogen atom of the imidazole ring of His, most likely the Nrc atom. 
Addition of Zn2+ to Msp4 resulted in a dramatic change in the amide I band ( see Figure 
3.37). A weak component band appears at 1684 cm-1 and a shoulder appears at 1630 
cm-
1
. The appearance of these two weak bands probably reflects the formation of an 
intramolecular ~-sheet structure in the zinc-bound form of Msp4. Upon addition of 
Ca2+ and Mg2+ to Msp4, the amide I band becomes broader, suggesting the possibility of 
metal binding to the C=O group of the amide backbone and to the terminal coo- group. 
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Figure 3.36: Binding of other metals to Msp 1 peptide. FTIR second derivative spectra 
of Mspl in 2H2O at 2.5 mM peptide concentration, in the absence and presence of 10 
mM metal salts (CuCh, ZnCh, CaCh, MnCh, and MgCh), at pH 8.0. 
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Figure 3.37: Binding of other metals to Msp4 peptide. FTIR second derivative spectra 
of Msp4 in 2H2O at 2.5 n1M peptide concentration, in the absence and presence of 10 
mM metal salts (CuCh, ZnCh, CaCh, MnCh, and MgCh), at pH 8.0. 
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3.5. Conclusions 
Information on the conformation of PrP-repeat peptides of marsupial origin has been 
obtained. In the absence of copper, the structure of the repeat peptides is random coil, 
as suggested by the position of the amide I band. Interaction with copper ion induces 
the formation of more hydrogen-bonded structure. Although short repeats (Msp 1, 11 
residues and Msp2, 21 residues) show some structural modification towards more 
ordered structure upon interaction with copper, the major increase in helical content 
occurs in the long-repeat (Msp3, 31 residues and Msp4, 41 residues) peptides. 
Modes for copper binding in the marsupial PrP-repeat peptides have been proposed, 
based on their FTIR spectra. These binding modes differ from those proposed for 
human PrP repeats. Also as marsupial PrP has four repeats, each with slightly different 
sequence, the binding modes differ from each other. It is suggested that the first-repeat 
sequence (PQGGGTNWGQ) does not bind copper ions. The lack of a His residue 
prevents copper binding to this repeat, while the GGG segment does not appear 
sufficient to mediate the binding by itself. The second- and third-repeat sequences 
t 
' :.-: 
(PHPGGSNWGQ PHPGGSSWGQ) are deduced to bind copper ion at pH 8.0 and 
above, based on the assignment of the FTIR spectra of the Msp2capNC peptide 
(PHPGGSNWGQ PHPGGSNWGQ). The fourth-repeat sequence (PHGGSNWGQ) 
binds copper ion well at pH 8.0 and possibly also at lower pH. In this peptide copper 
ion binds predominantly to the N1 atom of the second His and the nitrogen atoms of the 
third and fourth Gly amides. Thus overall, it is proposed that the marsupial PrP-repeats 
region binds only one copper ion below pH 8.0, while at pH 8.0 and above it will 
probably bind two copper ions. However, this stoichiometry still needs further 
clarification. A substantial literature implicates a role for mammalian PrP in regulating 
intracellular copper concentration (refer to Chapter I). The findings here support a 
similar mechanism for regulating intracellular copper concentration in marsupial brain. 
} J ·_. 
Mutation of the third Pro residue into Gly 1n the second-repeat sequence 
(PHPGGSNWGQ into PHGGGSNWGQ) changes the binding pattern significantly. 
This peptide binds copper very effectively at pH 8.0 and below, via Cu-Nn: and Cu-N-c 
bonds of His and a Cu-N bond of the amide backbone of the third and fourth Gly 
residues. This mutated sequence is analogous to the mammalian PrP-repeat sequence in 
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the first half of the repeat: the results suggest that mammalian PrP-repeats are more 
effective at binding copper than the marsupial PrP-repeat region. 
The experiments also showed copper complexes of multi-repeat peptides at pH 8.0 and 
below have very low solubility compared with the single-repeat peptide. This low 
solubility is associated with more folded structure in which the Trp environment is more 
shielded from solvent. The consequences of this for the solubility of the multi-repeat 
region of marsupial PrP when embedded in the complete protein are not predictable, but 
lead to a reduction in overall protein solubility. Copper-bound repeats may also be less 
available for proteolysis or may configure the protein for enhanced binding with other 
ligands, such as sugar. 
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Chapter IV 
Fluorescence Titration Spectrophotometry 
Fluorescence spectrophotometry is a widely used technique in the study of protein-
ligand interactions. Although it does not provide detailed structural information, the 
technique can be used to characterize functionality and biochemistry of a protein or 
peptide by studying the binding of particular compounds. In this project, fluorescence 
spectrophotometry has been used to characterize one proposed function of PrP, namely 
the binding of copper ions to synthetic peptides of the N-terminal tandem repeat region 
of a marsupial PrP (Msp). 
4.1. Introduction 
Fluorescence is the process that occurs when a molecule absorbs light at a particular 
wavelength and then quickly re-emits the energy at a slightly longer wavelength. 
Fluorescence occurs in certain molecules, which are called fluorophores. The 
fluorescence properties of these molecules arise from delocalized electrons formally 
present in conjugated double bonds. The fluorescence process is illustrated in Figure 
4 .1, which is the energy level diagram also known as a Jablonski diagram. The diagram 
shows that absorbing light will excite the electror/ of the fluorophore from the lowest I 
energy level, S0 (singlet ground state), to a higher energy level of either S1 (first singlet 
state) or S2 (second singlet state). The fluorescence radiation occurs when the paired 
electron returns from the first excited state to the ground state (Lakowicz, 1983 p.4). 
The fluorescence of proteins originates from Phe, Tyr, and Trp residues. In most 
proteins the fluorescence of Tyr and Phe residues is greatly exceeded by that of Trp 
residues: the extinction coefficient at the wavelength of excitation and the quantum 
yield of emission of Trp are considerably greater than the respective values for Tyr and 
Phe. The fluorescence sensitivity, which is the quantum yield multiplied by the 
extinction coefficient, is 730 for Trp, 200 for Tyr and 4 for Phe (Schmid, 1997). 
The emission maximum of Trp is highly sensitive to solvent polarity, as well as to 
specific interactions between the solvent and the indole ring. As a result, the emission 
maximum of proteins is dependent upon these factors, which affect the exposure of the 
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Trp residues to the aqueous phase (Lakowicz, 1983 p.354). · The sensitivity of Trp 
fluorescence to the surrounding environment thus makes it a very useful probe to study 
the binding of protein to ligand. The association of a ligand with a protein to form a 
complex is sometimes accompanied by a change in the fluorescence spectrum of the 
protein, due to changes in protein conformation. The emission maximum of Trp in the 
protein will be blue shifted if the binding of ligand results in Trp being more buried in 
the interior of the protein and shielded from contact with the solvent water. When 
binding causes Trp to be more exposed to water, a red shift will occur (Lakowicz, 1983 
p.358-359). Such shifts of the emission maximum, resulting from conformational 
changes, are often accompanied by a decrease in the emission intensity. These 
properties of Trp fluorescence provide considerable potential for quantification of 
association reactions between proteins and other molecules. 
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Figure 4.1: Jablonski diagram illustrating the processes involved in the creation of 
fluorescence. Excitation (1 ), a molecule is initiated with a photon of energy hVEx 
creating an excited electronic singlet state (S 1 ') from the ground state (S 0); excited state 
lifetime (2), typically 1-10 nanoseconds, during this time, the fluorophore loses part of 
its energy due to its interaction with the environment resulting in a relaxed singlet 
excited state (S 1); fluorescence emission (3), the fluorophore returns to its ground state 
by emitting a photon of energy hVEM (Haughland, 2001 ). 
Besides the presence of intrinsic fluorophores such as Trp, the quantification of the 
binding process between protein and ligand using the fluorescence method must meet 
several other conditions. According to Pesce (1971 ), first, the changes in fluorescence 
should be rapid relative to the binding process, so that the only time-dependent 
processes are the actual binding processes. The second condition is the dissociation 
constant, which should be about 1 o-8 M or more in order to be able to detect changes 
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due to ligand binding, given the lowest protein concentration that can be managed 
(Pesce, 1971 p.212). 
All of the above requirements are fulfilled in the copper-binding PrP-repeats system. 
Fluorescence spectrophotometry has previously been used to study copper binding to 
the repeats (Hornshaw et al., 1995a; Jackson et al., 2001; Kramer et al. , 2001) . In this 
case, the measurable parameter is the fluorescence quenching of the intrinsic Trp ( or 
Tyr for avian repeats) upon binding of copper. The fluorescence results reported in the 
literature are included in Table 1.3 of Chapter I. 
Table 1.3 indicates that binding of copper to synthetic peptides containing four 
tandemly repeated units of the consensus sequence of the human PrP octarepeats 
([PHGGGWGQJ4) (Octa4) showed a measured Ket of 6.7 µM, while for the chicken PrP 
hexarepeat ([NPGYPHJ4) (Hexa4) the value was 4.5 µM (Hornshaw et al., 1995a). A 
similar binding affinity of 5 .5 µM was reported for synthetic peptide spanning residues 
60-91 of the N-terminal human PrP (Kramer et al., 2001), which contains the sequence 
of 4 consensus octarepeats ([PHGGGWGQ]4), exactly the same as Octa4 reported by 
Hornshaw et al. (1995a). The affinity and cooperativity were increased if the octarepeat 
region was C- and N-terminally extended. Thus, the affinity for copper binding to 
human PrP60-109 was reported as 2.5 µM, and to human PrP23_9g, human PrP23 _11 2, and 
human PrP23_231 all as 2.2 µM (Kramer et al., 2001). Copper ions also bind to the C-
terminal structured part of murine PrP121_231 with a dissociation constant of 8 µM 
(Kramer et al., 2001). 
As mentioned in Chapter I, the Ket values in the micromolar range obtained from 
fluorimetry experiments of Hornshaw et al. (1995a) and Kramer et al. (2001) are in 
good agreement with those from other methods, but in contrast to one fluorimetry study 
by Jackson et al. (2001). Jackson et al. (2001) measured the copper-binding affinity of 
PrPs2-98 in the presence of a weak chelator, Gly (500 µM), and obtained an apparent Ket 
of 3.2 µM, that when back calculated from the competitive buffering effect of Gly 
resulted in a real Ket of 8 fM. Jackson et al. (2001) argued that incorporation of Gly in 
the system abolished the weak binding, and weakened the apparent binding affinity of 
the tight sites, to a level that is measurable by fluorescence. In the absence of Gly, the 
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only measurable signal observed represents binding to the weak site, while the tight site 
has already been saturated in the early states of titration. Jackson et al. (2001) also 
show that the real l<{l was unaffected by the Gly concentration. This suggested Gly as a 
suitable chelating agent to weaken the affinity of the tight sites (Jackson et al., 2001 ). 
However, this idea has been challenged by recent CD experiments of Garnett and Viles 
(2003), which show that Gly, for which the affinity for copper is 12 nM, completely 
abolishes the binding between copper and the human repeat peptide (PrP58_91 ). Thus, 
Garnett and Viles (2003) suggest that the affinity of copper binding to PrP-repeat 
peptide should be less than the affinity of copper binding to the amino acid Gly, or the 
Kd value should be higher than 12 nM (Garnett and Viles, 2003). 
To measure binding equilibria, it is necessary that experimental conditions be such that 
free peptide, free ligand, and protein complex are all present in detectable 
concentrations (in equilibrium). To achieve this condition, the concentration of peptide 
must be less than or about equal to Kct, and certainly not greater than a factor of 10 
different (Pesce, 1971 p.211; Bagshaw and Harris, 1987). So to be able to identify the 
tight binding sites for copper in PrP in the absence of a weak chelator, the peptide 
concentration would need to be of the same order as the Kct. This requirement 
sometimes cannot be fulfilled, especially if the intrinsic Trp is used as a fluorophore, as 
it can only be detected down to about 100 nM in the best of cases; this is a drawback of 
using Trp as a fluorescence probe. Hence, the method of using a weak chelating agent 
to elucidate the tight copper-binding site in PrP, such that has been developed by 
Jackson et al. (2001), could be an alternative way of elucidating the tight binding site. 
However, it would be good to confirm this method by using a different type of chelator 
with different copper-binding affinity. If the method is valid, then by varying the type 
of chelator, the real l<{l of copper binding to PrP should remain the same. 
4.2. Aims 
Fluorescence spectrophotometry experiments were performed to measure the l<{l of 
complexes between Msp peptides (see Table 4.1) and copper ions at various pHs. 
Experiments using mutant Msp 1 peptides, His-methylated peptides, and peptides with 
modified repeat sequence were carried out to gain information on the possible roles of 
some residue groups in copper binding. 
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4.3. Materials and methods 
4.3.1. Sample preparation 
Table 4.1: Synthetic peptides used in the experiments. 
Group Peptide Sequence 
Msp4 group Msp4 (PHPGGSNWGQ)4G 
Msp4capC (PHPGGSNWGQ)4G-NH2 
Msp4capNC Ac-(PHPGGSNW GQ)4G-NH2 
Msp3 group Msp3 (PHPGGSNWGQ)3G 
Msp3capC (PHPGGSNWGQ)3G-NH2 
Msp3capNC Ac-(PHPGGSNW GQ)3G-NH2 
Msp2 group Msp2 (PHPGGSNWGQ)2G 
Msp2capC (PHPGGSNWGQ)2G-NH2 
Msp2capNC Ac-(PHPGGSNW GQ)2G-NH2 
Mspl group Mspl PHPGGSNWGQG 
MsplcapC PHPGGSNWGQG-NH2 
MsplcapNC Ac-PHPGGSNWGQG-NH2 
Msp 1 variant MsplcapN Ac-PHPGGSNWGQG 
and mutant Msp1H2A P APGGSNWGQG 
Msp1N7A PHPGGSA WGQG 
MsplQl0A PHPGGSNWGAG 
Mspl Msp 1 His( 1 Me )capC PH[1Me]PGGSNWGQG-NH2 
His-methylated Msp1His(3Me)capC PH[ nMe ]PGGSNW GQG-NH2 
Modified repeat MsplP3GcapNC Ac-PHGGGSNWGQG-NH2 
sequences Msp lstrepcapNC Ac-PQGGGTNWGQG-NH2 
Msp 4threpcapNC Ac-PHGGSNWGQG-NH2 
HulcapNC Ac-PHGGGWGQG-NH2 
Size 
41 
41 
41 
31 
31 
31 
21 
21 
21 
11 
11 
11 
11 
11 
11 
11 
11 
11 
11 
11 
10 
9 
Msp + Cu at different pHs. For the measurement of ~ at various pHs, 0.5 µM 
peptide (see Table 4.1) solution was prepared in 25 mM phosphate buffer pH 6.0, 7.4 
and 8.0. The ionic strength of the solution was kept constant at 0.1 by incorporating 0.1 
M NaCl in the buffer solution. The presence of 0.1 M NaCl also prevents nonspecific 
binding of copper to Msp peptides (Kramer et al., 2001 ). During the titration, 
incremental 1 µL aliquots of 100 µM Cu(Gly)2 were added to the peptide solution in 
experiments at pH 6.0, 7.4, and 8.0. These experiments were performed before the 
Jackson et al. (2001) paper was published. The reason why copper ion was supplied as 
Cu(Gly)2 was to prevent the precipitation of copper as copper hydroxide at the higher 
pH (Brown et al., 1997). The final concentration of Gly (2 x Cu) is much lower (0-2.5 
µM) than in the experiments of Jackson et al. (500 µM) . Also, the total concentration of 
copper ions added to the solution during the titration is very low, in most cases under 1 
µM, so collisional quenching of Trp by copper ions and the inner filter effect of copper 
can be neglected. 
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Mutant Mspl + Cu. The conditions for investigating copper.binding to mutant Msp 1 
peptides were different: in each experiment 2 µM peptide (Msp 1, Msp 1 capN, 
MsplcapNC, Msp1H2A, Msp1N7A, and MsplQl0A) was used. During the titration, 
incremental 1 µL aliquots of 100 µM CuSO4 were added to the peptide solution until 
the final concentration of CuSO4 was 2.5 µM . The solution was maintained at pH 7.4 
by PBS buffer (for concentrations of buffer components refer to section 2.2.2.1 of 
Chapter II). 
4.3.2. Conditions of data acquisition and data analysis 
The measurements were carried out using the LS SOB Perkin-Elmer Spectrofluorimeter. 
The temperature was regulated by means of a circulating water bath to be around 25 ± 
0.2 °c. The sample, 3 mL Msp peptide (from 100 µM stock) solution in appropriate 
buffer, was placed in a 3 mL quartz cuvette with four-sided polished windows of path 
length 10 mm. The sample was excited at 280 nm with band slit width 5 nm. Emission 
spectra were recorded between 300 and 500 nm before and after addition of incremental 
1 µL aliquots of copper ion solution. 
To determine the Ki in conditions where the concentration of metal-binding sites was 
smaller than Ki ( equilibrium binding conditions), quenching data were fitted to 
Equation 4.1 (Jackson et al., 2001). The fitting was carried out with non-linear least 
square methods using the computer program GraphPad Prism 3. However, most of the 
curves of fluorescence intensity (F) versus copper concentration [Cu] indicate that the 
experiments have been conducted under stoichiometric binding conditions where the 
peptide concentration is equal to or greater than Kd. Therefore, the binding data was 
fitted to the quadratically derived equation (Equation 4.2) (Jackson et al. , 2001 ; Ozer 
and Tacal, 2001). 
F=Fo-{(F0-Fs)[Cu]/(Ki+[Cu])} (Equation 4.1) 
F=F o-{ (Fo-F s) [( Cs+[ Cu ]+Ki)± { ( Cs+[ Cu ]+Ki)2 -4Cs[ Cu] } 0·5]/2Cs} (Equation 4 .2) 
F o F, and F s are fluorescence at zero, sub-saturating and saturating copper concentration 
[Cu]. Cs is the concentration of copper-binding sites. 
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4.4. Results and discussion 
4.4.1. The emission maximum of Msp peptides does not change upon copper 
addition 
The wavelength of the emission maximum of Msp peptides is typically at 354-356 nm 
(see Figure 4.2). As this is the same as free amino acid Trp (Schmid, 1997), it indicates 
that Trp residues in the peptides are highly exposed to solvent. Upon copper binding 
the emission maximum does not change; this suggests that the Trp residues do not 
become more buried but are still exposed to water even though conformational changes 
take place. FTIR experiments (Chapter III) showed that the conformation of the Msp 
peptides in the absence of copper is random coil, while in the presence of copper it is a 
solvent-exposed a-helix. Both conformations would allow the Trp residues to be in 
contact with the solvent water, and are thus consistent with the unchanged emission 
maximum of the fluorescence spectra at 354-356 nm. 
4.4.2. Titrations have been carried out under stoichiometric binding conditions 
Copper-binding sites in Msp peptides, except in Msp 1 H2A, 0.1 µM Msp 1 capC, and 0.1 
µM Msp4capC, are saturable as shown by the curves that reach a plateau at µM 
concentration (see Figures 4.3 - 4.10, and 4.12 - 4.15). The plot of fluorescence versus 
[Cu] is bi-phasic with no curved regions: most of the graphs except for copper binding 
to Msp1H2A (see Figure 4.12 D), 0.1 µM MsplcapC (Figure 4.14 E) and 0.1 µM 
Msp4capC (Figure 4.15 D) are composed simply of two linear segments. In the initial 
phase, increase in the copper ion concentration resulted in a linear decrease of 
fluorescence as long as there are sites available on the peptides. When all sites have 
been occupied the fluorescence no longer decreases; it reaches a saturation point, which 
occupies the second phase of the curve. The absence of a curvature region indicates the 
presence of extremely tight binding between copper and Msp peptides. This bi-phasic 
behavior also shows that the concentration of the peptides used in the experiment is far 
greater than the Ki. This condition is often referred to as stoichiometric binding in 
which either the peptide or ligand ( or both) is fully bound (Pesce, 1971 p.208), and, 
therefore no free copper ions are left in the system. The binding curves that exhibit a 
sharp transition at the saturation point, indicating tight binding, were also observed for 
copper titration to segments of PrP octarepeat (HGGGW, HGGG, and HGG) (Garnett 
and Viles, 2003). 
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Figure 4.2: Typical fluorescence emission spectra ( excitation at 280 nm) of Msp 
peptides during copper ion titration. Spectra of 2 µM Msp 1 N7 A in PBS buffer pH 7 .4 
titrated with 1 µL aliquots of 300 µM CuSO4 . 
4.4.3. Different equations used to describe different binding conditions 
A straight line in the initial part of titration under stoichiometric binding conditions 
(Figures 4.3 -4.10, and 4.12 -4.15) shows a linear relationship between fluorescence 
intensity and the addition of copper ion solution. This is evidence for the validity of the 
assumption that the change in quantum yield of a protein or ligand is the same for each 
molecule of ligand bound (Pesce, 1971 p.220). This assumption is made for the validity 
of the usage of Equations 4.1 and 4.2. 
From the fluorescence titration curves (see Figures 4.3 - 4.10, and 4.12 - 4.15), it is 
apparent that all titration experiments, except those with Msp1H2A (see Figure 4.12 D), 
0.1 µM MsplcapC (Figure 4.14 E) and 0.1 µM Msp4capC (Figure 4.15 D), were 
conducted under stoichiometric binding conditions (Pesce, 1971 p.208). These data 
were best fitted by nonlinear regression analysis using Equation 4.2 (Jackson et al., 
2001; Ozer and Tacal, 2001). 
The graph of F versus [Cu] in Msp1H2A (see Figure 4.14 D), 0.1 µM MsplcapC 
(Figure 4.11 E) and 0.1 µM Msp4capC (Figure 4.12 D) shows the curvature region. 
This indicates that the binding between copper and these peptides is under equilibrium 
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conditions (Pesce, 1971 p.208). In this situation, free copper; free peptide, as well as 
the complex are present in the system. The Kct for copper binding to these peptides was 
calculated using Equation 4.1 (Jackson et al., 2001; Ozer and Tacal, 2001). 
Kci values generated from analysis of the stoichiometric binding data that fit to Equation 
4.2 are very approximate, ev~n though the R2 values in most cases are reasonably high. 
Under stoichiometric conditions, the binding parameter that can be determined with 
reasonable accuracy is the number of binding sites or the binding stoichiometry (in 
Equation 4.2 it is represented as Cs), while in the equilibrium binding conditions it is the 
Kci value that can be accurately determined. 
4.4.4. Copper-binding properties of Mspn (n = 1, 2, 3, and 4) group peptides 
4.4.4.1. The effect of N-terminal capping on copper binding to the peptides 
The experiments show that copper addition to uncapped Msp 1 and Msp 1 capC peptides 
resulted in quenching of Trp fluorescence intensity, which suggests binding occurs 
between the peptides and copper ions. Copper ion addition to the Msp 1 capNC peptide, 
on the other hand, does not result in quenching of Trp fluorescence intensity, indicating 
no binding between the peptide and copper ion, and suggesting that copper binding to 
the peptide requires the free imino group of Pro at the N-terminus. These data are in 
good agreement with FTIR results, which also show the importance of the imino group 
of Pro in copper binding. 
. 
4.4.4.2. The Ket values for copper binding to the peptides at pH 6.0, 7.4, and 8.0 
Quantitative data in Table 4.2 show that pH has a significant influence on the Kci values 
for copper binding to Mspn group peptides. Several .experiments at pH 7.4 and 8.0 
result in Kci values that do not differ if the errors are taken into account. Kci values at pH 
6.0 are generally much higher than values at pH 7.4 and 8.0, which indicates weaker 
binding, which is likely due to the His residue being protonated. Several points 
regarding the Kci values in Table 4.2 are discussed below. 
The large error in the Kci value for copper binding to MsplcapC at pH 8.0 (0.2 ± 0.2 
nM; see Figure 4.4.F and Table 4.2) indicates it is only approximately determined. As 
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has been pointed out in the above section, the binding conditions under which these data 
were acquired is stoichiometric binding conditions, where Kd determination is not 
accurate. 
One Kct value for copper binding to Msp2capC at pH 7 .4 is 1.1 nM with no standard 
error, as the data have been fitted to Equation 4.2 by incorporating this Kd value as a 
constant to get the best R2 parameter. 
Kct values for copper binding to Msp3capC and Msp4capC show large variation 
between duplicate experiments. The large variation suggests sensitivity to set up, and 
may also be du~ in part to fact that the experimental conditions ( stoichiometric binding 
conditions) are not appropriate for the determination of Kct. Also, in Msp4capC, the 
differences in Kct as a function of pH are not so prominent. 
The Kct values for copper binding to Mspn (n = 1, 2, 3, 4) group peptides (see Table 4.2) 
are in the nM range. This is significantly lower than values for copper binding to other 
PrP peptides reported in the literature (see Table 1.3 of Chapter I), where the 
measurements were conducted using the fluorimetry method, but in the absence of a 
chelator (Hornshaw et al., 1995a; I<ramer et al., 2001). However, the difference 
between these Kct values and those of Hornshaw and Kramer probably arise mainly from 
the difference in the way the data have been analyzed. Hornshaw et al. (1995a) utilized 
linear regression analysis, which is the double reciprocal plot of the binding data, while 
Kramer et al. (2001) employed a modified Stern-Volmer equation to calculate the Kct. 
However, some differences will also result from the different repeat sequence (we have 
used marsupial PrP sequence) and other experimental conditions (pH, peptide 
concentration, etc.). Kct values here fall between the flv1 (Jackson et al. , 2001) and µM 
ranges (Hornshaw et al., 1995a; Kramer et al., 2001) reported for copper binding to PrP-
repeat peptides obtained from fluorimetry experiments. Garnett and Viles (2003) 
predict the Kct values for human repeats are between 10 nm - 10 µM (see Table 1.3 of 
Chapter I). 
The effect of pH on the Kct value (lower pH resulted in higher Kct and vice versa) is 
consistent with a proposed function of PrP as a copper transport protein, which shuttles 
99 
copper ions from the extracellular milieu to endolysosomes (Pauly and Harris, 1998). 
As the pH of the extracellular space is neutral and the pH of the endolysosomes is 
slightly acidic, it can be predicted that copper will bind more tightly to PrP in the 
extracellular space and will dissociate in the endolysosomes. 
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Figure 4.3: Fluorescence titration curves for copper (II) binding to Msp 1. Experiments 
were carried out with 0.5 µM peptide titrated with 1 µL aliquots of 100 µM Cu(Gly)2 in 
phosphate buffer pH 6.0 (A), pH 7.4 (B) and pH 8.0 (C). Squares represent the data 
points and the line results from nonlinear regression analysis according to Equation 4.2. 
The analysis generates Ki values of 10.4 ± 2.8 nM at pH 6.0 (A), 2.2 ± 0.7 nM at pH 7.4 
(B), and 0.5 ± 0.3 nM at pH 8.0 (C). 
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Figure 4.4: Fluorescence titration curves (in duplicate) for copper (II) binding to 
Msp 1 capC. Experiments were carried out with 0.5 µM peptide titrated with 1 µL 
aliquots of 100 µM Cu(Gly)2 in phosphate buffer pH 6.0 (A & D), pH 7.4 (B & E) and 
pH 8.0 (C & F). Squares represent the data points and the line results from nonlinear 
regression analysis according to Equation 4.2. The analysis generates Ka values of 8.2 
± 1.6 nM (A) and 10.9 ± 1.7 nM (D) at pH 6.0, 1.0 ± 0.5 nM (B) and 0.5 ± 0.2 nM (E) 
at pH 7.4, and 0.9 ± 0.4 nM (C) and 0.2 ± 0.2 nM (F) at pH 8.0. 
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Figure 4.5: Fluorescence titration curves for copper (II) binding to Msp2. Experiments 
were carried out with 0.5 µM peptide titrated with 1 µL aliquots of 100 µM Cu(Gly)2 in 
phosphate buffer pH 6.0 (A), pH 7.4 (B) and pH 8.0 (C). Squares represent the data 
points and the line results from nonlinear regression analysis according to Equation 4.2. 
The analysis generates Ki values of 4.9 ± 0.7 nM at pH 6.0 (A), 0.4 ± 0.2 nM at pH 7.4 
(B), and 0.3 ± 0.2 nM at pH 8.0 (C). 
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Figure 4.6: Fluorescence titration curves (in duplicate) for copper (II) binding to 
Msp2capC. Experiments were carried out with 0.5 µM peptide titrated with 1 µL 
aliquots of 100 µM Cu(Gly)2 in phosphate buffer pH 6.0 (A & D), pH 7.4 (B & E), and 
pH 8.0 (C & F). Squares represent the data points and the line results from nonlinear 
regression analysis according to Equation 4.2. The analysis generates Ki values of 2.6 
± 1.1 nM (A) and 2.8 ± 0.5 nM (D) at pH 6.0, 1.2 ± 0.7 nM (B) and 1.1 nM (E) at pH 
7.4, and 0.8 ± 0.5 nM (C) and 0.2 ± 0.1 nM (F) at pH 8.0. 
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Figure 4. 7: Fluorescence titration curves for copper (II) binding to Msp3. Experiments 
were carried out with 0.5 µM peptide titrated with 1 µL aliquots of 100 µM Cu(Gly)2 in 
phosphate buffer pH 6.0 (A), pH 7.4 (B), and pH 8.0 (C). Squares represent the data 
points and the line results from nonlinear regression analysis according to Equation 4.2. 
The analysis generates Kct values of 7.7 ± 1.0 nM at pH 6.0 (A), 3.9 ± 0.9 nM at pH 7.4 
(B), and 3.7 ± 0.5 nM at pH 8.0 (C). 
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Figure 4.8: Fluorescence titration curves (in duplicate) for copper (II) binding to 
Msp3capC. Experiments were carried out with 0.5 µM peptide titrated with 1 µL 
aliquots of 100 µM Cu(Gly)2 in phosphate buffer pH 6.0 (A & D), pH 7.4 (B & E), and 
pH 8.0 (C & F). Squares represent the data points and the line results from nonlinear 
regression analysis according to Equation 4.2. The analysis generates Ki values of 7.0 
± 2.3 nM (A) and 1.3 ± 0.7 nM (D) at pH 6.0, 1.7 ± 0.8 nM (B) and 0.5 ± 0.5 nM (E) at 
pH 7.4, and 8.4 ± 2.1 nM (C) and 0.3 ± 0.4 nM (F) at pH 8.0. 
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Figure 4.9: Fluorescence titration curves for copper (II) binding to Msp4. Experiments 
were carried out with 0.5 µM peptide titrated with 1 µL aliquots of 100 µM Cu(Gly)2 in 
phosphate buffer pH 6.0 (A), pH 7.4 (B), and pH 8.0 (C). Squares represent the data 
points and the line results from nonlinear regression analysis according to Equation 4.2. 
The analysis generates Ki values of 9.3 ± 1.6 nM at pH 6.0 (A), 3.2 ± 1.0 nM at pH 7.4 
(B), and 2.6 ± 1.0 nM at pH 8.0 (C). 
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Figure 4.10: Fluorescence titration curves (in duplicate) for copper (II) binding to 
Msp4capC. Experiments were carried out with 0.5 µM peptide titrated with 1 µL 
aliquots of 100 µM Cu(Gly)2 in phosphate buffer pH 6.0 (A & D), pH 7.4 (B & E), and 
pH 8.0 (C & F). Squares represent the data points and the line results from nonlinear 
regression analysis according to Equation 4.2. The analysis generates :Ki values of 31.2 
± 8.5 nM (A) and 5.0 ± 2.0 nM (D) at pH 6.0, 5.1 ± 2.0 nM (B) and 1.2 ± 0.6 nM (E) at 
pH 7.4, and 9.1 ± 3.0 nM (C) and 4.8 ± 1.7 nM (F) at pH 8.0. 
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Table 4.2: Effect of pH on Ki values of copper binding to Msp and MspcapC peptides. 
Experimental conditions Results Fig no. 
Peptide [peptide] pH Ki (nM) Cs (µM) R2 
Mspl 0.5 µM 6.0 10.4±2.8 0.366 + 0.014 0.9895 4.3 A 
7.4 2.2 ± 0.7 0.400 (c) 0.9954 4.3 B 
8.0 0.5 ± 0.3 0.434 + 0.003 0.9991 4.3 C 
MsplcapC (a) 0.5 µM . 6.0 8.2 ± 1.6 0.335 + 0.006 0.9988 4.4.A 
7.4 1.0 ± 0.5 0.286 + 0.004 0.9983 4.4.B 
8.0 0.9 ± 0.4 0.269 + 0.003 0.9988 4.4 C 
MsplcapC (b) 0.5 µM 6.0 10.9 ± 1.7 0.254 + 0.005 0.9992 4.4D 
7.4 0.5 ± 0.2 0.239 + 0.002 0.9995 4.4 E 
8.0 0.2 ±0.2 0.232 (c) 0.9976 4.4 F 
Msp2 0.5 µM 6.0 4.9 ± 0.7 0.566 + 0.005 0.9988 4.5 A 
7.4 0.4 ±0.2 0.620 + 0.002 0.9996 4.5 B 
8.0 0.3 ±0.2 0.617 + 0.003 0.9995 4.5 C 
Msp2capC (a) 0.5 µM 6.0 2.6±1.1 0.279 + 0.006 0.9973 4.6A 
7.4 1.2 ± 0.7 0.268 + 0.005 0.9979 4.6 B 
8.0 0.8 ±0.5 0.264 + 0.004 0.9982 4.6 C 
Msp2capC (b) 0.5 µM 6.0 2.8 ± 0.5 0.283 + 0.002 0.9996 4.6D 
7.4 1.l(c) 0.268 (c) 0.9738 4.6 E 
8.0 0.2 ± 0.1 0.242 + 0.002 0.9997 4.6 F 
Msp3 0.5 µM 6.0 7.7 ± 1.0 0.524 + 0.006 0.9982 4.7 A 
7.4 3.9 ± 0.9 0.581 + 0.007 0.9974 4.7 B 
8.0 3.7 ± 0.5 0.584 + 0.004 0.9992 4.7 C 
Msp3capC ( a) 0.5 µM 6.0 7.0 ±2.3 0.140 + 0.009 0.9920 4.8 A 
7.4 1.7 ± 0.8 0.153 + 0.005 0.9959 4.8 B 
8.0 8.4 ± 2.1 0.110 + 0.008 0.9933 4.8 C 
Msp3capC (b) 0.5 µM 6.0 1.3 ± 0.7 0.213 + 0.004 0.9980 4.8D 
7.4 0.5 ± 0.5 0.188 + 0.004 0.9950 4.8 E 
8.0 0.3 ±0.4 0.171 + 0.004 0.9969 4.8 F 
Msp4 0.5 µM 6.0 9.3 ± 1.6 0.364 + 0.008 0.9964 4.9A 
7.4 3.2 ± 1.0 0.376 + 0.007 0.9967 4.9B 
8.0 2.6 ± 1.0 0.370 + 0.008 0.9953 4.9 C 
Msp4capC (a) 0.5 µM 6.0 31.2 ± 8.5 0.131 + 0.021 0.9891 4.10A 
7.4 5.1 ±2.0 0.136 + 0.009 0.9904 4.10 B 
8.0 9.1 ± 3.0 0.107 + 0.011 0.9880 4.10 C 
Msp4capC (b) 0.5 µM 6.0 5.0 ±2.0 0.172 + 0.008 0.9951 4.10D 
7.4 1.2 ± 0.6 0.168 + 0.004 0.9977 4.10 E 
8.0 4.8 ± 1.7 0.141 + 0.007 0.9956 4.10 F 
( a) and (b) are duplicates, Cs is copper concentration at saturation point, which indicates 
the binding stoichiometry, ( c) the data have been fitted to Equation 4.2 by incorporating 
this Kd or the Cs value as a constant to get the best R2 parameter. · 
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4.4.4.3. The stoichiometry of the binding (Cs) 
As noted earlier, the binding data show that experiments were conducted under 
stoichiometric binding conditions. Under these conditions, the number of binding sites 
can be determined accurately: this is shown by the low standard errors for the Cs values. 
The Cs values indicate the concentration of copper ions bound to the peptide, or the 
concentration of the binding sites in the peptide that is occupied by copper. 
The Cs values for copper binding to 0.5 µM Mspl and MsplcapC (shown in Table 4.2) 
indicate the concentration of copper ion bound to peptide is lower than the peptide 
concentration. The Cs value suggests less than one copper ion bound per peptide 
molecule. This may mean that under these conditions one copper ion binds to two 
Msp 1 molecules. However, except for these fluorimetry data, there is no evidence for 
the formation of Cu(II) - 2 Msp 1 or Cu - 2 Msp 1 capC complexes. 
The concentration of copper ion bound to 0.5 µM Msp2 (see Table 4.2) indicates that 
one copper ion binds per peptide molecule (Cu(II) - Msp2). Amidation of the C-
terminus resulted in reduction of the number of copper ions bound. The Cs value for 
copper binding to 0.5 µM Msp2capC, shown in Table 4.2, is half that for Msp2, which 
may suggest, as above, that one copper ion binds to two Msp2capC molecules ( Cu(II) -
2 Msp2capC). But again, except for these fluorimetry results, there is no evidence for 
the formation of these complexes. 
The Cs values for the binding to 0.5 µM Msp3, shown in Table 4.2, suggest one copper 
ion bound per peptide molecule. The number of copper ions bound per peptide 
molecule is less than one in Msp3capC peptide, as shown by the Cs values in Table 4.2. 
In analogy to above, this might suggest one copper ion binds to 3 molecules of 
Msp3capC (Cu(II) - 3 Msp3capC). But again, there is no other evidence to support this 
suggestion. 
0.5 µM Msp4 binds to 0.364 - 0.376 µM of copper ions. This result differs from those 
for Msp2 and Msp3, but is similar to that for Mspl, which also binds less than one 
copper ion per peptide molecule. As also happens for Msp2 and Msp3, there is a 
marked decrease in the copper-binding stoichiometry for the C-terminally capped 
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peptide. The concentration of copper ion bound to 0.5 µM Msp4capC, shown in Table 
4.2, suggests formation of Cu(II) - 4 Msp4capC complexes, extension again of the 
analogy with the other C-capped peptides. These multi-peptide complexes seem 
increasingly unlikely. 
The results show that in general the Cs values for C-terminally capped peptides are 
lower than for the uncapped peptides. This suggests the coo- group at the C-terminus 
participates in the binding, and that the absence of this group reduces the stoichiometry. 
However, binding to the coo- group is physiologically irrelevant, as this group does 
not exist in the real protein. 
4.4.5. Effect of peptide concentration on ~ and Cs values 
The effect of peptide concentration has been investigated using Msp 1 capC (Figure 4.11) 
and Msp4capC (Figure 4.12) peptides. At 5 µM Msp 1 capC concentration, the Ki value 
is 3.0 ± 2.4 nM (see Table 4.3 and Figure 4.11). Large standard error indicates 
inaccuracy of the calculation. Under these conditions, the Cs value is 5.511 + 0.033 
µM, suggesting one copper ion binds per peptide molecule or Cu(II) - Msp 1 capC. As 
shown in the previous experimental data (Table 4.2), copper binding to 0.5 µM 
MsplcapC is predicted to form a Cu(II) - 2 MsplcapC complex. Data in Table 4.3 
confirms this form (0.277 + 0.002 µM Cu(II) for 0.5 µM MsplcapC). Ki values for 
copper binding to 0.5 µM MsplcapC is 0.4 ± 0.2 nM. Although this value bears a large 
standard error, comparison with previous experimental data (Table 4.2) suggests the 
value is of the same order of magnitude as the previous results. A complex of Cu(II) -
2 MsplcapC is also observed at 0.25 µM peptide concentration (Cs values from 
duplicate experiments are 0.131 + 0.003 µMand 0.125 + 0.002 µM, see Table 4.3) . 
The Ki values are now 2.6 ± 0.6 nM or 1.2 ± 0.3 nM, from duplicate experin1ents. The 
standard error of the Ki at 0.25 µM Msp 1 capC concentration is lower than at higher 
peptide concentrations. This suggests that the measurement may get more accurate as 
the peptide concentration is lowered. This is probably because the peptide 
concentration approaches the Ki value or moves toward the equilibrium binding 
conditions. At 0.10 µM MsplcapC, the shape of the curve (Figure 4.11 ) indicates 
equilibrium binding conditions, as there is a curvature region. The lack of a saturation 
point prevents determination of the binding stoichiometry. The data was best fitted 
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using Equation 4.1 and resulted in a Ki value of 37.1 ± 6.3 nM. Under these conditions, 
the Ki value also bears a reasonably low standard error. 
The Ki value for copper binding to Msp4capC at 5 µM peptide concentration is 18.6 ± 
11.8 nM. As just pointed out for Msp 1 capC, the large standard error indicates 
inaccuracy of the determination. Stoichiometry of the binding as shown by the Cs value 
is 3.125 + 0.069 µM copper ions, or around 2 molecules of Msp4capC bind to one 
copper ion (Cu(II) - 2 Msp4capC). It may also mean part of the sample binds 1 
Cu/Msp4capC and the other part 1 Cu/2 Msp4capC. At 0.5 µM peptide concentration, 
the Ki value (6.0 ± 1.4 nM) is of the same order of magnitude as the previous result (see 
Table 4.2). The stoichiometry of the binding (Cs value of 0.103 + 0.005 µM) is also the 
same as the previous result (Table 4.2) only about a quarter of the 0.5 µM Msp4capC 
concentration. This indicates around 4 Msp4capC molecules bind to one copper ion 
(Cu(II) - 4 Msp4capC). At 0.25 µM Msp4capC, the stoichiometry of the binding is 
even lower (0.017 + 0.002 µM). However, this value is clearly suspect, as it would 
indicate that more than 10 molecules of Msp4capC bind to one copper ion. The Ki at 
0.25 µM Msp4capC is 5.8 ± 0.9 nM. The standard error of Ki for this binding condition 
is lower than for higher peptide concentrations. As noted earlier, the Ki measurement 
will be more accurate at lower peptide concentration, as the concentration of the peptide 
approaches the Ki value. As the peptide concentration was lowered to 0.10 µM, the 
binding curve showed a large curvature region (Figure 4.12). The data were best fitted 
using Equation 4.1 and resulted in a Ki of 4.3 ± 0.3 nM. 
The data (Table 4.3) show both Ki and Cs values are affected by peptide concentration, 
which indicates that apart from the binding between copper and the peptide, the 
association between peptide molecules also occurs in the system. It is possible such 
association is mediated by copper ion, as the stoichiometry parameter (Cs) is always 
lower than the peptide concentration. 
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Figure 4.11: Fluorescence titration curves for copper binding to Msp 1 capC. 
Experiments were carried out at various concentrations of peptide: 5 µM (A), 0.5 µM 
(B), 0.25 µM (C and D) and 0.1 µM (E), titrated with 1 µL aliquots of 100 µM Cu(Gly)2 
in phosphate buffer pH 7.4. Squares represent the data points and the line results from 
nonlinear regression analysis according to Equation 4.2 -(A, B, C, and D) and Equation 
4.1 (E). The analysis generates Kct values of 3.0 ± 2.4 nM (A), 0.4 ± 0.2 nM (B), 2.6 ± 
0.6 nM (C), 1.2 ± 0.3 nM (D), and 37.1 ± 6.3 nM (E). 
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Figure 4.12: Fluorescence titration curves for copper binding to Msp4capC. 
Experiments were carried out at various concentrations of peptide: 5 µM (A), 0.5 µM 
(B), 0.25 µM (C) and 0.1 µM (D), titrated with 1 µL aliquots of 100 µM Cu(Gly)2 in 
phosphate buffer pH 7.4. Squares represent the data points and the line results from 
nonlinear regression analysis according to Equation 4.2 (A, B, and C) and Equation 4.1 
(D). The analysis generates KI values of 18.6 ± 11.8 nM (A), 6.0 ± 1.4 nM (B), 5.8 ± 
0.9 nM (C), and 4.3 ± 0.3 nM (D). 
Table 4.3: Effect of peptide concentration on KI values of copper binding to Msp 1 capC 
and Msp4capC peptides at pH 7.4. 
Experimental conditions Results Fig no. 
Peptide [peptide] Ki (nM) Mo (µM) R2 
MsplcapC 5.00 µM 3.0 ±2.4 5.511 + 0.033 0.9974 4.11 A 
0.50 µM 0.4 ± 0.2 0.277 + 0.002 0.9992 4.11 B 
0.25 µM 2.6 ± 0.6 0.131 + 0.003 0.9981 4.11 C 
0.25 µM 1.2 ± 0.3 0.125 + 0.002 0.9985 4.11 D 
0.10 µM 37.1 ± 6.3 (a) 0.9683 4.11 E 
Msp4capC 5.00 µM 18.6±11.8 3.125 + 0.069 0.9932 4.12 A 
0.50 µM 6.0 ± 1.4 0.103 + 0.005 0.9945 4.12 B 
0.25 µM 5.8 ± 0.9 0.017 + 0.002 0.9919 4.12 C 
0.10 µM 4.3 ± 0.3 (a) 0.9903 4.12D 
(a): data were fitted to Equation 4.1. 
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4.4.6. Copper binding to mutant and variant Mspl peptide 
About 55% quenching was observed for Msp 1 upon addition of copper (Figure 4.13). 
The same quenching percentage was also observed for Msp 1 N7 A and Msp 1 Q 1 0A, 
where the Ala residue replaces Asn and Gln, respectively. The similar quenching 
percentage suggests that Asn and Gln residues do not participate in copper binding. 
Furthermore, both ~ and Cs values of Msp 1 N7 A and Msp 1 QI 0A are the same as those 
of Mspl (Figure 4.14 A-C, E-H and Table 4.4). 
Addition of copper ions resulted in about 33% quenching for MsplH2A (Figure 4.13). 
This substantial quenching of Msp1H2A (where His is replaced by Ala) suggests that 
copper can bind to the peptide even without the His residue. The titration curve for 
Msp 1 H2A (Figure 4.14 D) is not bi-phasic, suggesting that the copper-binding affinity 
for this peptide is much lower than for Msp 1. To obtain a ~ value, the titration curve 
was fitted to a nonlinear regression analysis using Equation 4.1. The result (Figure 4.14 
D and Table 4.4) shows the binding strength is reduced significantly with Ki value of 
1560.0 ± 72.5 nM, or 100 times weaker than copper binding to Mspl. 
An approximately 8 % quenching was observed for the acetylated peptides (Msp 1 capN 
and MsplcapNC). The same value was observed for copper addition to the free amino 
acid Trp (as a control). As has been pointed out earlier (see section 4.4.4.1), the most 
likely explanation for the lack of quenching upon addition of copper ion to the N-
terminally capped Mspl is that copper ions require the imino group of Pro at the N-
terminal end as an essential binding site. The fluorescence quenching simply does not 
occur as a consequence of the absence of binding. 
Overall the results of fluorimetry experiments, in good agreement with FTIR (Chapter 
III), suggest that in Msp 1 copp.er may bind to His and the imino group of Pro at the N-
terminus. Copper may also bind to coo- at the C-terminus. This is implied from the 
results discussed in section 4.4.4.3. The combined effect of copper binding to Mspl 
(where His, free imino, and free coo- exist together) was greater than the sum of 
binding to MsplcapNC (where only histidine exists) and to Msp1H2A (where the free 
in1ino and free coo- exist). The consequence for removing the free imino group is 
greater than for removing the His group. 
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Figure 4.13: Copper binding to Mspl and its mutant peptides. The data are presented 
as: (A) bar graphs of fluorescence intensity in the absence and presence of 2.5 µM 
CuSO4 and its quenching percentage, (B) relative fluorescence intensity during copper 
(II) titration. Experiments were carried out in PBS buffer pH 7 .4 and peptide 
concentration of 2.0 µM. 
Table 4.4: Ki values of copper binding to Mspl and its mutant peptides at pH 7.4. 
Experimental conditions Results Fig no. 
Peptide [peptide] Kl (nM) Cs (µM) R2 
Mspl (a) 2.0µM 13.4 ± 3.9 1.506 + 0.031 0.9938 4.14 A 
Mspl (b) 2.0µM 8.3 ± 3.0 1.511 + 0.023 0.9961 4.14 B 
Mspl (c) 2.0µM 11.4 ± 3.9 1.581 + 0.028 0.9951 4.14 C 
Msp1H2A 2.0µM 1560.0 ± 72.5 (d) 0.9968 4.14 D 
Msp1N7A 2.0µM 1.1 ± 0.8 1.514 + 0.010 0.9991 4.14 E 
Msp1N7A 2.0µM 13.4 ± 6.5 2.277 + 0.026 0.9983 4.14 F 
MsplQl0A 2.0µM 3.8 ±2.3 1.916 + 0.019 0.9982 4.14 G 
MsplQl0A 2.0µM 0.9 ± 0.9 2.292 + 0.013 0.9994 4.14 H 
(a), (b) and (c) are triplicates, (d): data were fitted to Equation 4.1. 
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Figure 4.14: Fluorescence titration curves for copper binding to Msp 1 and its mutant 
peptides. Experiments were carried out in PBS pH 7 .4 and 2 µM concentration of Msp 1 
(A, B, and C), MsplH2A {D), Msp1N7A (E & F) and MsplQl0A (G and H). Copper 
ion is presented as CuSO4 solution. Squares represent the data points and the line 
results from nonlinear regression analysis according to Equation 4.2 (A, B, C, E, F, G, 
and H) and Equation 4.1 (D). The analysis generates Ki values of 13.4 ± 3.9 nM (A), 
8.3 ± 3.0 nM (B), 11.4 ± 3. 9 nM (C), 1560 ± 72.5 nM (D), 1.1 ± 0.8 nM (E), 13.4 ± 6.5 
nM (F), 3.8 ± 2.3 nM (G), and 0.9 ± 0.9 nM (H). 
The binding to the N- and C-terminal groups of the peptide is physiologically irrelevant, 
as these groups do not exist in the real protein. Therefore, the only relevant copper-
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binding site that has been identified here is the His residue. In order to identify to 
which nitrogen atom of His the copper ion binds, experiments were conducted using 
His-methylated peptide as presented below. 
4.4.7. Copper binding to Mspl His-methylated peptide 
The imidazole ring exists as two tautomeric forms depending on which nitrogen atom 
the proton binds to (for a more detailed explanation see section 3.4.1.4). Copper ions 
can bind to the unprotonated nitrogen, which can be either N1 or Nrr atom. To clarify 
which nitrogen binds copper in the repeats, we synthesized two peptides, each with 
either the N1 or Nrr atom methylated. In this way we can direct copper ion to bind to the 
unmethylated nitrogen and measure its copper-binding properties. 
The copper-binding properties of MsplHis(lMe)capC is similar to that of MsplcapC 
peptide. The Cs values (Table 4.5) indicate two peptide molecules bind to one copper 
ion. The Ka value for copper binding to MsplHis(lMe)capC (7.89 + 1.52 nM) at pH 
6.0 is similar with that of MsplcapC peptide (8.2 ± 1.6 nM and 10.9 ± 1.7 nM, see 
Table 4.2). Ka values at pH 7.4 and 8.0, 0.03 + 0.11 nM and 0.02 + 0.21 nM, 
respectively (Table 4.5), are significantly lower (10 times) than those for copper binding 
to MsplcapC (see Table 4.2). This indicates that copper ion binds more strongly to 
MsplHis(lMe)capC peptide. However, the standard error for these two Ka values is 
very large (the quoted error is bigger than the quoted Ka value itself). As noted earlier, 
this large error is due to the experimental conditions (stoichiometric binding conditions) 
that are not suitable for accurate determination of Ka. 
The titration experiment was also carried out for copper binding to Msp 1His(3Me )capC 
peptide. Addition of copper ion to 0.5 µM Msp1His(3Me)capC produced significantly 
lower fluorescence quenching compared with that for MsplHis(lMe)capC. At pH 6.0 
there is simply no quenching observed, while at pH 7 .4 the quenching is very low and 
may not be accurate. As the pH is increased to 8.0, the observed fluorescence 
quenching increases and the data can be fitted to Equation 4.1. The analysis gave a Ka 
value of 1873 + 539 nM. This Ka value is very much higher than that for 
MsplHis(lMe)capC and suggests very · weak binding between copper and 
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Msp1His(3Me)capC. This weak binding indicates copper ions greatly prefer binding to 
the Nn atom rather than the N1 atom. 
A 
>, 900 
~ 
"' a5 800 
.... 
C: 
a, 700 
0 
C: 
Q) 
~ 600 
Q) 
I.. 
g 500 
LL 
400-+---~------,----.---~ 
0.00 
B 
>, 1000 
~ 
"' 900 C:
Q) 
.... 
C: 800 
Q) 
0 
C: 700 Q) 
0 
"' 600 Q) 
I.. 
0 
:J 500 LL 
400 
0.00 
C 
>, 1000 
~ 
"' 900 C:
Q) 
.... 
C: 800 
Q) 
0 
C: 700 Q) 
0 
"' 600 Q) 
I.. 
0 
:J 500 LL 
400 
0.00 
0.25 
0.25 
0.25 
0.50 
[Cu2+] µM 
0.50 
[Cu2+] µM 
0.50 
[Cu2+] µM 
0 .75 1.00 
• 
0.75 1.00 
0.75 1.00 
Figure 4.15: Fluorescence titration curves for copper binding to MsplHis(lMe)capC. 
Experiments were carried out with 0.5 µM peptide titrated with 1 µL aliquots of 100 
µM Cu(Gly)2 in phosphate buffer pH 6.0 (A), pH 7.4 (B) and pH 8.0 (C). Squares 
represent the data points and the line results from nonlinear regression analysis 
according to Equation 4.2. The analysis generates Ki values of 7.9 ± 1.5 nM (A), 0.03 
± 0.10 nM (B), and 0.02 ± 0.21 nM (C). 
118-
Table 4.5: Ki values of copper binding to Mspl His-methylated peptides. 
Experimental conditions Results Fig no 
Peptide [peptide] pH Kd(nM) Cs (µM) RL 
Msp 1 His( 1 Me )capC 0.5µM 6.0 7.89 + 1.52 0.328 + 0.005 0.9987 4.15 A 
7.4 0.03 + 0.11 0.293 + 0.003 0.9989 4.15 B 
8.0 0.02 + 0.21 0.287 + 0.003 0.9979 4.15 C 
Msp 1 His(3 Me )capC 0.5 µM 8.0 1873 + 539 (a) 0.9803 (na) 
(na): figure not shown, (a): data were fitted to Equation 4.1. 
4.4.8. Copper binding to repeat peptides with modified sequences 
FTIR investigation (see Chapter III) has shown that replacement of Pro3 with Gly3 in 
the sequence of Ac-PHPGGSNWGQG-NH2 (MsplcapNC) to produce Ac-
PHGGGSNWGQG-NH2 (MsplP3GcapNC) significantly changes the binding 
properties of the N-terminally capped peptide. The peptide with Gly3 binds copper ion, 
while the one with Pro3 does not. A fluorescence titration experiment was carried out to 
investigate whether copper binding to the peptide with Gly3 instead of Pro3 .will result in 
fluorescence quenching. As noted in Chapter I, literature data for mammalian PrP 
repeats suggests that the unprotonated nitrogen atom of . the amide backbone of Gly3 
participates in copper binding. Therefore, lack of the unprotonated nitrogen atom might 
be predicted to result in reduction or abolition of binding in the marsupial repeat 
peptide. This subsection will also discuss copper binding to several other peptides with 
modified sequences: Msp_lstrepcapNC (Ac-PQGGGTNWGQG-NH2), 
Msp_ 4threpcapNC (Ac-PHGGSNWGQG-NH2), and HulcapNC (Ac-PHGGGWGQG-
NH2). 
The results show that copper addition to these peptides does not result in quenching of 
Trp fluorescence intensity. FTIR shows they bind copper, except for 
Msp_lstrepcapNC. Fluorescence measurements to detect binding rely on changes in 
the Trp microenvironment; if binding did occur but did not change the Trp environment, 
then there would be no quenching. The more obvious possibility for the absence of 
quenching is simply that there is no binding under these conditions of low (0.5 µM) 
peptide concentration at pH 7.4. It is possible that the binding is so weak that in order 
to be able to see the effect of the binding process on Trp fluorescence intensity the 
experiments need to be conducted at higher peptide concentration. Note that the FTIR 
experiments show binding takes place at 2.5 mM peptide concentration at pH 8.0 (see 
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Chapter III). However, due to time constraints, fluorimetry experiments at higher 
peptide concentration could not be done. 
As noted in section 4.1, fluorescence quenching experiments have been used to study 
copper binding to the human PrP-repeat peptide (Hornshaw et al., 1995a; Jackson et al., 
2001; Kramer et al., 2001 ). However, the peptides employed in those studies were not 
capped at their N- and C-termini. Copper binding to uncapped Hul peptide 
(PHGGGWGQ) was not investigated in this study. Nevertheless, a fluorescence 
quenching was predicted to occur upon copper addition to uncapped Hul peptide, based 
on observation in this study that quenching occurred upon addition of copper to 
uncapped Msp 1 peptide. 
As mentioned in Chapter I, several studies reported copper binding to capN C octarepeat 
peptide (Ac-PHGGGWGQ-NH2) using methods other than fluorimetry. These have 
employed a rather high concentration of peptide, as required for each method. Raman 
spectroscopy used 20 mM peptide (Miura et al., 1996; Miura et al., 1999), CD used 398 
µM peptide (Aronoff-Spencer et al., 2000) and 230 µM peptide (Bonomo et al., 2000), 
EPR used 1 mM peptide (Aronoff-Spencer et al., 2000), potentiometry used 1 mM, and 
NMR used 5.2 mM peptide (Luczkowski et al., 2002). Lower peptide concentration 
was also employed in CD experiments for peptide fragments of octarepeat (50 µM Ac-
HGG-Et and 50 µM Ac-HGGG-Et) and octarepeat N-terminally extended by one 
residue (50 µM Ac-QPHGGGWGQ-Et) (Garnett and Viles, 2003). At this lower 
concentration, copper binding to these peptides was still observed. However, the 
concentration of peptide for the fluorimetry experiments (0.1-5 µM) is still much lower 
than the concentration employed in those reports. Overall, the phenomena observed in 
this study and those in the literature indicate that the mode of copper binding to PrP 
repeats depends on the concentration of the peptide. 
4.5. Conclusions 
The fluorimetry experiments allowed determination of copper-binding affinities (Ki) of 
PrP repeats of marsupial origin. The Ki values are much lower than those for other PrP 
repeats from mammals and chicken reported in the literature and determined using the 
fluorescence spectrophotometry method. Copper binding to Msp peptides is affected by 
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pH and peptide length. The Kd and stoichiometry of binding have been shown to 
depend on the peptide concentration. The dependence of ~ and stoichiometry on 
peptide concentration indicates that there is some other process occurring besides metal 
binding upon addition of copper ions. Probably, at certain peptide concentrations, the 
association between peptide molecules occurs as a result of copper binding. This 
suggestion is supported by the results from FTIR experiments, in which upon addition 
of copper some of the peptide (Msp 1) molecules presumably form an intermolecular 
antiparallel 0-sheet structure. 
Fluorimetry experiments also provide some clues as to which groups and which amino 
acid residues participate in copper binding. The results suggest that the imino group of 
Pro at the N-terminus participates in the binding. The coo- group at the C-terminus 
participates in the binding, and was shown to have a role in determining the binding 
stoichiometry. The absence of this group resulted in reduction of the number of copper 
ions bound per peptide molecule, or increase in the number of peptide molecules bound 
to one copper ion. 
The His residue has also been identified as a copper-binding site. The absence of the 
His residue resulted in a 100-fold reduction in binding strength. Copper ions preferably 
bind to the Nn atom of the imidazole ring of His, rather than to the N1: atom. 
Experiments show that copper ions bind strongly to Nrmethylated His peptide, but very 
weakly to Nn-methylated peptide. 
Initially it was thought that mutation of Pro3 into Gly3 of the sequence 
1PHPGGSNWGQ10 would reduce the role of the free imino group of 1Pro, as has been 
observed in FTIR experiments (Chapter III). However, fluorescence experiments could 
not detect quenching upon addition of copper ions to this capNC peptide, or to 
Hul capNC. This leads to the suggestion that the mode of copper binding in PrP-repeat 
peptide depends on the concentration of the peptide. 
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Chapter V 
Fluorescence Resonance Energy Tran sf er 
As reviewed in Chapter I, structural features of the PrP-repeat region, either as a 
complex with copper or br itself, have been intensively studied using a range of 
biophysical techniques. In its copper-free form, only one molecular model of the repeat 
region is available (Yoshida et al., 2000), while a number of models of the structure of 
the repeat region as a copper complex have been reported (Stockel et al., 1998; Miura et 
al., 1999; Viles et al., 1999; Aronoff-Spencer et al., 2000; Bonomo et al., 2000; Jackson 
et al., 2001; Bums et al., 2002; .Luczkowski et al., 2002). 
As shown by the NMR structures (Donne et al., 1997; Riek et al., 1997; Lopez Garcia et 
al., 2000; Zahn et al., 2000), the N-terminal region of PrP containing the repeats does 
not adopt a single defined conformation. There is some disagreement on the structure 
of the copper-free form of mammalian PrP repeats. Several studies showed it is 
unstructured (Hornshaw et al., 1995a; Miura et al., 1996; Viles et al., 1999; Bonomo et 
al., 2000; Whittal et al., 2000; Gustiananda et al., 2002). However, other studies report 
the presence of poly-L-proline type II left-handed helix (Smith et al., 1997) or loop and 
P-tum structure (Yoshida et al., 2000). 
This chapter reports results from use of the fluorescence resonance energy transfer 
(FRET) method, which is able to probe one feature of the repeat region of PrP: the 
average distance between Trp and the N-terminal residue of the peptide. 
5.1. Introduction 
FRET is a technique that has been widely used for measuring distances between two 
points, either within or between molecules. The proximity of two points of interest in 
the protein molecule can be measured by labeling them with different chromophores. 
One is called the donor, which is the chromophore that initially receives the energy and 
transfers it to the other chromophore, which is called the acceptor. The donor must 
have a fluorescent property while the acceptor does not necessarily fluoresce. If the 
energy transfer occurs from the donor to the acceptor, the fluorescence of the donor 
(both intensity and lifetime) decreases, while the fluorescence of the acceptor, if it 
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fluoresces, increases. The distance between donor and acceptor can be calculated by 
employing the Forster equation (Forster, 1948), which relates the efficiency of transfer 
with distance (for reviews see Stryer, 1978; Wu and Brand, 1994; dos Remedios and 
Moens, 1995; Selvin, 1995). 
Although FRET is usually used for measuring distance in a protein that adopts a defined 
conformation, in this study FRET is employed for PrP-repeat peptides, which are 
unstructured and likely adopt a range of conformations, dictated by their environment. 
5.2. Aims 
Aims of this study is to measure the distance between one Trp residue (donor) and the 
N-terminus of the peptide that had been labeled with the dansyl group (acceptor). In the 
case where the peptide possesses more than one Trp, a mutant with a single Trp residue 
was created, by replacing other Trp(s) with Phe. For the purpose of discussion, a 
correlation of the results with molecular dynamics (MD) simulations undertaken by Dr. 
Peter Cummins and analyzed by Dr. John Liggins in our group, and a summary of 
FRET results for an extended set of the peptides done by Dr. John Liggins, are also 
reported briefly. 
5.3. Materials and methods 
5.3.1. Sample preparation 
All peptides and their dansylated forms (Table 5 .1) were chemically synthesized and 
supplied by the Biomolecular Resources Facility (BRF) at the John Curtin School of 
Medical Research, Australian National University. The procedure for syntheses is 
described in Chapter II Materials and Methods. 
The concentrations of the nondansylated peptides were determined using UV /Vis 
spectrophotometry based on the Trp absorption maximum at 280 nm (A 28o) and 
extinction coefficient (E280) of 5500 M-1 cm-1 (Pace and Schmid, 1997). The 
concentration of the dansylated peptides and the degree of labeling were determined 
based on the dansyl absorption maximum at 331 nm (A331) and extinction coefficient 
( £331) of 4000 M-1 cm-1, and a correction factor for absorption by dansyl at 280 nm of 
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0.386 (Haughland, 2001). Hence, for 1 cm path length cuvette, the peptide and dansyl 
concentrations are: 
[peptide]= {A230 - (A331 x 0.386)} I 5500 
[dansyl] = A331 / 4000 
The degree of labeling (DO L) was calculated by using the formula 
DOL = [peptide]/[dansyl] x 100% 
(Equation 5 .1) 
(Equation 5.2) 
(Equation 5.3) 
The degree of labeling for all dansylated peptides was found to be 100%. 
For FRET measurement, peptide concentrations were 5 µM in universal buffer 
(multicomponent buffer, which is a mixture of 25 mM citric acid, 25 mM KH2PO4, 25 
mM sodium tetraborate, 25 mM Tris, 25 mM KCl) (Perrin and Dempsey, 197 4) at pH 
3.0, 5.0, 6.5, 7.2, and 9.5. 
5.3.2. Fluorescence measurements 
A steady-state method was employed, in which the fluorescence emission intensity of 
peptide in a 5 mm path length quartz cuvette with maximum volume 0.5 mL was 
measured using a Perkin Elmer LS 5 OB spectrofluorimeter. Measurements were made 
to monitor the intrinsic fluorescence of the Trp residue in the nondansylated peptide, 
and in the dansylated peptide undergoing FRET from Trp to dansyl. 
Trp residues are capable of undergoing homotransfer, i.e. an energy transfer process 
between Trp groups (Weber and Shinitzky, 1970). To prevent the homotransfer, Trp is 
excited at 295 nm. However, in these experiments, there is only one Trp residue per 
peptide and initial experiments indicated that the FRET distance does not differ between 
measurements with excitation at 280 nm and 295 nm. As the fluorescence emission 
intensity with excitation at 280 nm is significantly higher and, hence, provides higher 
sensitivity for excitation at 280 nm rather than at 295 nm, 280 nm excitation was used, 
with band slit width 5 nm. Emission spectra were obtained between 300-550 nm and 
emission intensities at 355 nm (Trp emission maximum) and 535 nm (dansyl emission 
maximum) were recorded. The temperature was set constant at 25 °c by means of a 
circulating water bath, except where the effect of temperature was investigated when it 
was varied (15, 20, and 25 °c). 
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Table 5.1. Pairs of peptides for measuring FRET distances. Nondansylated peptides are peptides that contain donor only, which is an intrinsic Trp (W) residue. Peptides are amidated and acetylated at the N- and C-termini respectively, except for Mspl where the N- and C-termini are uncapped and 
MsplcapN where ·only the N-terminus is capped. Dansylated peptides are peptides that contain donor (Trp) and acceptor, which is the dansyl group 
attached to the N-terminus. Except for DansMsp 1, which has a free alpha carboxyl group, all dansylated peptides are amidated at the C-terminus. 
Distance between 
W8 and Dansyl in Msp 1 
W8 and Dansyl in MsplcapN 
W8 and Dansyl in MsplcapNC 
W8 and Dansyl in Msp2Fl8capNC 
W18 and Dansyl in Msp2F8capNC 
W28 and Dansyl in Msp3F8,Fl8capNC 
W6 and Dansyl in HulcapNC 
W6 and Dansyl in Hu2F14capNC 
W14 and Dansyl in Hu2F6capNC 
N ondansylated peptides 
Mspl 
NH-PHPGGSNWGQG-COOH 
MsplcapN 
AcN-PHPGGSNWGQG-COOH 
MsplcapNC 
AcN-PHPGGSNWGQG-CONH2 
Msp2F 18capN C 
AcN-PHPGGSNWGQPHPGGSN.E_GQG-CONH2 
Msp2F8capNC 
AcN-PHPGGSNFGQPHPGGSNWGQG-CONH2 
Msp3F8,F18capNC 
AcN-(PHPGGSNFGQ)2PHPGGSNWGQG-CONH2 
HulcapNC 
AcN-PHGGGWGQG-CONH2 
Hu2F14capNC 
AcN-PHGGGWGQPHGGGFGQG-CONH2 
Hu2F6capNC 
AcN-PHGGGFGQPHGGGWGQG-CONH2 
Dansylated peptides 
DansMspl 
Dansyl-PHPGGSNWGQG-COOH 
DansMspl . 
Dansyl-PHPGGSNWGQG-COOH 
DansMsp 1 capC 
Dansyl-PHPGGSNWGQG-CONH2 
DansMsp2F 18capC 
Dansyl-PHPGGSNWGQPHPGGSNFGQG-CONH2 
DansMsp2F8capNC 
Dansyl-PHPGGSNFGQPHPGGSNWGQG-CONH2 
DansMsp3F8,Fl 8capC 
Dansyl-(PHPGGSNFGQ)2PHPGGSNWGQG-CONH2 
DansHulcapC 
Dansyl-PHGGGWGQG- CONH2 
DansHu2F 14capC 
Dansyl-PHGGGWGQPHGGGFGQG-CONH2 
DansHu2F6capC 
Dansyl-PHGGGFGQPHGGGWGQG-CONH2 
Size 
11 
11 
11 
21 
21 
31 
9 
17 
17 
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5.3.3. Calculation of donor-acceptor apparent distance 
Experimental data were analyzed using the Forster equation (Forster, 1948), which 
relates energy transfer efficiency (E) with distance (R) between donor and acceptor 
parrs: 
(Equation 5.4) 
Where Ro is the Forster distance (in A) at which the transfer efficiency is 50% and 
specific for a particular donor-acceptor pair, and defined as: 
(Equation 5.5) 
The value of R0 depends on J, the spectral overlap integral, K2 (kappa squared), the 
orientation factor for a dipole-dipole interaction, n, the refractive index of the medium 
between the donor and acceptor, and Q0 , the quantum yield of fluorescence of the 
energy donor in the absence of acceptor. 
The value of K2 cannot be directly measured and is the major uncertainty 1n the 
calculation of distance. Its value depends on the relative orientations of the donor and 
acceptor transition dipoles; it is O if all angles are perpendicular, and 4 if both transition 
moments are in line with the separation vector. Provided that both donor and acceptor 
can undergo unrestricted isotropic motion and rotate freely, K2 assumes a numerical 
value of 2/3. Dos Remedios and Moens (1995) argue that the assumption of a value of 
2/3 for K2 appears to be valid for small peptides and small proteins, and its uncertainty 
in the determination of FRET distances may not be as critical as originally thought ( dos 
Remedios and Moens, 1995). The Trp and dansyl groups should have considerable 
motional freedom as they are attached to the rest of the peptide molecule via a single 
covalent bond. Assuming that K2 = 2/3 for the Trp and dansyl pair, the value of Ro is 21 
A (Dunn et al., 1981 ); this value was used in the calculation of distances. 
As the presence of an energy acceptor in the vicinity of an excited energy donor 
provides an additional mode for the de-excitation process from donor quenching, E is 
calculated from the equation: 
(Equation 5. 6) 
where InA is the fluorescence intensity of the _donor in the presence of acceptor, and In is 
the fluorescence intensity of the donor only. 
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5.4. Results and discussion 
5.4.1. Spectral overlap between Trp and dansyl 
The fluorescence em1ss1on spectrum of Trp appreciably overlaps the absorption 
spectrum of dansyl bound to a representative Msp peptide, as shown in Figure 5. I .A. 
Such effective overlap is n~cessary for efficient FRET, as illustrated in Figure 5 .1.B, 
which shows the steady-state fluorescence spectra of the dansylated and nondansylated 
forms of Mspl peptide. The Amax value for Trp emission intensity of 355 nm indicates 
the Trp residue is highly exposed to solvent as the aqueous Trp amino acid emits at 355 
nm (Schmid, 1997). The significant decrease in Trp emission intensity for the 
dansylated peptide indicates substantial energy transfer. The similarity of the Amax 
values and general spectral shape for the dansylated and nondansylated forms suggests 
that introduction of the dansyl group does not change the environment around the Trp 
residue, which is still highly exposed to solvent. This result also provides some 
confidence that attachment of the dansyl group to the N-terminus of PrP-repeat peptides 
does not perturb their structure greatly. 
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Figure 5.1: Spectral overlap between Trp and dansyl, and typical data from FRET 
experiments. (A). Spectral overlap between the Trp emission spectrum (Amax 355 nm, 
Aexc 280 nm) and the absorption spectrum of dansyl (Amax 355 nm) in the 
DansMsp 1 capC peptide. The absorption and emission units are arbitrary. (B) . Typical 
data from FRET experiments, which show the Trp emission intensity (Amax 355 nm, Aexc 
280 nm) of 5 µM DansMsp 1 is lower than that of 5 µM Msp 1. Energy transfer also 
causes a sensitized emission of dansyl fluorescence (Amax 535 nm), which appears as a 
small bun1p around 500-550 nm. 
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5.4.2. CD spectra of dansylated peptide 
A further check for possible perturbation was made by running CD spectra of 
dansylated and nondansylated forms of two Msp peptides and Hu peptide, as shown in 
Figure 5.2. The CD spectra of nondansylated peptides (MsplcapNC, Msp2F8capNC, 
and Hu 1 capN C) show the characteristics of disordered structure, with a strong negative 
band around 200 nm, and a small maximum around 220 nm accompanied by a very 
weak negative band near 230 nm. For reference, disordered peptide is reported to have 
a strong negative band just below 200 nm, with a weak positive or negative band around 
218 nm accompanied by a very weak negative band near 235 nm (Johnson, 1990; 
Woody, 1994; Woody, 1995). 
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Figure 5.2: CD spectra of dansylated and nondansylated peptides. Spectra were taken 
from dansylated peptides (200 µM DansMsp 1 capC, 100 µM DansMsp2F8capC, and 
200 µM DansHul capC) and nondansylated peptides (200 µM Msp 1 capNC, 100 µM 
Msp2F8capNC, and 200 µM HulcapNC) in H20 at pH 5.0. Measurements are taken at 
constant temperature 25 °c, with path length cell 1 mm. 
Although spectral changes are apparent for the dansylated forms , the spectra do not 
resemble those of any category of secondary structure other than random coil/disordered 
polypeptide. This evaluation, however, has to be taken cautiously because aromatic 
rings including the naphthalene group in dansyl, and in some cases the aromatic side 
chains of peptides, can contribute to the CD spectrum in the far UV region (Woody, 
1994). Other work has also reported the tendency of the naphthalene ring in the dansyl 
group to affect the CD spectra of peptides in the region of 190-250 nm (Stella et al. , 
2002). 
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Based on the above indications from CD and the Trp emission spectra of little structural 
perturbation upon dansyl attachment, a nu1nber of pairs of dansylated and 
nondansylated peptides to measure FRET distances between Trp and the N-terminal 
residue of marsupial and human PrP-repeat peptides (see Table 5.1) were used. This 
pair of probes has previously been used to measure the distance between Trp and the N-
terminal residue of small-disordered peptides (19 residues) (Lakowicz et al., 1994). 
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Figure 5.3: Fluorescence emission intensity of dansyl upon energy transfer from Trp. 
The dansyl emission intensity of DansMsp2F8capNC is lower than that of 
DansMsp2Fl 8capNC as the distance between the acceptor (Trp) and the donor ( dansyl) 
in the first peptide is longer than that in the second peptide. Msp2F8capNC and 
Msp2Fl 8capNC do not emit fluorescence in this wavelength region, as shown by the 
flat baselines underneath the two spectra. 
5.4.3. Dansyl fluorescence at 535 nm as other evidence for energy transfer 
Figure 5. l .B shows that energy transfer also causes dansyl fluorescence, which has a 
Amax value of 5 3 5 nm. The increase in intensity of acceptor en1ission upon energy 
transfer is called the sensitized emission, which can be used as another way to measure 
the extent of energy transfer (Selvin, 1995) because it also depends on the distance 
between donor and acceptor as shown in Figure 5.3. Figure 5.3 shows the dansyl 
fluorescence of dansylated and nondansylated forms of two Msp2 peptides 
(Msp2F8capNC and Msp2Fl8capNC). The dansyl em1ss1on intensity of 
DansMsp2Fl 8capC is higher than that of DansMsp2F8capC, indicating, as expected, 
that the distance between Trp8 and dansyl in Msp2Fl 8capNC is shorter than the 
distance between Trp 18 and dansyl in Msp2F8capNC. Although this sensitized emission 
could be used to quantify the energy transfer, the sensitivity of measurement would be 
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very low as the intensity of the 535 nm band is very low, suggesting that the quantum 
yield of the dansyl attached to Msp peptides is very small. For that reason, in these 
experiments, the energy transfers were quantified by monitoring the decrease of the Trp 
fluorescence intensity rather than the increase of the dansyl fluorescence intensity. 
5.4.4. pH effect on the Trp fluorescence emission intensity of dansylated and 
nondansylated peptides 
As shown in Figure 5.4, the fluorescence intensity (A-ex 280 nm, A-em 335 nm) of 
dansylated and nondansylated peptides was pH dependent within the 3.0 to 9.5 range, 
indicating effects from protonation and deprotonation of some groups. The intensity of 
dansylated peptide is highest at pH 3.0, but falls to roughly constant from pH 5.0 
(Figure 5.4.A). The pattern for nondansylated peptide is the reverse; it is lowest at pH 
3.0 and rises until it is roughly constant from pH 6.5 (Figure 5.4.B). 
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Figure 5.4: pH effect on fluorescence emission intensity of dansylated and 
nondansylated peptides. (A). Fluorescence emission intensity of dansylated peptides. 
(B). Fluorescence emission intensity of nondansylated peptides. All peptide 
concentrations were 5 µM in universal buffer pH 3.0, 5.0, 6.5, 7.2 and 9.5. The 
solutions were excited at 280 nm with band slit width 5 nm and the intensity at 355 nm 
was monitored while the temperature was n1aintained at 25 °c. 
Trp fluorescence anses from the indole ring of its side chain, and the decrease in 
intensity at lower pH has been ascribed to a loss of aromaticity in the indole cationic 
form (Pesce, 1971 p.82); this ionization explains the pH dependence of nondansylated 
peptides in Figure 5 .4.B. The different pH dependence of the dansylated peptides in 
Figure 5.4.A is due to compounding emission at 335 nm from protonated dansyl, which 
has a pKa around 4 for the dimethylamino substituent (Lagunoff and Ottolenghi, 1966). 
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Thus, although the neutral dansyl group emits at 535 nm (Aex 331 nm), its protonated 
form has strong emission at 335 nm (Aex 280 nm). When the dansyl group is 
protonated, its intensity at 335 nm increases and its intensity at 535 nm decreases. The 
reverse happens when dansyl is deprotonated (Lagunoff and Ottolenghi, 1966). Thus, 
the intensity at 355 nm in dansylated peptides at pH 3.0 (Figure 5.4.A) is the highest 
due to a large contribution from the dansyl fluorescence. Due to this complication at 
low pH, the FRET measurements were restricted to the pH range 6.5 to 9.5. 
5.4.5. pH dependence of FRET distances 
The pH dependence of the FRET distances at pHs 6.5, 7.2, and 9.5 at 25 °c was 
measured for peptide sets 1-5 and 7 in Table 5 .1, which includes the Msp 1 set of 
uncapped, N-terminally capped, and N- and C-terminally capped forms, 
Msp2F18capNC and Msp2F8capNC, and HulcapNC. 
Results for the calculated FRET distances between Trp8 and dansyl for the Msp 1 set are 
shown in Table 5.2. These were obtained from duplicate measurements of the Trp 
emission intensities for both dansylated and relevant nondansylated forms (Table 5 .1) at 
355 nm (Aex 280 nm), calculating the energy transfer efficiencies using Equation 5 .6, 
and hence, calculating the distance using Equation 5.4, assuming Ro is 21 A (Dunn et 
al., 1981). 
The FRET distance in the Msp 1 peptide set (free Pro for nondansylated reference 
peptide) is slightly longer than that in the other two peptides (Msp 1 capN and 
Msp 1 capNC). This effect may be due not only to ionization but also to a hydrophobic 
effect from acetylation in capN peptides. The distance in Msp 1 capN is similar to that in 
Msp 1 capNC, indicating that amidation of the C-terminus does not affect the distance as 
much as acetylation of the N-terminus. 
Table 5.2 also shows some trends for pH dependence of FRET distance: at pH 9.5 < 6.5 
< 7.2 for Mspl and MsplcapN; pH 9.5 < 6.5, 7.2 for MsplcapNC. The duplicates at pH 
9 .5 seem to be the most consistent as shown by smaller errors compared with those at 
pH 6.5 and 7.2. This inconsistency in the results at lower pH, especially at pH 6.5, is 
likely linked to His ionization. 
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Table 5.2: FRET distance between Trp8 and dansyl in Mspl, MsplcapN, and MsplcapNC peptides. The FRET distances (R values) are averages of duplicate measurements. The table also presents the protonation states of the peptides based on pKa values for the a-carboxyl (pKa 2.34), a-imino (pKa 10.96), and the imidazole side chain of His (pKa 6.0) taken from the electronic sources stated below. 
http ://themerckindex. cam bridgesoft. com/TheMercklndex/ Additional Tables/pdfs/ AminoAcidsAb breivationsandpK. pdf. 
Mspl MsplcapN MsplcapNC 
pH 
Protonation state R(A) Protonation state R(A) Protonation state R(A) 
6.5 NH2 + -PHPGGSNWGQG-coo- 15.15 ± 0.26 AcN-PHPGGSNWGQG-COO- 14.67 ± 0.29 AcN-PHPGGSNWGQG-CONH2 14.90 ± 0.24 
7.2 NH2 + -PHPGGSNWGQG-coo- 15.47 ± 0.36 AcN-PHPGGSNWGQG-COO- 15.01 ± 0.40 AcN-PHPGGSNWGQG-CONH2 14.91 ± 0.19 
9.5 NH2 + - PHPGGSNWGQG-coo- 14.83 ± 0.13 AcN-PHPGGSNWGQG-COO- 14.35 ± 0.09 AcN-PHPGGSNWGQG- CONH2 14.52 ± 0.07 
Table 5.3: Effect of pH on FRET distances of Msp and Hu PrP-repeat peptides. FRET distances (A) between the dansyl group (attached to the N-terminal Pro1) and Trp8 in MsplcapNC and Msp2Fl8capNC, Trp18 in Msp2F8capNC, and Trp6 in HulcapNC at 25 °c. The distances are averages of duplicate measurements. 
pH HulcapNC MsplcapNC Msp2Fl 8capNC Msp2F8capNC 
6.5 14.22 ± 0.07 14.90 ± 0.24 16.26 ± 0.25 19.44 ± 0.24 
7.2 14.19 ± 0.37 14.91 ± 0.19 16.04 ± 0.01 19.45 ± 0.02 
9.5 13 .54 ± 0.09 14.52 ± 0.07 15.84 ± 0.10 19.33±0.14 
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The fact that the distance between Trp8 and dansyl in the Mspl set peptide at pH 9.5 is 
the shortest is in good agreement with two phenomena observed in FTIR experiments 
(Chapter III). Firstly, upon increasing pH from 6.0 to 9.0, the intensity of the 1360 cm-1 
band increases, indicating that the Trp residue moves into a more hydrophobic 
environment, probably getting closer to the Pro side chain or to the N-terminal part of 
the peptide. Secondly, upon increasing pH from 6.0 to 9 .0, the amide I band shifts to 
lower frequency, indicating some structural modification, which results in a more folded 
structure so that Trp is closer to the N-terminal part of the peptide. 
5.4.6. Comparison of FRET distances in MsplcapNC, Msp2capNC, and 
HulcapNC peptides 
FRET distances at pHs 6.5, 7.2, and 9.5 for the two longer Msp peptides 
(Msp2F18capNC and Msp2F8capNC) and the shorter HulcapNC peptide are shown in 
Table 5.3. Although there is some evidence for the distances for the Mspl set in Table 
5.2 and the short HulcapNC peptide in Table 5.3 to be lower at pH 9.5 than at pH 6.5 or 
7.2, this effect diminishes for the longer peptides, Msp2F18capNC and Msp2F8capNC. 
Distances at pHs 6.5 and 7.2 are very similar for the N- and C-capped peptides. In 
general, there appears to be little effect from pH variation. 
The results in Table 5.3 begin to show the variability in the FRET distances as a 
function of distance in sequence space between the donor and acceptor, as well as a 
modulating effect from total peptide length. Thus, at pH 7 .2, although the sequence 
distance for the Msp2Fl 8capNC peptide, i.e. Trp8 to dansyl, is the same as in the 
Msp 1 capNC peptide, the results show a FRET distance of,__, 16 A which is ,__, 1.1 A longer 
than in Msp 1 capNC. In the Msp2F8capNC peptide where FRET measures the distance 
between dansyl and Trp18, i.e. 10 residues more · in sequence length than for 
Msp2F18capNC, the FRET distance of approximately 19.5 A is longer by only,__, 3.5 A. 
This indicates that the peptide chain loops back upon itself, by shortening the distance 
between Trp 18 and the N-terminus. The presence of Pro residues, which can bend the 
peptide chain, in the second repeat (positions 11 and 13) of Msp2F8capNC, could cause 
the peptide to fold and, hence, reduce the FRET distance. The results in Table 5 .3 also 
show that in the shortest peptide Hul capNC, where the FRET measurement is between 
Trp6 and dansyl, the average FRET distance of approximately 14.2 A (pH 6.5 and 7.2) 
133 
is shorter by only ,.__, 0. 7 A, compared with the distance between Trp8 and dansyl in 
MsplcapNC of 14.9 A. 
5.4.7. The FRET distance indicates the peptides are loosely compacted 
In general, the experimental_ FRET distances between Trp and dansyl are much lower 
than their theoretical distances in a fully extended peptide chain; these were estimated in 
the following way. The length of the peptide backbone between successive residues is 
3.63 A (Creighton, 1983 p.4). In a fully extended Mspl, the N-tern1inus and the Trp8 
residue is separated with 7 peptide bonds, and hence, the total backbone length is 25 .41 
A. After addition of the lengths of the dansyl group and the Trp side chain, the total 
distance between the centres of the dansyl group attached to the N-terminus and the 
indole group of Trp8 in the fully extended peptide chain is approximately 32.6 A. 
Thus, the shorter FRET distance in MsplcapNC (14.9 A) indicates that the peptide is 
loosely folded. The Hul capNC peptide is similarly loosely folded because the 
experimental FRET distance between Trp6 residue and the dansyl group (14.2 A) is less 
than the theoretical FRET distance in the fully staggered peptide (25 .3 A). The same 
behavior is observed for Msp2capNC, Msp3capNC, and Hu2capNC (Figure 5 .5). 
A factor that can stabilize a folded structure in PrP-repeat peptides is the interaction 
between Trp and His residues. This interaction has previously been observed in both 
the NOE data and NMR structure calculations of human octarepeat peptides, which 
indicate that the ~-proton of His is in close proximity to the aromatic ring of Trp, which 
is 4 residues distant (Yoshida et al., 2000). The . interaction of His and Trp has been 
mainly explained by cation-TC interaction or TC-TC interaction (Gallivan and Dougherty, 
1999), depending on the protonation state of the His residue. The latter interaction can 
also occur between aromatic residues in the form of TC-stacking (Gazit, 2002). Yoshida 
et al. (2002) proposed that the cation-TC interaction between His and Trp stabilizes a loop 
structure in human PrP-octarepeat peptide. Gazit (2002) proposed that a TC-stacking 
interaction might occur in PrP-repeat peptides leading to the formation of amyloid 
fibrils through a self-assembly process, as is proposed for the formation of prion 
particles. 
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5.4.8. Temperature dependence of FRET distances 
Experiments were carried out to investigate the effect of temperature on the structure of 
PrP-repeat peptides. Preliminary experiments for the MsplcapNC and Msp2F8capNC 
systems at 15, 20, and 25 °c at pHs 6.5, 7.2, and 9.5 were done to check for any 
differences in pH dependence of the FRET distances at lower temperatures. As the pH 
dependence at these temperatures (Table 5.4) shows similar trends, the temperature 
dependence studies, which were extended to both lower and higher temperatures, were 
restricted to pH 7 .2. The results of duplicate experiments ( experiments were conducted 
by Dr. John Liggins) at temperatures 5, 15, 25, 40, 55, 70 and 85 °c for the 7 set of the 
N- and C-terminally capped peptides in Table 5.1 are shown in Figure 5.5. 
Table 5.4: Preliminary data on the effect of temperature on FRET distances. FRET 
distances between Dansyl and Trp8 in MsplcapNC and Trp 18 in Msp2F8capNC at 
temperatures 15, 20, and 25 °care averages of duplicate measurements. 
pH 
MsplcapNC Msp2F8capNC 
15 OC 20 OC 25 °c 15 OC 20 OC 25 OC 
6.5 14.56 ± 0.14 14.85 ± 0.15 14.90 ± 0.24 19.15±0.05 19.07±0.19 19.44 ± 024 
7.2 14.39 ± 0.20 14.41 ± 0.15 14.91 ± 0.19 19.10±0.03 18.96±0.13 19.45 ± 0.02 
9.5 14.33 ± 0.01 14.47 ± 0.02 14.52 ± 0.07 18.93 ± 0.30 18.75±0.11 19.33±0.14 
The tendency for the FRET distance in peptides with the same distance in sequence 
space between Trp and dansyl to be longer when they are attached to longer peptides is 
also observed in these experiments. Figure 5 .5 shows that the FRET distances at the 
temperatures studied are as expected from the distance in sequence space modulated by 
the effect of the peptide length. The ·FRET distances of Trp6-dansyl in HulcapNC < 
Trp6-dansyl in Hu2F14capNC < Trp8-dansyl in MsplcapNC < Trp8-dansyl in 
Msp2F18capNC < Trp14-dansyl in Hu2F6capNC < Trp 18-dansyl in Msp2F8capNC < 
Trp28 -dansyl in Msp3F8Fl 8capNC. However, starting at 60 °c, the FRET distance 
between Trp8-dansyl in Msp 1 capNC becomes greater than that between Trp8-dansyl in 
Msp2Fl 8capN C. 
Figure 5.5 also shows that FRET distances increase regularly with increasing 
temperature, indicating that the macroscopic average of the peptide conformation 
becomes more extended. However, at the highest temperature studied (85 °C), the 
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structures are still much less than fully extended. These results suggest that 
intramolecular interactions, as discussed in section 5.3.7, continue to hold the structure 
of the peptides together so that it does not collapse upon increasing ten1perature. 
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Figure 5.5: Temperature dependence of FRET distances at pH 7.2. The results of 
duplicate experiments (experiments were conducted by Dr. John Liggins) at 
temperatures 5, 15, 25, 40, 55, 70 and 85 °e for the 7 set ofN- and e-terminally capped 
peptides. The syn1bols ( diamond, square, triangle, etc.) represent the data points. The 
lines represent the linear trend of the data points fitted using the computer program 
GraphPad Prism 3. The slopes of the lines are as follows: MsplcapNe 0.043 + 0.002 
A1°e; Msp2F18capNe 0.025 + 0.005 A1°e, Msp2F8capNe 0.036 + 0.007 A1°e, 
Msp3F18capNe 0.035 + 0.003 A1°e, HulcapNe 0.029 + 0.003 Al0e, Hu2F14capNe 
0.029 + 0.002 Al0 e, and Hu2F6capNe 0.029 + 0.002 Al0 e. 
It is possible that it is the interactions between Trp and His and aromatic residues in 
PrP-repeat peptides that cause the structure to remain slightly folded at the highest 
ten1perature studied (85 °e). The interaction between Trp and His in the fonn of a 
cation-n interaction is recognized as an important noncovalent binding interaction in 
structural biology ( Gallivan and Dougherty, 1999). The cation-n interaction also 
contributes significantly to maintaining the stability of thermophilic proteins (Gromiha, 
2002; Gromiha et al., 2002). The interaction of His-Trp has been reported to be the 
cause of an elevated pKa for one His in bamase, which has a value of 7. 7 5 (Loewenthal 
et al., 1991; Loewenthal et al., 1992). An alteration of the His side chain pKa values 
was also reported in peptides, in which His and Trp residues engaged in cation-n 
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interactions, which stabilized a-helical structure in model Ala-based peptides 
(Fernandez-Recio et al., 1997). Thus, it is possible that this cation-n interaction 
stabilizes folded structure in PrP-repeat peptides, even at pH 7 .2. Experiments to 
determine the apparent pKa value of His are necessary to clarify this issue. 
Figure 5. 5 shows small but interesting trends in the rate of increase of distance with 
temperature, which is implied in the slope of the lines. As the slope reflects the stability 
of the structure of the peptides, the results in Figure 5. 5 indicate that in terms of 
structural stability, Msp2Fl 8capNC is the most stable, followed by the set of three Hu 
peptides, Msp2F8capNC and Msp3F8Fl 8capNC, with MsplcapNC being the least 
stable. The paragraphs below will try to explain this phenomenon using the hypothesis 
of cation-n interaction. 
Table 5.5 shows that the peptides where Trp is 4-residues distant from His generally 
have smaller slopes than peptides where Trp is 6-residues distant from His. The 
interaction of His and Trp in geometry of WH i,i+4 or HW i,i+4 was reported to be the 
most stabilizing one in a-helical peptides (Fernandez-Recio et al., 1997). The WH i,i+4 
geometry was also proposed as a stabilizer for the loop structure in Hu PrP-octarepeat 
peptide (Yoshida et al., 2000). Table 5 .5 also shows that the presence of Phe either 4-
or 6- residues distant from His does not seem to influence the slopes. The literature 
suggests that the Trp residue is the most likely of the aromatics to be involved in a 
cation-n interaction (Gallivan and Dougherty, 1999). Thus, replacement of Trp with 
Phe would result in a decrease of the cation-n interaction in the mutant peptides relative 
to wild-type ones. 
Thus, overall, the data suggest that in the wild-type Msp peptide, the structure of multi-
decarepeat peptide is expected to be more stable than that of single-decarepeat peptide 
because in multi-decarepeats there is at least one cation-n interaction with geometry of 
WH i,i+4. For the same reason, the folded structure in Hu octarepeat peptide is 
predicted to be more stable than that in Msp decarepeat peptides. 
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Table 5.5: Temperature dependence of the FRET distances, and the geometry of the possible cation-JC interactions in Msp and Hu PrP-repeat peptides. The possible cation-JC interaction with geometry of HW i, i+4 or WH i, i+4 is presented in the shaded area. 
Peptide Sequence Slope (A/vC) Geometry 
MsplcapNC PHPGGSNWGQG 0.043 ± 0.002 HW i,i+6 
Msp2F8capNC P HPGGSNFGQP HPGGSNWGQG 0.036 ± 0.007 I HF i,i+6; FH i,i+4; HW i,i+6 I . 
Msp3F8Fl 8capNC I (P HPGGSN;EGQ)2P HPGGSNWGQG I o.o3s ± 0.003 I HF i,i+6; FH i,i+4; HF i,i+6; FH i,i+4; HW i,i+6 
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Figure 5.6: A con1parison of experi1nental FRET distances and MD simulation results. Full 
details of the MD protocol will be reported elsewhere (Gustiananda, Liggins, Cun11nins, and 
Gready, paper in preparation). The replica-exchange n1olecular dynainics (REMD) sin1ulation 
technique was used to sainple effectively the conforn1ational space of the peptide in solution. 
The REMD sin1ulations were perfonned using 24 parallel trajectories (replicas) at te1nperatures 
distributed exponentially from a minin1u1n value of 280 K to a maxin1u1n value of 620 K. The 
initial energy 1nini1nization and equilibration, and the REMD si1nulations were perforn1ed using 
the computer progran1, Molecular Orbital Progran1s for Si1nulations (MOPS) developed by Dr. 
Peter Cmn1nins. Coordinates for analysis were collected every 0.1 ps (720,000 "snapshot" 
peptide structures in total). The 24 sin1ulation ten1peratures translate to the experimental range 
7 - 347 °C: (7, 16, 27, 37, 48, 59, 71 , 83, 96, 109, 122, 136, 150, 165, 181, 197,213,230,248, 
266, 285, 305, 325 and 347 °C). The distance for each snapshot coordinate set was calculated 
between the 1nid-points of the bridging bonds of the naphthalene ( dansyl) and the indole (Trp) 
rings. The extended chain estin1ate of 32.6 A corresponds to the largest distance between the 
1nid-points of the bridging bonds of the naphthalene and the indole rings obtained for a single 
snapshot. Msp 1 capNCinit represents the data points of the preliminary experin1ents over 
ten1perature range 15 - 25 °c. Msp 1 capNCext represents the data points of the later 
experi1nents (perforn1ed by Dr. John Liggins) over the extended temperature range of 5, 15 , 25 , 
40, 55, 70 and 85 °c. R (average) is the average (from 2 ns to 3 ns of the sin1ulation tin1e) of 
the si1nulated Forster distance. For the si1nulation temperature of 27 °c, an R (average) value 
of 13.0 A was obtained (average of 10,000 replicas), which is son1ewhat smaller than the 
experi1nental value of 15 .6 A at 25 °c. However, this is not the 1nost informative way to 
compare the simulation with the experi1nent. The experin1ental Forster distance was calculated 
fron1 the experin1entally obtained transfer efficiency using the equation: R = 2 lA x (E- 1 - 1 ), 
where 21A is the value of Ro obtained assu1ning a kappa squared value of 2/ 3. In order to really 
co1npare the si1nulation with the experin1ent, the saine equation which was used to calculate the 
experin1ental value of R (R = 21A x (E-1 - 1)) was used to calculate a value of R (RavE) fron1 
the average si1nulated value of E; this was obtained fro1n the forn1ula E = Ro 6 I (Ro 6 + R6). Full 
details of the de novo calculation of kappa squared will be reported elsewhere (Liggins et al., 
1nanuscript in preparation). The values of RavE are in close agreen1ent with the experi1nentally 
obtained values of R. 
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5.4.9. A comparison of FRET distances and MD simulation 
MD simulations and analysis were performed by Dr. Peter Cummins and Dr. John 
Liggins. MD simulations were performed to provide an independent estimate of 
distance between the Trp and dansyl groups for comparison with the experimental 
results. The test system was dansylated Msp 1. 
As shown in Figure 5.6, there are two values of MD Forster distances, which were 
calculated in two different ways. The first value, R (average), was simply calculated 
directly as the 6th root of the average value of R6, in which R was measured directly 
from each snapshot coordinate set. The second value, RavE, was obtained from 
calculation of R from the average simulated values of E, which was obtained from back 
calculation of the first value, R (average) (see caption of Figure 5.6 for fuller details). 
Forster distances calculated from the REMD simulation data for DansMsp 1 are 1n 
remarkably close agreement with the experimental results for 
MsplcapNC/DansMsplcapC over the measured temperature range (5-85 °C), both in 
terms of absolute values and rates of increase with increasing temperature (Figure 5 .6). 
The agreement is particularly striking when one compares the simulated and 
experimental values with the value for the fully extended polypeptide chain, of 32.6 A. 
5.4.10. Copper-ion binding and FRET distances 
The results presented demonstrate that distances are reproducible and sensitive to 
experimental conditions; orderly T progression, some pH dependence. FRET can be 
used to monitor the structural changes in the protein or peptides as a result of ligand 
binding ( dos Remedios and Moens, 1995). Previous chapters have presented results 
showing that copper ion binds to marsupial PrP-repeat peptides, and in so doing induces 
more folded structure. The FRET experiment, using dansyl and Trp as probes, to detect 
the structural changes in PrP-repeat peptides upon copper binding, is difficult to carry 
out mainly because under fluorimetry conditions the binding of copper to repeat 
peptides requires the free a-in1ino group of Pro at the N-terminus (see Chapter IV). 
Attachment of dansyl to the a-imino group of Pro at the N-terminus thus prevents the 
copper binding. Other pairs of probes would need to be introduced for the detection of 
structural changes associated with copper binding using the FRET method. 
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5.5. Conclusions 
FRET has been found to be useful to investigate structural properties of PrP-repeat 
peptides. Inter-residual distances obtained from FRET experiments can be used as a 
distance constraint in structural models of PrP-repeat peptides derived from information 
compiled from various other spectroscopic techniques, or to validate MD simulations 
which can then be used to predict conformational distributions. 
Trp-dansyl FRET has been found to be an efficient system for studying the PrP-repeat 
peptides. The method has excellent sensitivity because the initial intensity of Trp is 
high. This is because, in PrP-repeat peptides, Trp is solvent exposed and not 
undergoing thermal de-excitation, as it would be if buried in a protein. However, a 
major source of error is determination of concentration. Experience with two 
experimenters (myself and Dr. John Liggins) and repeat experiments show that small 
differences in concentration between dansylated and nondansylated samples may give 
variation of >0.5 A; this error is not apparent in duplicates samples which were made 
from the same diluted stock. 
Another potential source of error is the effect of dansyl attachment on both the Trp 
environment and on the structure of the peptide. The FRET method requires separate 
measurements of Trp emission intensity for nondansylated and dansylated pairs of 
peptides. As Trp intensity is very sensitive to the environment around the Trp residue, 
the method requires that this environment is unchanged in the dansylated peptide so that 
its intrinsic intensity is the same as in the reference nondansylated form. If this is not 
the case then the measured intensity decrease due to the resonance energy transfer to 
dansyl would contain other contributions and lead to errors in estimation of the Trp to 
dansyl distance from use of the Forster equation. Most applications of FRET involve 
folded proteins for which disturbance of the protein structure from dansylation is readily 
detectable, or can be minimized by optimum design of donor and acceptor positions if a 
high-resolution structure is available. For peptides lacking formal structure, such as 
studied here, there is no guidance in the literature on the effect of dansylation. In this 
study, CD was used to check for an effect. The CD spectra for the nondansylated form 
showed characteristic features of disordered structure. Although some spectral changes 
were apparent for the dansylated forms, the spectra are not consistent with any 
secondary structure category and most resemble random-coil or disordered polypeptide. 
141 
Hence, it is assumed that dansylation did not cause structural changes which would 
invalidate application of the FRET method. 
FRET experiments and molecular dynamics simulations have shown that PrP-repeat 
peptide, either from marsupial or human, adopts disordered structure that is somewhat 
loosely folded. This structure is only moderately perturbed towards more extended 
conformations by increasing the temperature. The interaction of Trp-His through the 
cation-n interaction is proposed to be the major factor that stabilizes the folded structure 
in PrP-repeat peptides. The disposition of a four-residue interval between Trp and His 
is apparent in the more stable peptides. 
The literature reports, and results in preceding chapters confirm, that PrP-repeat 
peptides adopt a random-coil structure, and do not adopt a single preferred stable 
conformation. This type of peptide will thus certainly have heterogeneity in the donor-
acceptor distance; the MD simulations show that the peptide does not adopt a single 
preferred structure, but a distribution for which the average (see Figure 5.6 caption) is 
close to the FRET distance (Cummins et al., unpublished 2003). This heterogeneity 
cannot be detected by using the steady-state intensity measurements employed in this 
study. Such information in principle can be obtained by using fluorescence decay (time 
resolved) or fluorescence anisotropy decay experiments. However, it will be desirable 
to do such experiments to see if a large distribution of distances between chromophores 
is detectable, as fluorescence decay experiments have been applied to study the 
conformational dynamics of small flexible peptides such as RN ase S-peptide (Maliwal 
et al., 1993), melittin (Lakowicz et al., 1994 ), galanin (Kulinski et al., 1997), and 
bradykinin ( de Souza et al., 2000). Such distance distributions reflect the populations of 
peptide conformations, which coexist in equilibrium during the fluorescence lifetime. 
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Chapter VI 
Electrospray Ionization Mass Spectrometry 
Use of electrospray ionization mass spectrometry (ESI MS) for studying noncovalent 
protein complexes has been established for some time. ESI is a soft ionization 
technique for transferring protein molecules from their initial state in a sample 
(solution) to ionized states in gas phase, so that the molecular ions can be detected and 
mass analyzed. The gentleness of this ionization allows the noncovalent protein 
complex to survive the process without the protein undergoing any molecular 
fragmentation or complex dissociation. Although ESI MS detects the molecular ions in 
the gas phase, several recent studies suggest that a gas-phase measurement can reveal 
the complex properties in the solution phase (for reviews see Loo (1997) and Veenstra 
(1999)). 
Due to its ability to measure accurately the molecular mass of the complex being 
studied, an important property of the complex that can be measured by ESI MS is the 
stoichiometry of the binding. Based on the mass difference between the complex and 
the apoprotein, the signals can be translated into stoichiometry (Hu and Loo, 1995). 
Some reports have also suggested that other complex properties such as dissociation 
constants (Bruce et al., 1995; Jorgensen et al., 1998; Whittal et al., 2000), 
conformational changes (Hutchens and Allen, 1992; Veenstra et al., 1998a; Veenstra et 
al., 1998b) and differentiation of cooperative vs. sequential binding (Hu and Loo, 1995) 
can be measured by ESI MS. However, careful and appropriate controls as well as 
interpretation of the data should be applied in such studies (Smith and Lightwahl, 1993). 
6.1. Introduction 
6.1.1. Principles of electrospray ionization mass spectrometry 
There are three successive stages in ESI MS: spraying the liquid, forming ions from the 
highly charged droplets, and sampling and mass analysing the ions in a mass analyzer in 
vacuum (Mann, 1992). The first two stages are sketched in Figure 6.1 and the 
formation of molecular ions is described below. 
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Figure 6.1: Schematic diagram of ESI MS process. The figure 1s taken from 
http://www-methods.ch.cam.ac.uk/meth/ms/theory/esi.html. 
ESI MS produces singly or multiply charged ions directly from solution by creating a 
fine spray of highly charged droplets in the presence of a strong electric field. The 
sample solution is forced through a needle, which has a high electric field at the tip. 
This electric field is produced from the potential difference applied between the needle 
and the surrounding electrode. The high potential disperses the emerging liquid into a 
very fine spray of charged droplets, which all have the same polarity. Driven by the 
field, the charged droplets move away from the needle tip towards the end plate of the 
chamber located a few centimeters away. A drying gas flowing counter to the droplets' 
direction of motion helps to evaporate the solvent; this shrinks the droplets' size and 
increases the concentration of charge at the droplets' surface. At some point, the charge 
concentration at the droplet surface is so high that it exceeds the constraints of the 
surface tension of the droplets, which explode into smaller droplets with lower charge. 
The molecular ions are the final result of the repeated process of droplet shrinking and 
explosion. The molecular ions then enter the capillary and are focused into the mass 
analyzer through a series of lenses (Mann, 1992; Veenstra, 1999). 
As the molecule has been transformed into a multiply charged ion, the mass 
spectron1etry data (relative abundance of the various charge states of the molecule) are 
plotted against their mass-to-charge ratio (m/z). This is often referred to as a m/z 
spectrum. However for many applications (i.e. the spectra of mixtures) it is better that 
the data are transformed and displayed on a true molecular mass axis. The 
transformation process or deconvolution was carried out using software included within 
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the instrument software. The data plot on the true molecular mass axis is called the 
deconvoluted or transformed spectrum (Mann, 1992; Veenstra, 1999). 
6.1.2. Mass spectrometry in the study of copper binding to PrP-repeat peptides 
There are many examples of ~he application of mass spectrometry to the study of metal 
binding to peptides and proteins (Allen and Hutchens, 1992; Hutchens et al., 1992; Yu 
et al., 1993; Hu and Loo, 1995; Jiao et al., 1995; Moreau et al., 1995), and this method 
has also been applied to the study of copper binding to PrP repeats (Hornshaw et al., 
1995b; Whittal et al., 2000; Kramer et al., 2001) (see Table 1.3 and 1.4 of Chapter I). 
Using MALDI TOF (matrix assisted UV laser desorption/ionization time-of-flight) 
mass spectrometry, Hornshaw et al. (1995b) showed that synthetic peptides containing 
three or four copies of an octapeptide repeat sequence (PHGGGWGQ) preferentially 
bind copper over other metals with a stoichiometry of one copper per repeat. Peptides 
from the analogous region of chicken PrP, which contain an N-terminal repeat domain 
of the hexapeptide (NPGYPH), showed similar specificity and stoichiometry for copper 
binding (Hornshaw et al., 1995b). 
Whittal et al. (2000) employed ESI MS to measure both the stoichiometry and binding 
affinity of copper ions to the repeat region of PrP, including pre- and post-repeat 
sequence. The stoichiometries of the complexes measured directly by ESI MS were pH 
dependent: a peptide containing four octarepeats chelated two copper ions at pH 6.0 but 
four at pH 7.4. Dissociation constants (Ki) for each copper ion binding to the 
octarepeat peptides were mostly in the low micromolar range. Copper ions also bound 
to the pre- and post-repeat sequence. In the C-terminally extended peptide (include 
post-repeat sequence), which has a fifth His residue, the binding of multiple copper ions 
at the higher pH occurs with a high degree of cooperativity. Whittal et al. also report 
the participation of free alpha amino group of the N-terminus in copper binding at 
higher copper concentration but not at lower copper concentration (Whittal et al., 2000). 
In contrast to Whittal et al. (2000), Kramer et al. (2001) used ESI MS only to elucidate 
the stoichiometry of copper binding. They argued that ESI mass spectra for PrP and its 
peptides appear to reflect the situation in solution only qualitatively, not quantitatively. 
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The reported stoichiometry was four copper ions bound to human PrP60_91 , while 
binding of up to five copper ions was observed for the full-length murine PrP23 _23 1 
(Kramer et al., 2001). 
6.2. Aims 
In this project, ESI MS was used to detect noncovalent interactions between synthetic 
marsupial PrP-repeats peptide (Msp) (see Table 6.1) and copper ions as well as other 
metal ions. The method was also used to measure the copper-binding stoichiometry and 
elucidate the copper binding ability of some modified Msp 1 peptides (peptides with 
single residue replacements by Ala and protection ofN- and C-termini) (see Table 6.1). 
The data for copper binding ability of the modified Msp 1 peptides should be able to 
provide information on the groups involved in copper binding. Therefore, the aim of 
using ESI MS is to determine the stoichiometry of the complex formation between 
copper and Msp peptides, screen the possible binding of other metals to Msp peptides, 
and identify the copper-binding sites. 
6.3. Materials and methods 
Table 6.1: Synthetic peptides used in the experiments 
Peptide Sequence Size 
Msp4 (PHPGGSNWGQ)4G 41 
Msp3 (PHPGGSNWGQ)3G 31 
Msp2 (PHPGGSNWGQ)2G 21 
Mspl (PHPGGSNWGQ)1 G 11 
Msp1H2A (P APGGSNWGQ)1 G 11 
Msp1N7A (PHPGGSA W GQ)1 G 11 
MsplQl0A (PHPGGSNWGA)1 G 11 
MsplcapN Ac-(PHPGGSNWGQ)1 G 11 
MsplcapC (PHPGGSNWGQ)1G-NH2 11 
MsplcapNC Ac-(PHPGGSNWGQ)1 G-NH2 11 
6.3.1. Sample preparation 
Typically, unless otherwise stated, the sample had final peptide concentration of 10 µM 
and CuSO4 concentration of 100 µM in buffer. The buffer was either 10 mM 
ammonia/formic acid at pH 7.4 or 10 mM N-ethylmorpholine (NEM)/formic-acid at pH 
7.4. A 50 µL sample was injected into the ESI MS machine. 
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6.3.2. Choice of buffers 
At the initial stage of the research, the buffer used was 10 mM ammonia/formic acid pH 
7.4 for it is volatile and does not interact with copper ions. This buffer was also 
employed as a standard volatile buffer in the mass spectrometry laboratory of the 
Research School of Chemistry ANU. This buffer is recommended for use in pH ranges 
7.0-10.0 (Perrin and Dempsey, 1974). However, over several hours during the ESI MS 
experiments, the sample solutions initially buffered at pH 7.4 became acidic (pH,...., 4.0). 
Due to this problem, the subsequent experiments used 10 mM N-ethylmorpholine 
(NEM)/formic acid buffer pH 7 .4 instead. NEM does not interact with copper ions 
. 
(Viles et al., 1999) and has been used in ESI MS experiments of copper binding to PrP-
repeat peptides (Kramer et al., 2001). The NEM/fonnic acid buffer proved to be more 
stable than the ammonia/formic acid buffer in maintaining the pH at 7.4. However, the 
results of the experiments using ammonia/formic acid buffer are reported in this chapter 
(section 6.4.1, 6.4.2, and 6.4.3) to give an initial overview of the binding of copper and 
other metals to the peptide. These experiments were not repeated using NEM/formic 
acid buffer due to the time constraints of the thesis. 
6.3.3. Conditions of data acquisition 
Mass spectrometry of the peptides, with and without copper ions, was performed on a 
VG Quatro II Electrospray Ionization Mass Spectrometer in positive ion mode. The 
applied spray ( capillary) voltage was 3.5 kV. Capillary temperature was set at 70 °c. 
6.4. Results and discussion 
6.4.1. Copper binding to Msp2, Msp3, and Msp4 peptides 
ESI MS of the synthetic peptides containing several copies of the second repeat 
sequence of a marsupial PrP (Msp) resulted in the expected average masses for the 
apopeptides. Average mass units (an1u) are Msp2, 2111; Msp3, 3129; and Msp4, 4147 
(see Table 6.2 and Figures 6.2 and 6.3). 
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Figure 6.2: ESI MS data of copper binding to Msp peptides presented as mass/charge 
spectra. Mass/charge (m/z) (in Dale) spectra were taken from 10 µM Msp peptides 
(Msp2, Msp3, and Msp4) in 10 mM ammonia/formic acid buffer pH 7.4 in the absence 
(upper panels) and presence (lower panels) of 100 µM CuS04. The most intense signal 
in the mass spectrum for Msp2 is [Msp2+3HJ3+, for Msp3 is [Msp3+3HJ 3+, and for 
Msp4 is [Msp4+4H]4+. Addition of copper ion does not change the most intense signal 
of the Msp peptides in the spectra. Addition of ten times molar ratio of copper to the 
Msp peptides did not change the charge states of the peptides, suggesting that the charge 
states are not derived from the bound metal ion. Increases in mass as a result of the 
addition of copper ions with no change in charge states suggests complex formation via 
noncovalent binding of copper to Msp peptides, rather than just cation adduction as a 
result of the electrospray process. 
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Figure 6.3: ESI MS data of copper binding to Msp peptides presented as transformed 
spectra. The spectra were taken from 10 µM Msp peptides (Msp2, Msp3, and Msp4) in 
10 mM ammonia/formic acid buffer pH 7 .4, in the absence and presence of 100 µM 
CuSO4. When components have been identified in the m/z spectrum (Figure 6.2), the 
data system assigns charge states to each peak. The Transform algorithm uses this 
information to display the m/z spectrum on a true molecular mass axis. The average 
incremental difference in mass of approximately 61.5 between two neighboring 
molecular mass peaks suggests that the binding of one atom of copper releases two 
protons. The maximum number of copper ions that can be bound by Msp peptides is: 
three for Msp2, four for Msp3, and three for Msp4. 
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Addition of a 10-fold excess of CuSO4 resulted in mass spectra of apopeptides with 
several additional peaks (see Figure 6.2 and 6.3). Table 6.3 and Figure 6.3 show that 
there is an increase of 61. 5 amu in the molecular mass between neighboring peaks upon 
addition of copper, suggesting that the binding of one atom of copper releases two 
protons from the peptide molecule. The maximum numbers of copper ions that can be 
bound by Msp peptides are: three for Msp2, four for Msp3, and three for Msp4. 
Table 6.2: Mass assignment for Msp peptides 
Peptide Sequences Predicted Molecular Mass Observed 
Monoisotopic Average Molecular Mass 
Msp2 (PHPGGSNWGQ)2G 2109.92 2111.18 2111.13+0.55 
Msp3 (PHPGGSNWGQ)3G 3127.36 3129.24 3128.32+0.09 
Msp4 (PHPGGSNWGQ)4G 4144.80 4147.29 4146.58+0.41 
The most intense signals in the m/z spectra (see Figure 6.2 top) are: Msp2, 
[Msp2+3H]3\ Msp3, [Msp3+3H]3\ and Msp4, [Msp4+4H]4+. Addition of copper did 
not change the most intense signal or the charge states of the peptides (see Figure 6.2 
bottom). As just mentioned above, the m/z spectra (Figure 6.2) as well as the 
transformed spectra (see Figure 6.3) show that additional peaks emerge as a result of 
copper ions bound to Msp2, Msp3 and Msp4. It has been previously reported (Allen 
and Hutchens, 1992) that increases in mass as a result of the addition of metal ions with 
no change in charge states toward higher z values (lower m/z) suggest complex 
formation via noncovalent binding of metal to peptides, rather than just cation adduction 
as a result of the electrospray process. Thus, the additional peaks in the Msp spectra 
appear to reflect these peptide-copper complexes. 
While the absence of a charge state shift towards higher z values upon addition of metal 
ions reflects the specific noncovalent interaction between peptides and metal ions, a 
charge state shift towards lower z values could reflect changes in conformation upon 
metal binding, in which the holopeptides are more folded or more structured than the 
apopeptides. Conformational changes reflected by changes in the charge envelope of 
the molecular ions have been previously reported in the literature (Hutchens and Allen, 
1992; Veenstra et al., 1998a; Veenstra et al., 1998b). It has also been reported that 
addition of copper ions to full-length PrP, as well as to peptide con·esponding to the N-
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terminal tandem repeat region of PrP, resulted in a significant shift of the m/z peaks to 
lower charge z values, and thus higher m/z values. This suggests conformational 
changes associated with copper binding, resulting in a more folded conformation 
compared with the apopeptides or apoproteins (Whittal et al. , 2000; Kramer et al. , 
2001). 
The phenomenon of charge state shift towards lower z values was not observed in this 
study. Furthermore, under the experimental conditions, only small peaks of copper 
adducts were observed. The reason for only small peaks of copper adducts in the 
spectra is probably due to the pH being lower than 7 .4, so that the binding of copper to 
the peptides is not optimum. As mentioned in section 6.3.2, the buffer used in these 
experiments is ammonium formate, which has a buffering capacity from pH 2.75-4.75 
(pKa of formate is 3.75), so that it does not work well in maintaining the pH at 7.4. 
This pH effect, leading to the appearance of only small peaks of copper adducts, was 
reported by Whittal et al. (2000) for copper addition to ShaPrP(57-91) at pH 3.5: the 
free peptide peak (relative intensity around 80%) dominates the peaks for the copper 
adducts, which have relative intensities of less than 20% for one bound copper, around 
5% for two bound, with the rest (three, four, and five copper ions) around 2%. He11-ce, it 
is important to use a buffer that works well at pH 7.4. As ESI MS requires the use of a 
volatile buffer, the choices are limited. Kramer et al. (2001) reported that the ESI MS 
of copper binding to PrP and its peptides is quite sensitive to the chosen buffer and 
introduced a new buffer system, N-ethylmorpholine (NEM). NEM has a pKa of 7.7 and 
an effective pH range of 6.7-8.7. 
There are two possible explanations for why the charge states do not shift towards lower 
z values in the Msp spectra of copper complexes. Firstly, copper ions do not bind 
optimally to the peptides as a result of lower pH, and, thus no conformational changes 
are induced. Secondly, it is possible that the conformation induced by copper ions is an 
open conformation such as a solvent-exposed a-helix structure, which is detected in 
FTIR experiments (see Chapter 111). In this case, there would be no change in the 
charge envelope of the molecular ions as the residues or groups that carry the charges 
are still accessible and not buried within the molecule. These two possible explanations 
need to be clarified by repeat of the experiments using a reliable buffer, such as NEM, 
so that copper binding. to Msp peptides will be optimum. 
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Table 6.3: Molecular mass assignment for Msp peptides (Msp2, Msp3, and Msp4) and 
their copper complexes observed by ESI MS 
Peptide No. of copper [M-2nH+nCu] Mass observed Incremental 
atoms bound (n) calculated difference in mass 
Msp2 0 2111.1808 2111.03+0.03 
61.83 
1 2172.7109 2172.86+0.12 
61.07 
2 2234.2410 2233.93+0.15 
61.39 
3 2295.7711 2295.32+0.58 
Average incremental difference in mass 61.43 
Msp3 0 3129.2375 3129.33+0.50 
61.01 
1 3190.7676 3190.34+0.80 
61.25 
2 3252.2978 3251.59+0.62 
61.82 
3 3313.8279 3 313. 41 +0. 81 
62.47 
4 3375.3580 3375.88+0.43 
Average incremental difference in mass 61.64 
Msp4 0 4147.2943 4147.12+0.03 
62 
1 4208.8244 4209.12+0.77 
61.15 
2 4270.3545 4270.27+ 1.23 
61.02 
3 4331.8846 4331.29+1.28 
Average incremental difference in mass 61.39 
152 
6.4.2. Binding of other metal ions to Msp2 
Msp2 was found to bind other metal ions such as calcium, zmc, magnesium and 
manganese (see Figures 6.4 and 6.5). As there is little evidence for significant binding 
of these ions to PrP-repeat peptides using other techniques, these ESI MS results 
suggest caution; it is likely that the additional peaks upon addition of metals in mass 
spectrometry are a result of non-specific ionic interaction in the gas phase. Note that 
similar behavior to the copper binding experiments was observed; the most intense 
signal did not change upon addition of the metal ions and the charge state remained the 
same before and after addition of metal ions, suggesting that the charge states are not 
derived from the bound metal ion. 
Thus, as before, increases in mass as a result of the addition of the metals with no 
change in charge state suggests complex formation via noncovalent binding of metals to 
Msp2, rather than just cation adduction as a result of the electrospray process. The 
average incremental difference in mass of 61.5 (Cu), 38.02 (Ca), 63.54 (Zn), 22.22 
(Mg), and 52.17 (Mn) between two neighboring peaks (see Figure 6.5 and Table 6.4) 
suggests that the binding of one metal atom releases two protons. 
The MALDI-TOF mass spectrometry investigation reported by Hornshaw et al. (1995b) 
showed that the human octapeptide repeat sequence preferentially binds copper over 
other divalent metal ions such as zinc, manganese, cobalt, nickel, iron, calcium, and 
magnesium. This result was confirmed by fluorescence quenching experiments, which 
showed that only after addition of copper, and not other metal ions, was quenching 
significant (Hornshaw et al., 1995a). Whittal et al. (2000) also observed specificity of 
copper binding over that of zinc and nickel to the PrP repeats as monitored by ESI MS. 
Under identical experimental conditions, only peptides with added copper showed 
significant charge shift towards lower z values (higher rn/z) as well as the appearance of 
metal-ion adducts with high relative intensity and reduced relative intensity of the 
metal-free species (Whittal et al., 2000). The specificity of copper binding for full-
length ShaPrP29_231 was shown by the lack of fluorescence quenching upon addition of 
other metals (Stockel et al., 1998). 
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Figure 6.4: ESI MS data of binding of other metal ions to Msp2 peptide presented as 
mass/charge spectra. Mass/charge (m/z) (in Dale) spectra were taken from 10 µM 
Msp2 in 10 mM ammonia/formic acid buffer pH 7.4 in the absence and presence of 100 
µM CuSO4, CaCb, ZnCb, MgCh, and MnSO4. The most intense signal in the mass 
spectra for Msp2 is [Msp2+3H]3+. Addition of metal ions does not change the most 
intense signal of Msp2 in the spectra. Addition of ten times molar ratio of metal ions 
does not change the charge states of the peptide, suggesting that the charge states are not 
derived from the bound metal ion. 
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Figure 6.5: ESI MS data of binding of other metal ions to Msp2 peptide presented as 
transformed spectra. The spectra were taken from 10 µM Msp2 in 10 mM 
ammonia/formic acid buffer pH 7 .4, in the absence and presence of 100 µM CuSO4, 
CaCb, ZnCh, MgCb, and MnSO4. When components have been identified in the m/z 
spectrum (Figure 6.4), the data system assigns charge states to each peak. The 
Transform algorithm uses this information to display the m/z spectrum on a true 
molecular mass axis. The average incremental difference in mass of 61.5 (Cu), 38.02 
(Ca), 63.54 (Zn), 22.22 (Mg), and 52.17 (Mn) between two neighboring molecular mass 
suggests that the binding of one metal atom releases two protons. 
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Table 6.4: Molecular mass assignment for Msp2 and Msp2-metal complexes observed 
byESI MS 
Peptide or No. of metal [M-2nH+nmet] Mass observed Incremental 
Complexes atoms bound calculated difference in 
(n) mass 
Msp2 0 2111.18 2111.23+0.15 
Msp2+Cu 0 2111.18 2111.20+0.20 
61.5 
1 2172.71 2172.70+0.15 
61.63 
2 2234.24 2234.33+0.02 
61.99 
3 2295.77 2296.32+0.56 
Average incremental difference in mass 61.71 
Msp2+Ca 0 2111.18 2111.1 0+0. 34 
38.13 
1 2149.24 2149.23+0.11 
37.91 
2 2187.30 218 7 .14 +0 .14 
Average incremental difference in mass 38.02 
Msp2+Zn 0 2111.18 2111.25+0.15 
63.16 
1 2174.55 2174.41 +0.25 
62.55 
2 2237.93 2236.96+0.81 
64.9 
3 2301.30 2301.86+0.44 
Average incremental difference in mass 63.54 
Msp2+Mg 0 2111.18 2111.25+0.14 
22.06 
1 2133 .47 2133.31 +0.40 
22.39 
2 2155.76 2155.70+0.26 
Average incremental difference in mass 22.22 
Msp2+Mn 0 2111.18 2110.90+0.50 
53.2 
1 2164.10 2164 .1 o+o .1 7 
53.13 
2 2217.02 2217.23+0.05 
Average incremental difference in mass 53.17 
While there are many reports of the specificity of PrP and its N-terminal octapeptide 
repeats to bind copper (Hornshaw et al., 1995a; Hornshaw et al. , 1995b; Stockel et al. , 
1998; Whittal et al., 2000), others have demonstrated the ability of octapeptide (Jackson 
et al., 2001) as well as full-length PrP (Brown et al. , 2000) to bind other metal ions as 
well. Fluorescence quenching studies showed that other metal ions such as Zn(II), 
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Ni(II) and Mn(II) can bind to the N-terminal octapeptide of PrP with affinity three or 
more orders of magnitude more weakly than Cu(II) (Jackson et al., 2001). Substitution 
experiments demonstrated manganese could replace copper in the PrP molecule, 
indicating the ability of PrP to bind other metals (Brown et al., 2000). 
So there is evidence in the literature to support the possibility that Msp peptides could 
bind other metal ions such as calcium, zinc, manganese, and magnesium. The binding 
of other metal ions to Msp peptides has been checked by FTIR experiments (see 
Chapter III), which suggests they can bind zinc, calcium, and magnesium ions but not 
manganese. The binding properties of these metal ions need to be characterized further. 
6.4.3. Copper ion titration of Msp4 
ESI MS experiments were carried out to titrate Msp4 with copper. F~gure 6.6 shows the 
complete spectra while Figure 6. 7 .A shows an expanded view. Data for Cu/Msp4 molar 
ratio higher than 8 cannot be obtained due to instability in the electrospray at higher 
copper ion concentration. Blockage of the electrospray channel by copper hydroxide 
precipitation that occurs at pH 7 .4 presumably caused such instability. Copper ion 
titration of Msp4 shows stepwise loading ( of the binding sites), as depicted in Figure 
6. 7, suggesting that the sites are independent and identical. However, in the presence of 
up to 8 mol of copper per mol of Msp4, the Msp4 molecule was never totally bound in a 
complex. There could be two reasons for this. Firstly, there is probably an equilibrium 
established between uncomplexed and complexed forms. Fluorimetry experiments 
showed that the l<{l of copper binding to Msp4 at pH 7 .4 is of the order of nM. The ESI 
MS titration experiments were conducted at 10 µM Msp4 and varied concentration of 
copper ions (0 - 80 µM). As the highest copper concentration is 8 times the peptide 
concentration, all peptide should have bound copper ions. However, the data show that 
a large proportion of Msp4 molecules still exist as free peptide. Secondly, the pH of the 
solution is probably much lower than 7.4; as mentioned earlier, ammonium formate is 
not an effective buffer system to work at pH 7.4. At more acidic conditions, probably 
around pH 3.0-4.0, the affinity of copper binding to Msp4 will be reduced significantly. 
At this pH copper binding is weak, as reflected in the small peaks in the ESI mass 
spectrum. 
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Figure 6.6: ESI MS data of copper ion distribution in copper Msp4 complex presented 
as transf armed spectra. The spectra were taken from 10 µM Msp4 in 10 mM 
ammonia/formic acid buffer pH 7.4, in the absence (1 :0) and presence of 5 µM (1 :0.5), 
7.5 µM (1 :0.75), 10 µM (1 :1), 20 µM (1:2), 40 µM (1:4), 50 µM (1:5), and 80 µM 
CuSO4 (1 :8). In the presence of up to 8 mol of copper/mol Msp4, Msp4 was never 
totally bound in a complex, although the intensity of the complexes increased as copper 
was added. 
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Figure 6. 7: ESI MS data of copper ion distribution in copper Msp4 complex presented 
as detailed transformed spectra and saturation curves. A. Transformed spectrum 
displayed in detail to show the stepwise loading of the binding sites. B. Saturation 
curves of copper ion binding to Msp4 peptide. The stepwise loading of Cu2+ ion 
suggests that the sites are independent and identical. 
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6.4.4. Copper binding to Mspl and its modified peptides 
ESI mass spectra of modified Msp 1 peptides and their copper complexes have been 
obtained (Figure 6.8 and Table 6.5). The experiments were conducted at pH 7.4 
(NEM/formic acid buffer), with peptide concentration of 10 µM and copper 10n 
concentration in the final solution of 100 µM. 
The mass spectrum of Mspl (Figure 6.8 A) shows the expected average mass of 1093.1. 
Upon addition of copper, a single peak representing the copper complex of Msp 1 is 
observed at 1154.0 (see Figure 6.8 B), suggesting the stoichiometry of binding is one 
copper bound to Mspl, i.e. all Mspl is found in its copper-complexed form. 
To investigate possible copper-binding sites in Msp 1, peptides which have the His, Asn, 
and Gln residues replaced by Ala (Msp1H2A, Msp1N7 A, and MsplQl0A respectively) 
were investigated by ESI MS. The possibility of copper binding to the free carboxylate 
group at the C-terminus . as well as to the free imino group (Pro) at the N-terminus was 
also examined using peptides with the N- or C-terminus protected (Msp 1 capN or 
MsplcapC, respectively) and with both ends protected (MsplcapNC). 
No additional peaks emerge as a result of copper addition to Msp 1 capN ( compare 
Figure 6.8 C and D), which means that copper ions do not bind to this peptide. The 
result suggests that copper binding requires the free a-imino group as one of the binding 
sites. The involvement of the free a-amino group at the N-terminus in copper binding 
to ShaPrPs1-91 has been reported by Whittal et al. (2000), who also found that N-
terminal acetylation of ShaPrP23 _98 caused some reduction in the stoichiometry of 
copper binding. The involvement of the free a-imino group was also observed in the 
fluorescence titration experiments (see Chapter IV) and in the FTIR experiments (see 
Chapter III), in which copper addition to the N-terminally capped Msp peptides does not 
cause spectral changes. 
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Figure 6.8: Mass/charge spectra of copper binding to 
Msp 1 and its modified peptides. The spectra were taken 
from 10 µM Mspl (A and B), MsplcapN (C and D), 
MsplcapC (E and F), MsplcapNC (G and H), 
Msp1H2A (I and J), Msp1N7A (K and L), and 
MsplQl0A (Mand N) peptide in 10 mM NEM/formic 
acid buffer pH 7.4 in the absence (A, C, E, G, I, K, and 
M) and presence of 100 µM CuSO4 (B, D, F, H, J, L, 
and N). The figure is in this form because individual 
figures were scanned from the printout spectra. 
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Table 6.5: Molecular mass assignment for modified Mspl peptides and their copper 
complexes observed by ESI MS. 
Peptide or No. of copper [M-2nH+nCu] Mass observed Figure 
Complexes atoms bound (n) calculated No. 
Mspl 0 1093.0 1093.1 6.8 A 
Mspl+Cu 0 1093.0 none 6.8 B 
1 1154.5 1154.0 
Average incremental difference in mass: 60.9 
MsplcapN 0 1135.0 1135 .1 6.8 C 
MsplcapN+Cu 0 1135.0 1135 .1 6.8D 
1 1196.5 none 
Average incremental difference in mass: none 
MsplcapC 0 1092.0 1092.2 6.8 E 
MsplcapC+Cu 0 1092.0 1092.0 6.8 F 
1 1153.5 1152.9 
Average incremental difference in mass: 60.7 
MsplcapNC 0 1134.0 1134.2 6.8 G 
MsplcapNC+Cu 0 1134.0 1134.0 6.8 H 
1 1195 .5 none 
Average incremental difference in mass: none 
Msp1H2A 0 1027.0 1027.1 6.8 I 
Msp1H2A+Cu 0 1027.0 1027.1 6.8 J 
1 1088.5 1087.9 
Average incremental difference in mass: 60.8 
Msp1N7A 0 1050.0 1050.0 6.8 K 
Msp1N7A+Cu 0 1050.0 1050.0 6.8 L 
1 1111.5 1111.0 
Average incremental difference in mass: 61.0 
MsplQl0A 0 1036.0 1036.2 6.8M 
MsplQl0A+Cu 0 1036.0 1035.9 6.8N 
1 1097.5 none 
Average incremental difference in mass: none 
The mass spectrum of Msp 1 capC shows a peak at 1092.2 (Figure 6.8 E). Upon addition 
of copper, a new peak at 1152.9, which represents a complex that binds one copper, is 
observed (Figure 6.8 F). The fact that in the absence of the a-carboxyl group the 
peptide (Msp 1 capC) still binds copper ion suggests this group does not participate in 
copper binding. This result is in good agreement with the FTIR ( Chapter III) and 
fluorimetry (Chapter IV) data, which also show that copper binding to Msp 1 capC 
peptide still occurs. 
Copper ions do not bind to MsplcapNC as shown in Figure 6.8 G and H. This result is 
also confirmed by the fluorescence quenching experiment (Chapter IV). The ESI MS 
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result again supports the suggestion that the a-rm1no group 1s essential for copper 
binding. 
The ESI MS of MsplH2A in the absence and the presence of copper (see Figure 6.8 I 
and J) indicates the involvement of His in copper binding. The spectra show that 
replacement of His with Ala resulted in a relative intensity of copper-free peptide twice 
as high as for the copper-complex peptide (Figure 6.8 J). Thus, the data suggest that the 
absence of the His residue caused reduction in copper-binding affinity. This is 
supported by the Ki value for copper binding to MsplH2A obtained from fluorimetry, 
which is two orders of magnitude higher than the Ki for copper binding to Msp 1. The 
ESI MS and fluorimetry data suggest that Msp I peptide lacking the His residue is able 
to bind copper ion via a His-independent mechanism, probably involving the free a-
imino group at the N-terminus together with the nitrogen atoms of deprotonated amide 
groups. The His-independent mechanism, which involves the free amino terminus, is 
also suggested by Whittal et al. (2000) for copper binding to ShaPrP73_91. 
Experiments were carried out to investigate the possibility of copper binding to the 
amide side chains of Asn and Gln. There is one additional peak observed in the ESI 
mass spectrum of MsplN7 A upon addition of copper (see Figure 6.8 Kand L). The 
peak of copper-free MsplN7 A is also observed with relative intensity less than I/6th 
that of the copper complex. These data suggest Asn plays a small role in copper 
binding. Gln replacement with Ala (MsplQlOA) resulted in the absence of copper 
binding to the peptide (see Figure 6.8 M and N), suggesting that Gln is important for 
copper binding. Such involvement of the amide side chain of Gln residue in copper 
binding to a repeat region of PrP is the first to be reported. However, this observation is 
not consistent with FTIR and fluorimetry results reported here, both of which show 
Msp 1 Q 1 OA binds copper ion well. The ESI MS experiment for copper binding to 
Msp IQ I OA needs to be repeated to confirm if it is correct. 
In summary, the ESI MS experiments show copper ions bind to the free imino end 
group of Pro and the imidazole side chain of His. Elimination of the free imino group 
abolishes binding entirely. Contrary to expectation, the replacement of His with Ala 
resulted in only 50% reduction in the population of the copper-bound species. 
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6.5. Conclusions 
ESI MS experiments provide information on the copper-binding stoichiometry of Msp 
peptides. Experiments on copper binding to Msp2, Msp3 and Msp4 were performed in 
ammonium formate as suggested by the literature at the time. However, it is not an 
effective buffer at pH 7.4 and the real pH was lower. This caused copper binding to the 
Msp peptides to be sub-optimum, so that the population of copper complexed was very 
low. Under these conditions, the stoichiometry for copper binding to Msp2 is 3 copper 
ions, Msp3 4 copper ions, and Msp4 3 copper ions. The experiments need to be 
repeated with a more suitable buffer to work at pH 7 .4, such as NEM. 
The possibility of other metal ions binding to Msp2 has been investigated. While early 
reports in the literature suggested the specificity of copper binding to octapeptide 
(Hornshaw et al., 1995a; Hornshaw et al., 1995b; Whittal et al., 2000) and full-length 
PrP (Stockel et al., 1998), more recent reports suggested that other metal ions such as 
nickel could bind to the octapeptide (Jackson et al., 2001) and manganese to full-length 
PrP (Brown et al., 2000) under certain conditions. Msp2 has been shown to have 
capacity to bind other metal ions such as calcium, zinc, manganese and magnesium. 
However, this should be confirmed by other methods as ESI MS is prone to cation 
adduction, which results in non-specific binding. Although zinc, calcium, and 
magnesium binding to Msp peptides is confirmed by FTIR, the binding properties need 
to be characterized more fully. 
Copper ion titration of Msp4 has revealed stepwise loading of the binding sites, 
suggesting that the sites are independent and identical. However, under the conditions 
where the pH of the solution is not maintained at 7 .4 ( due to the use of ammonium 
formate as a buffer), the peaks of copper-complexed Msp4 are very weak compared 
with those of copper-free Msp4; the number of copper-binding sites in Msp4 is thus 
inconclusive. The experiments need to be repeated using a more suitable buffer to work 
at pH 7.4. 
ESI MS investigation of copper binding to modified Msp 1 peptides has helped to define 
the groups forming the copper-binding site. The free cx-imino group was found to be 
essential for copper binding; acetylation of the N-terminus abolished the copper binding 
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ability of the peptide. Replacement of His with Ala only partially reduced the copper 
binding ability of the peptide, indicating that the His role in copper binding is not as 
essential as the a-imino group of Pro. Together, these data indicate that the anchoring 
site for copper ion in Msp peptide is the a-imino group of Pro instead of the imidazole 
ring of His. This suggestion is in good agreement with results of FTIR (Chapter III) and 
fluorescence (Chapter IV) experiments. 
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Chapter VII 
Other Approaches: Equilibrium Dialysis, 
Circular Dichroism, and Visible Absorption Spectroscopy 
The purpose of this chapter i.s to present results from use of three other methods which 
were, however, not extensively employed due to time constraints. Nonetheless, some 
results were obtained which complement those from experiments described in previous 
chapters. The three methods, equilibrium dialysis (ED), circular dichroism (CD), and 
visible absorption spectroscopy, are well-established · techniques to characterize 
complexes between copper and proteins. 
7.1. Equilibrium dialysis 
7.1.1. Introduction 
Equilibrium dialysis (ED) is a traditional method commonly used to characterize the 
binding properties of macromolecules such as peptides and proteins. The technique 
allows measurement of the amount · of ligand bound to a macromolecule. The 
. measurement of the bound ligand is typically done through an indirect method, in which 
the total amount of ligand (bound plus free) and free ligand are the parameters to be 
measured in the experiment. The free ligand is dialyzed through a membrane until its 
concentration across the membrane reaches equilibrium. The membrane used in ED is 
semipermeable, such that it should be permeable to the ligand but impermeable to a 
macron1olecule being studied. By measuring the concentration of ligand on one side of 
the membrane ( e.g. contains free ligand and ligand bound to the macromolecule) and on 
the other side (free ligand only), the concentration of bound ligand can be calculated 
(Klotz, 1989). The diagram of the dialysis process is shown in Figure 7.1. 
As mentioned in Chapter I, ED has been used to characterize copper-binding properties 
of PrP (Brown et al., 1997; Stockel et al., 1998). Recombinant PrP23_9g, which spans the 
entire N-terminal domain of human PrP that contains the four octapeptide 
(PHGGGWGQ) tandem repeat, at pH 7.4 binds 5 to 6 copper ions with dissociation 
constants (Ki) of 5.9 µM. Copper binding occurs with positive cooperativity, in which 
3 to 4 copper ions bound cooperatively (Brown et al., 1997). ED has also been used to 
study copper-binding properties of the full-length Syrian hamster PrP (ShaPrP29-231 ). At 
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slightly acidic condition (pH 6.0), ShaPrP29-231 exhibits two binding sites specific for 
copper ion with a Kct of 14 µM (Stockel et al., 1998) . 
.. left . O .· . · 1:-ight/ · 
Coo :. 
'.1 Q O ,j )S . ·.. . . . 
n q 
"/50 .. · 
0 · .. ·. Q . : 
. 0 · ..•. ·. 
0 
. ~ Q 
0 
0 
0 
.... ·. 0 . 
.. ¢ . 
o · 
0 . 
0 
.. 6 . 0:, . 0 . 
· • Seniipe,m:1.€:~le · 1:n~:rnbr.ane .. · .· 
0 · !vl.a.c:roi:nole cule · 
. c, ·. Ligand · 
Figure 7.1: Illustration of equilibrium dialysis process. A semipermeable membrane is 
placed in the middle, so that there are two chambers. A solution of a macromolecule 
(i.e. protein) is placed in the left chamber and ligand solution in the right chamber. The 
solution is allowed to reach equilibrium, at which time the free-ligand concentration is 
the same in both chambers. If the amount of ligand in the left chamber (free plus 
bound) is measured as well as the amount of ligand in the right chamber ( free ligand 
only), the amount of bound ligand can be determined by subtraction. 
7.1.2. Aims 
In this project, ED was used to demonstrate, directly, copper binding to Msp peptides. 
The binding properties of Msp4, Msp3, and Msp2 such as Kct and stoichiometry were 
extracted from the binding data. Due to its low molecular weight (MW), it is not 
' 
possible to carry out ED experiments for copper binding to Mspl (MW=l093), as the 
smallest pore-size membrane available in the market is 500 molecular weight cut off 
(MWCO). Although it is still smaller than the MW of Msp 1, it is considered unsafe to 
use membrane with MWCO larger than 1/3 of the MW of peptide. 
7.1.3. Materials and methods 
7.1.3.1. Materials and apparatus 
Synthetic peptides used in ED experiments are presented in Table 7 .1. Copper used in 
equilibrium dialysis was supplied in the form of copper diglycine chelate (Cu(Gly)2), 
which was made by combining solutions of CuSO4 and amino acid glycine (mol ratio 
1 :2). The reason for using Cu(Gly)2 is to prevent precipitation of copper as copper 
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hydroxide at pH 7.4, to mimic the in vivo situation and, because amino acid glycine 
competes for free copper, spurious binding to low-affinity sites is suppressed (Brown et 
al., 1997). The pH and ionic strength in both chambers was the same. The solution was 
maintained at pH 7.4 using 25 mM N-ethylmorpholine buffer (NEM), which was 
adjusted to pH 7.4 by I--ICL The ionic strength was maintained at 0.15 by addition of 
150 mM KCl (Brown et al., 1997). The membrane separating the two sides of dialysis 
chambers is a cellulose ester membrane with MW CO 1000 (for Msp4) and 5 00 ( for 
Msp3 and Msp2), manufactured by Spectrum. 
Table 7.1: Synthetic peptides used in the experiments 
Peptide Sequence Size MW 
Msp4 (PHPGGSNWGQ)4G 41 4147 
Msp3 (PHPGGSNWGQ)3G 31 3129 
Msp2 (PHPGGSNWGQ)2G 21 2111 
The dialysis chambers (perspex) were made by the JCSMR workshop. The initial 
design had dimensions of: 16 mm inner diameter, 8 mm depth of inner chamber, and 1.6 
mL half-cell volume (see Figure 7.2 A). The new dialysis chambers have dimensions 
of: 26 mm inner diameter, 3 mm depth of inner chamber, and 1.6 mL half-cell volume 
(see Figure 7.2 B). The improved design allows a larger membrane surface area with 
the same volume of solution inside half dialysis cells. A rotation apparatus ( see Figure 
7.2 C) was made by the JCSMR workshop to facilitate agitation during the dialysis. 
The rotation apparatus was equipped with clips to hold the dialysis cells during 
agitation. 
7.1.3.2. Methods 
Solutions containing different concentrations of Cu(Gly)2 in 25 mM NEM buffer pH 7.4 
and 150 mM KCl were prepared. 5 µM Msp peptide solution was also prepared in the 
same buffer (25 mM NEM pH 7.4 and 150 mM KCl). Cellulose ester membrane was 
cut into a round shape to fit the dialysis chamber. The membrane was placed between 
the two half dialysis cells, so that two compartments were formed. For each experiment 
20 ED chambers were prepared. One compartment of each ED apparatus was filled 
with 1.25 mL Cu(Gly)2 of variable concentration and the other compartment was filled 
168 
with 1.25 mL Msp peptide solution. A small air bubble was left in each compartment to 
facilitate mixing. The filled dialysis cells were agitated at 4 °c until equjlibriun1 was 
reached - 6 days for MW CO 1000 and up to three weeks for MW CO 5 00. The two 
solutions in the compartments were then collected, and the copper concentrations were 
measured by inductively coupled plasma optical emission spectroscopy (ICP OES). 
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me1nbrane 
New design 
Inlets and outlets 
3 3 
membrane 
\D 
N 
Figure 7.2: Design of dialysis chambers. (A) Initial design: inside diameter of 16 mm, 
8 mm depth, and volume of 1.6 mL. (B) Improved design: inside diameter of 26 mm, 
depth of 3 mm, and volume of 1.6 mL. (C) Rotation device to facilitate agitation during 
dialysis. The rotation device was equipped with clips to hold the dialysis cells during 
agitation. (D) Diagram of the dialysis chambers showing the dimension of the chan1bers 
in mm. The inlets and outlets were used to add and remove solutions from the two 
compartn1ents that were separated by the membrane. Peptide solutions were added to 
the left compartn1ents (Msp-containing compartments) and copper solutions were added 
to the right compartments (Msp-free compartments). 
Copper concentration in the Msp-containing compartment represents the total copper 
concentration [Cu]T (bound plus free copper) and copper concentration in the Msp-free 
compartment represents free copper concentration [Cu]r. The extent of binding (v) was 
calculated according to Equation 7 .1 , 
v = [Cu]b/[Msp] (Equation 7 .1) 
in which [Cu]b is the concentration of copper bound to the Msp peptide of concentration 
[Msp]. [Cu]b was calculated according to Equation 7.2. 
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[Cu]b = [Cu]r- [Cu]r (Equation 7 .2) 
The binding data v were then plotted against [Cu]r and analysed to get the dissociation 
constant CKi) and the number of copper ions bound to the Msp peptide ( n, 
stoichiometry). 
7.1.4. Results and discussion 
7.1.4.1. Design of the dialysis chamber 
The old design was taken from an ED chamber used many years ago in JCSMR. This 
initial design (see Figure 7.2 A) resulted in very long times for copper ions to 
equilibrate across the dialysis membrane. According to Fick' s law of diffusion 
(Equation 7.3), the rate of diffusion (d[Cu]/dt) is proportional to the area (A) across 
which diffusion occurs (from left ([Cu]L) to right ([Cu]R). For a given surface area, a 
larger volume of solution will require a longer equilibration time than a smaller volume 
of the same concentration; 
-d[Cu]/dt = {A([Cu]L- [Cu]R)}/T (Equation 7. 3) 
where A is surface area of the membrane across which diffusion occurs, and T is the 
time for the diffusion process. 
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Figure 7.3: Effect of chamber design on copper diffusion. Old chamber design: ins_ide 
diameter of 16 mm or membrane surface area of 804 mm2. New chamber design: inside 
diameter of 26 mm or membrane surface area of 2123 mm2. Dialysis experiments were 
carried out using 1000 MWCO membrane. 1.2 mL of 200 µM Cu(Gly)2 in NEM pH 
7 .4 was placed in the right chamber, while _ the left chamber contained buffer only. 
Dialysis was stopped after 1, 3, and 4 days, and copper concentration in each chamber 
was measured using the ICP OES method. 
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Design of the dialysis cells with the same volume but larger membrane surface area 
should lead to a decrease in dialysis time. Improved design of the dialysis chamber (see 
Figure 7.2 B) was compared with the initial design for copper diffusion time (Figure 
7.3). Figure 7.3 shows that copper diffusion in the improved design is 1.5 times faster 
than in the initial design. The design of the new chamber makes the membrane surface 
area larger while maintaining ·volume as the same for the old chamber. 
7.1.4.2. Time for equilibration 
In this experiment, the time necessary for establishing equilibrium was determined by 
investigating the copper diffusion across the dialysis membrane (MWCO 1000 and 500) 
in the absence of Msp peptides. By using the new design, equilibrium was reached after 
5 days of dialysis for MWCO 1000 and after approximately 13 days for MWCO 500 
(see Figure 7.4). In order to provide a safety margin, dialysis was carried out for 7 days 
when using MWCO 1000 and 18 days when using MWCO 500. 
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Figure 7.4: Time for copper diffusion across the dialysis membrane of MWCO 500 and 
MWCO 1000. 1.2 mL of 200 µM Cu(Gly)2 in NEM pH 7.4 was placed in the right 
chamber, while the left chamber contained buffer only. Dialysis was stopped after days 
indicated, and copper concentration in each chamber was measured using the ICP OES 
method. 
7.1.4.3. Copper binding to Msp peptides at pH 7.4 
Figure 7.5 (top) shows the relative ratio of copper bound per Msp4 molecule plotted 
versus the free copper concentration. The maximum molar ratio of copper ions to Msp4 
is between 2 and 2.5. The half-maximal binding observed for Msp4 is between 0.43 and 
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1.2 µM (average 0.73 µM). The data suggest that Msp4 molecule possesses two 
binding sites for copper with a dissociation constant of 0.73 µM. Figure 7.5 (bottom 
left) shows stoichiometry of one copper bound per Msp3 molecule, with a dissociation 
constant of 0.06 µM. A stoichiometry of two copper ions bound per Msp2 molecule 
and dissociation constant of 0.08 µMis shown in Figure 7.5 (bottom right). 
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Figure 7.5: Binding of Cu(Gly)2 to Msp peptides measured by equilibrium dialysis 
experiments. Saturation curve for copper binding to 5 µM Msp4 is the result of 4 sets 
of experiments (top). Saturation curve for copper binding to 5 µM Msp3 is the result of 
one set of experiments (bottom left). Saturation curve for copper binding to 5 µM Msp2 
is the result of one set of experiments (bottom right). The data were fitted with 
saturation binding equation: Y = (X . n)/(Kci + X) using the GraphPad Prism 3 program. 
7.1.5. Conclusions from ED experiments 
Thus, ED experiments show that 2 copper ions bind to Msp4, 1 copper ion binds to 
Msp3, and 2 copper ions bind to Msp2. This is not a regular pattern connecting the 
number of repeats with the number of copper ions bound. It is not clear why Msp2 
binds more copper than Msp3. These stoichiometries of copper binding to Msp 
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peptides are not in agreement with results of other ED experiments on PrP repeats from 
human, where one copper ion bound to one repeat (Brown et al., 1998) or with 
stoichiometries for chicken and human PrP repeats determined by other methods (Table 
1.4 of Chapter I). 
The ~ values from equilibrium dialysis experiments are 0. 73 µM for Msp4, 0.06 µM 
for Msp3 and 0.08 µM for Msp2. The Ki values for Msp4 are,...., 230 times higher than 
values from fluorimetry experiments (~ of 3.2 nM for 0.5 µM Msp4). The Kct value 
for Msp3 is 15 times higher than its value from fluorimetry experiments(~ of 4.0 nM 
for 0.5 µM Msp3), while that for Msp2 is 200 times higher than its value from 
fluorimetry experiments (0.4 nM for 0.5 µM Msp2). It should be pointed out that the 
ED experiments for copper binding to Msp3 and Msp2 were carried out for a very long 
time (up to three weeks). This is because a very small molecular weight cut off 
membrane (500 MWCO) needed to be used. The binding process takes place over a 
long time, which is good in one way as it provides a different scale time window for 
studying binding and should assure the system comes to equilibrium. The long time 
could be a source of error if during the process the peptide decays. However, the 
peptides are relatively stable and decay is unlikely. 
173 
7.2. Circular dichroism spectroscopy 
7.2.1. Introduction 
Circular dichroism (CD) measures differences in the absorption of left-handed polarized 
light versus right-handed polarized light by an optically active chromophore, which has 
structural asymmetry or chii:ality. Biological macromolecules such as peptides and 
proteins are composed of many optically active chromophore or chiral units, namely the 
asymmetric carbon atoms in their amino acid backbone. CD spectroscopy has therefore 
been used extensively to characterize the structure of proteins and peptides. The shape 
of the CD spectrum and the amplitude of the CD signal is characteristic for each type of 
secondary structure. The absence of regular structure in proteins results in zero CD 
intensity, while an ordered structure results in a spectrum, which can contain both 
positive and negative signals (for review see: (Johnson, 1988; Johnson, 1990; Woody, 
1994; Woody, 1995)). 
As noted in Chapter I, CD has been used to resolve the secondary structure of human 
octarepeats and chicken hexarepeats of PrP and the conformational changes associated 
with copper binding. The majority of the CD studies agree that PrP repeats are in 
random-coil form (Hornshaw et al., 1995a; Viles et al., 1999; Bonomo et al. , 2000; 
Whittal et al., 2000), and take up more ordered structure, such as loop and turns, when 
the peptide binds to copper ions (Viles et al., 1999; Bonomq et al., 2000; Whittal et al. , 
2000). CD has also been used as a method to monitor the progress of binding between 
PrP-repeat peptides and the metal ion (Viles et al., 1999; Garnett and Viles, 2003). The 
magnitude of spectral changes that occur upon copper addition was then analyzed to get 
the Kci value as well as the stoichiometry. 
7.2.2. Aims 
In this project, CD was mainly used to probe the conformation of peptides containing 
several copies of the second-repeat sequence [(PHPGGSNWGQ)nG, n = 1 and 2] of the 
N-terminal tandem repeat region of a marsupial PrP (Msp ). 
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7.2.3. Materials and methods 
7.2.3.1. Sample preparation 
Unless otherwise stated, the sample for CD experiments was taken from a solution 
remaining from the FTIR experiments. The purpose of this was to ensure that both CD 
and FTIR spectra originated from the same sample as it was hoped the results from the 
CD experiments would complen1ent the FTIR results, especially in terms of 
conformational changes. The peptide concentration was adjusted to 0.5 mM by diluting 
the FTIR samples accordingly. Blank solution was also prepared so that the 
concentration of salts (NaCl, N aOH, and HCl) was similar to that in the sample 
solution. 
7 .2.3.2. CD measurement. 
CD spectra were recorded on a Jobin-Yvon Model CD6 instrument at 25 °c. Typically, 
a cell with 0.01 cm path length with two detachable windows was used for spectra 
recorded between 180 and 260 nm, with points sampled every 0.5 nm. Sample and 
blank solution were scanned 10 times. The data were processed using the CD6 
dichrograph program. The blank spectrum was subtracted from the sample spectrum. 
The resultant spectrum was then smoothed. The measurement unit is 0 ( ellipticity in 
mdeg). 
7.2.4. Results and discussion: CD spectral changes associated with copper binding 
to Msp peptides 
CD spectra of MsplcapC (Figure 7.6.A), Msp2capC (Figure 7.6.C) and Msp2capNC 
(Figure 7.5.E) in the absence of copper ion at different pH values show the main 
features as an intense minimum at about 195 nm and positive band around 217 nm. 
This feature is typical of a disordered polypeptide backbone, and was also observed for 
PrP repeats from other species (Hornshaw et al., 1995a; Viles et al. , 1999; Bonomo et 
al. , 2000; Whittal et al., 2000; Garnett and Viles, 2003). No conformational changes 
associated with pH change are observed, despite some differences in band intensity: 
these could be due to inaccuracy in the determination of peptide concentration. 
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Figure 7.6: CD spectra of copper binding to Msp peptides. The spectra of 0.5 mM 
MsplcapC, Msp2capC, and Msp2capNC in the absence (A, C, and E, respectively) and 
presence (B, D, and F, respectively) of 2 mM CuCb at pH 6.0, 7.0, 8.0, and 9.0. The 
samples were taken from solution remaining from FTIR experin1ents, which were then 
diluted appropriately. 
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MsplcapC+Cu. Copper addition to MsplcapC (Figure 7.6.B) resulted in some 
changes in the CD spectrum. At pH 6.0 and 7.0, a new weak negative band was 
observed at around 227 nm. Increasing the pH to 8.0 and 9.0 resulted in a blue shift of 
the new band, so that the band is now located around 222 nm. The new negative band 
at pH 9.0 is stronger than at any of the other three pHs, which indicates the stronger 
association between peptide and copper ions at this pH. However, a strong minimum 
band at 195 nm and weak positive band at 212 nm are still present in the spectra at all 
pHs. Overall, the spectral features are not consistent with any known CD spectrum of 
common secondary structure, i.e. a-helix or P-sheet. 
The appearance of the new negative band at 222 and 227 nm is clearly associated with 
copper complexation of peptide molecule. The appearance of a new negative band at 
222 nm is quite common and is always observed in the spectra of copper complexes of 
human PrP octarepeats (Viles et al., 1999; Bonomo et al., 2000; Whittal et al., 2000). 
However, the rest of the published spectral features are different from those of 
MsplcapC. 
Msp2capC+Cu. Copper addition to Msp2capC resulted in the same effects as for 
MsplcapC. There is a new negative band around 230 nm observed at pH 6.0 to 8.0, 
which is blue shifted to 220 nm upon increasing pH to 9.q. As also observed in the 
copper complex of MsplcapC, the new negative band at pH 9.0 is stronger compared to 
the other three pHs. It clearly indicates this new band arises upon copper interaction 
with the peptide molecule, and that the interaction is stronger at pH 9.0. 
Msp2capNC+Cu. The new negative band at around 230 nm does not appear in the 
spectra of Msp2capNC upon addition of copper ion at pH 6.0 and 7.0. This is consistent 
with previous observations in FTIR (Chapter III), which suggest that N-terminally 
capped peptide does not bind copper ion at these two pHs. Consistent with FTIR, the 
CD spectra show binding occurs only at basic pH (above 8.0) where a weak negative 
band at 215 nm appears and becomes stronger at pH 9.0. 
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7.2.5. Conclusions 
The response of the complex toward increasing pH observed with CD is quite similar to 
that observed with FTIR. Both CD and FTIR indicated that copper interaction with the 
peptide was enhanced by increasing pH, so that at pH 9. 0 the largest spectral changes 
occurred. By FTIR this strong interaction at pH 9.0, especially for multi-repeat peptide, 
was shown as a large shift of the amide I band toward lower frequency, which was 
assigned as solvent-exposed a-helical structure. For single-repeat peptide, the amide I 
band shift is not so prominent, and the band is assigned as random-coil structure. 
Based on the FTIR results, CD spectra of the copper complex of Msp2capC were 
expected to show more helical structure at pH 9. 0 than at lower pH. Also, the structure 
was expected to be more helical than the structure of the copper complex of Msp 1 capC 
peptide. In CD spectra, a-helix in (folded) proteins appears with two negative bands at 
208 and 222 nm and a positive band at around 192 nm (Woody, 1994 ). The band at 220 
nm for a-helix structure is assigned as the peptide n-rc* transition component (Woody, 
1994). The CD spectra of the copper complexes of MsplcapC and Msp2capC both 
show the negative ellipticity at 230 nm with band intensity appearing to be higher in 
Msp2capC than in MsplcapC. As pH is increased to 9.0, this band shifts to around 220 
nm and increases in intensity. Again, the intensity of this band in Msp2capC is higher 
than that in Msp 1 capC. These data are in good agreement with that expected from 
FTIR. 
Although the new negative band at around 220-230 nm suggests the presence of an 
increasing amount of helical structure for Msp2capC, the rest of the spectrum (Figure 
7.6 Band D), which shows a negative band at 195 nm, does not resemble the usual CD 
spectrum for a-helical structure. Thus, although the appearance of the 230 nm band in 
copper complexes of Msp peptides might indicate a-helical structure, the dominant 
negative band at around 195 nm suggests the presence of a large amount of random-coil 
structure. Thus, in summary, conformational analysis suggests a mixture of helix and 
random-coil structure. 
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7.3. Visible absorption spectroscopy 
7.3.1. Introduction 
Visible absorption spectroscopy is a method to detect which atoms are bound to copper 
ions, based on the relationship between the ligand field around the central copper (II) 
and the position of the Amax of copper complexes (Bryce and Gurd, 1966). These bands 
shift to shorter wavelength as the number of strong-field atoms that are bound to copper 
increases. In general, in copper complexes of peptides coordinating groups may be 
classified according to field strength as a-amino nitrogen > peptide bond nitrogen > 
imidazole nitrogen > oxygen (from C=O peptide or coo- terminal) (Bryce and Gurd, 
1966; Breslow, 1973). 
Visible absorption spectroscopy has been used for the study of copper complexes of PrP 
repeats (Miura et al., 1999; Viles et al., 1999; Luczkowski et al., 2002). Viles et al. 
(1999) observed an absorption band at 625 nm with an extinction coefficient of 40 M-1 
cm-1, which was assigned as the 3N complex, where 2 nitrogen atoms from the 
imidazole ring of His and one nitrogen atom of a peptide bond coordinates to the copper 
10n. 
Miura et al. (1999) reported Amax of the copper complex of PHGGG located at 623 nm. 
Combined with Raman results, it was suggested that this band arises from one Nn: atom 
of His and two nitrogen atoms of deprotonated amides in the triglycine segment, which 
are the equatorial ligands in this complex. The fourth equatorial ligand is a water 
molecule. For the copper complex of OPl (PHGGGWGQ), the reported Amax was 615 
nm. As the value is close to that of the copper-PHGGG complex, the coordination of 
ligands in OPl was suggested to be the same as for this pentapeptide. The 8 nm 
difference in the Amax was attributed to a difference in coordination geometry or in the 
apical ligands. The Amax for the copper complex of OP2 ((PHGGGWGQ)2) depends on 
the concentration of copper ion. It changes from 610-613 to 597-599 nm with a 
transition midpoint at r=l, where it is the ratio of copper to peptide. It was suggested 
that at r below 1, each octapeptide unit independently binds copper, with structure very 
similar to that of OPl. Visible absorption spectra of the copper complex of OP4 
((PHGGGWGQ)4) show Amax at 607 and 600 nm at r=0.5 and 1, respectively. The Amax 
values are close to those observed for the copper complex of OP2, indicating that the 
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primary equatorial ligands are the same as in the copper complex of the peptide 
described above. Miura et al. (1999) observed partial aggregation of the peptide, and 
the intermolecular association may be a cause of the blue shift from 607 nm at r=0.5 to 
600 at r=l. 
' 
Luczkowski et al. (2002) observed a shift in the Amax value upon increasing pH, 
indicating an increase in the number of ligands bound to the copper ion (Table 7.2) . By 
monitoring "-max, the species formed at each pH can be predicted, with support from 
other spectroscopic data. 
According to Luczkowski et al. (2002), the proposed ligands in CuH_1 L species are the 
terminal imino group of Pro (NH), a deprotonated amide nitrogen (N-), and the nitrogen 
atom of the imidazole ring of His (Nimict). As pH increases above 8.0, more amide 
nitrogens deprotonate and coordinate to the copper ion. At this pH, the His residue no 
longer participates in the complex, so that now the coordination sphere was filled with 
NH, and 3 deprotonated amide nitrogens (3 x N). As the pH was raised above 10.0, the 
biuret complex, where the copper ion coordinates to deprotonated amide nitrogen 
atoms, is observed ( 4 x N-) . 
Table 7.2: Visible absorption spectroscopic data for copper binding to PrP-octarepeat 
peptides. The peptide sequences were PHGGGWGQ-NH2 and Ac-PHGGGWGQ-NH2. 
Data were taken from Luczkowski et al. (2002). 
Species pH Amax (nm) E (M-1 cm-1) Ligands 
PHGGGWGQ-NH2 
CuHL 2.0-4.0 596 18 
CuH_1L 3.0-9.0 597 75 NH, N-' N imid 
CuH_2L >6.0 588 98 
CuH_3L >8.0 541 114 NH, 3xN-
CuH_4L >10.0 505 211 4xN-
Ac-PHGGGWGQ-NH2 
CuL 4.0-7.0 742 22 
CuH_2L 6.0-10.0 621 97 
CuH_3L 7.0-11.0 589 99 
CuH-4L >8.0 531 183 
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7.3.2. Aims 
In these experiments, visible absorption spectroscopy was used to probe the ligands in 
the copper complex of Msp3 peptide. 
7 .3 .3. Experimental 
7.3.3.1. Sample preparation 
The sample used for these experiments was obtained from the remaining solution of 
FTIR samples of the copper complex of Msp3. All remaining solutions were combined 
so that the concentration of Msp3 and CuCb in the solution for Vis absorption 
spectroscopy measurement was not exactly known. The pH of the solution was initially 
brought to 12.0 by addition ofNaOH solution. The pH was then adjusted to the desired 
j 
pH by addition of HCL pH was measured using the Hanna pH meter equipped with a 
mini probe. 
7.3.3.2. Spectrum measurement 
Spectra of Msp3 solution in the presence of copper at various pHs were measured by 
UV/Vis spectrophotometry using the Varian Cary 1 Bio. The sample was placed in a 
500 µL quartz cuvette of 1 cm path length. Spectra were taken in the region of 500-700 
nm against water as a reference. 
7 .3.4. Results and discussion 
Results in Table 7.3 show that the Amax value shifts towards lower wavelength upon 
increasing pH, which indicates the involvement of more strong-field ligands in the 
copper coordination. FTIR and fluorescence spectroscopy data ( Chapters III and IV) 
have previously assigned the possible groups of Msp 1 that binds to copper ion, as the 
imino end group of Pro (NH), the nitrogen atom of the imidazole ring of His (Nimict) and 
amide nitrogen (N-). As noted above, the order of the field strength is NH > N- > Nirnict 
(Breslow et al. , 1973). The shift of the Amax towards lower wavelength upon increasing 
pH indicates the involvement of more amide nitrogens, as coordination to this group 
requires deprotonation of amide, which only occurs at high pH. Also the N- group is a 
strong-field ligand that will shift the Amax toward a lower value. Assignment of possible 
ligands at each Amax, and at each pH, is presented in Table 7.3. 
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The involvement of NH and Nimict (pKa 6.8-7.9 and 6.2, respectively (Creighton, 1983 
p. 7)) at pHs as low as 4.0 is in agreement with Luczkowski et al. (2000) who detected 
copper coordination to NH, Nimid, and N- groups in C-terminally capped human PrP 
octarepeat peptide (Table 7 .2). 
Table 7.3: Visible absorption spectroscopic data for copper complexes of Msp3 
peptide. The peptide sequence was (PHPGGSNWGQ)3G. 
Complex pH Amax Proposed Ligand 
NH-(PHPGGSNW GQG)3 G-O H 4.0 631 NHN· 'd 
' lilll 
5.0 592 NH, Nimid, coo-
6.0 594 NH, Nimid, coo-
7.0 584 NH, Nimid, coo-, N-
8.0 575 NH, Nimid, coo-, N-
9.0 563 NH, N imid, 2 x N-
7.3.5. Conclusions 
Although this was a rough preliminary experiment, it indicates that visible absorption 
spectroscopy is useful as a complementary method to assign binding sites for copper in 
Msp peptides. The blue shift that occurs upon increasing pH indicates the involvement 
of more nitrogen atoms of the peptide bond in the copper coordination sphere. Further 
study with simple peptides, such as Mspl, its mutants and other variants, will be able to 
provide more information about the copper-binding sites to con1plement the data from 
FTIR and other methods. 
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Chapter VIII 
Concluding Essay: 
Biophysical Properties of Marsupial PrP Repeats 
The studies of marsupial PrP. repeats presented in this thesis support the idea that this 
protein interacts with, and may play a role in, cellular metabolism of copper ion. The 
investigation was carried out using low-resolution spectroscopic methods plus the 
equilibrium dialysis technique, as there are several obstacles prohibiting the use of high-
resolution techniques in the study of repetitive protein sequences. 
The use of several spectroscopic methods is necessary to obtain information about all 
aspects of the biophysical properties of the peptide. However, various conditions - e.g. 
practicable ranges of peptide and copper ion concentrations, and types of buffer -
specific to different methods might cause disagreement in the final results of study of 
the same property. Nevertheless, conformational and other properties of disordered 
polypeptides will be better understood if their dependence on environmental conditions 
is also known. 
The sequence of possum decarepeat (PHPGGSNWGQ) was chosen as the main subject 
of this research as it was the only sequence then available. It is, however, expected to 
be typical of marsupial PrP-repeat sequences in its essential differences with 
mammalian PrP-repeat sequences. As shown in Table 1.1 of Chapter I, the PrP repeats 
of both marsupial species now known (brush-tailed possum and tammar wallaby) do not 
have the HGGGW segment, which is a feature of the consensus sequence of mammalian 
PrP repeats. Although the motif P[H/Q].GG.WGQ is conserved among the mammalian 
and marsupial sequences, this marsupial decarepeat used as the basis for these studies 
has a Pro inserted as its third residue ( after H/Q), which cannot coordinate copper ion 
through its amide nitrogen. 
The purpose of this chapter is threefold: (1 ). to provide a surnmary of the findings in the 
. previous Chapters III to VII; (2) to provide explanatory notes on the consistent and 
conflicting results indicated in those chapters; and (3) to provide some suggestions for 
future research. 
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8.1. Structure of marsupial PrP repeats 
8.1.1. Copper-free peptides 
The NMR structure of a full-length marsupial PrP is not yet available. However, the 
accumulated spectroscopy data (FTIR, CD, fluorescence, and FRET spectroscopy) 
reported in this thesis suggest that the repeats region of marsupial PrP is unstructured in 
the absence of copper ion. This is in good agreement with the structure of copper-free 
peptide of PrP repeats from mammalians (Hornshaw et al., 1995a; Miura et al., 1996; 
Viles et al., 1999; Bonomo et al., 2000; Whittal et al., 2000) and chicken (Hornshaw et 
al., 1995a). 
Although marsupial PrP-decarepeat peptides are unstructured, they are not staggered or 
fully extended but rather loosely folded as suggested by the FRET distance between Trp 
and the N-terminus ( dansyl group attached) of the peptides. The FRET distance 
between Trp and the N-terminus in human PrP octarepeat peptide also shows that the 
peptide is loosely folded. The loose folding of human octarepeat is in agreement with 
the loops and turns structure in Yoshida et al.' s NMR model, which shows Trp is close 
to the N-terminus of one octarepeat (Yoshida et al., 2000). 
Furthermore, Yoshida et al. (2000) suggest that cation-n ( at acidic pH 6.5) interaction 
between the imidazole ring of His and the aromatic ring of Trp stabilizes this loop 
structure in human octarepeat peptide. However, n-n interaction at neutral or alkaline 
pH with neutral His seems possible also. Based on the theory of cation-n interaction, 
Yoshida et al. (2000) predict that a chicken hexarepeat PHNPGY1 will adopt the same 
I 
loop structure because, just as in the case of human octarepeat, four residues make up 
I 
the distance between His and the aromatic ring of Tyr (Yoshida et al., 2000). In the 
case of marsupial decarepeats (PHPGGSNWGQ), however, there is a 6-residue interval 
between Trp and His. Thus, in marsupial decarepeats peptide, the cation-n or n-n 
interaction would likely induce the formation of a larger loop structure. 
8.1.2. Copper-complexed peptides 
FTIR experiments show that copper 10n addition to marsupial PrP-repeat peptides 
resulted in the formation of a more hydrogen-bonded structure, as the amide I band 
shifts significantly to lower frequency. The new frequency of the amide I band is 
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assigned as arising from a solvent-exposed ex-helical structure (Haris and Chapman, 
1995). The formation of ex-helix structure was also observed in CD spectra, which 
show emergence of a negative band at 220-230 nm upon addition of copper ion to the 
peptides. Fluorescence spectrosocopy data, which show the wavelength maximum peak 
does not shift toward a lower wavelength upon addition of copper ion, support the 
conclusion of solvent-exposed structure in the complexes. 
The presence of ex-helix structure, resulting from copper addition, was also detected in 
human PrP repeats, which were studied using Raman spectroscopy (Miura et al., 1996). 
However, these results are in disagreement with a CD study which suggested no 
structural changes upon addition of copper ion (Hornshaw et al., 1995a). Yet, other CD 
experiments suggested the presence of turns and structured loops resulting from copper 
addition to repeat peptides (Viles et al., 1999; Bonomo et al., 2000; Whittal et al., 2000). 
8.2. Dissociation constant (~) and stoichiometry of copper binding to marsupial 
PrP repeats 
Stoichiometry and ~ of copper binding to marsupial PrP repeats have been determined 
by m.ass spectro1netry, fluorescence spectrophotometry, and the equilibrium dialysis 
technique. 
Mass spectra of copper binding to Msp2, Msp3, and Msp4 showed that the peak 
intensity of the copper complexes of peptide was much lower than that of the free 
peptide. In contrast with the dissociation constant of the copper complex determined by 
fluorescence spectrophotometry in the nM range (which will be discussed later), such 
low peak intensity indicates that the binding of copper to the peptides is very weak. The 
reason for these conflicting data is, perhaps, due to the use of ammonia/formic acid 
buffer in the mass spectrometry experiments. As discussed in Chapter VI, the 
ammonia/formic acid buffer is unreliable for maintaining the pH at 7 .4, so that the pH 
of the solution is likely acidic by the time the sample is analyzed. Nevertheless, in this 
research these mass spectra revealed the first evidence of possible binding between 
copper ion and marsupial PrP repeats, which was then further investigated by using 
other methods. It should be noted that due to the aforementioned unreliable buffer, the 
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mass spectrometry experiments of copper binding to Msp2, Msp3, and Msp4 did not 
conclusively show the binding stoichiometry. 
The fluorescence spectrophotometry experiments at 0.5 µM peptide concentration 
demonstrated a stoichiometry of 1 copper ion binding per 1 peptide molecule of Msp2, 
Msp3, and Msp4. Under the same experimental conditions at 0.5 µM peptide 
concentration, the stoichiometry is 1 copper ion binding per 2 peptide molecules of 
Msp 1. The stoichiometry of copper ion binding to Msp 1 does not change after the free 
coo- group at the C-terminus of the peptide is amidated (MsplcapC). In the other 
three peptides (Msp2, Msp3, and Msp4), the elimination of the coo- group (in C-
terminally amidated peptides: Msp2capC, Msp3capC, and Msp4capC) decreases the 
copper-binding stoichiometry, as fluorimetry experiments show 1 copper ion binding 
per 2 peptide molecules of Msp2capC, 1 :3 Cu(II)/Msp3capC, and 1 :4 Cu(II)/Msp4capC. 
A marked decrease in the stoichiometry of copper binding per peptide molecule 
indirectly suggests coo- group as a copper-binding site; this will be discussed further 
in the next section. 
The stoichiometry of one copper binding to more than one molecule of peptide (Msp 1 
and all C-terminally amidated peptides) suggests the formation of multi-peptide 
complexes, which is not supported by results from other methods employed in this 
research. A method that can directly detect the formation of multi-peptide complexes is 
the analytical ultracentrifugation (AUC) technique. However, due to time constraints of 
this thesis, work using the AU C could not be pursued. 
The fluorescence spectrophotometry experiments also show that the stoichiometry and 
Kci depend on peptide concentration. This indicates that peptide molecule association, 
which is reflected in the stoichiometry of copper binding noted above, follows the 
copper-binding process. Fluorimetry experiments of copper binding to Msp 1 capC at 
varied peptide concentrations show peptide molecule association occurs at low, not 
high, peptide concentration. As previously mentioned, at 0.5 µM peptide concentration 
the stoichiometry is 1 copper binding per 2 Msp 1 capC molecules. At 5 µM peptide 
concentration the peptide molecule association does not occur, as shown in the 
stoichiometry of 1 copper ion binding per 1 Msp 1 capC molecule. This suggests that the 
number of copper ions binding per peptide molecule at high peptide concentration is 
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twice that at low peptide concentration. This phenomenon is also observed in the 
copper complex of Msp4capC. 
The equilibrium dialysis experiments show a stoichiometry of 2 copper ions binding per 
1 Msp4 molecule. This is in disagreement with the fluorimetry result, which shows that 
1 copper ion binds to 1 Msp4 molecule. The disagreement is probably caused by the 
peptide concentration used in the ED experiment ( 5 µM) which is 10 times higher than 
in the fluorimetry experiment (0.5 µM). Given this effect of concentration on the 
stoichiometry of binding, the fluorimetry experiment of copper binding to 5 µM Msp4 
v needs to be done to check whether consistent stoichiometry is now obtained. 
Nevertheless, as the stoichiometry data of copper binding to Msp4capC are available, 
the stoichiometry of copper binding to 5 µM Msp4 can be deduced as shown in Table 
8.1 below. 
Table 8.1: Effect of peptide concentration on the stoichiometry of binding between 
copper and Msp4. The predicted stoichiometry of copper binding to 5.0 µM Msp4 
(shown in the shaded area) was deduced from Msp4capC data obtained . from 
fluorescence experiments. 
Peptide concentration Stoichiometry in Msp4capC Stoichiometry in Msp4 
0.5 µM 1 Cu: 4 Msp4capC 1 Cu: 1 Msp4 
5.0µM 1 Cu : 2 Msp4capC 
As noted in Chapter IV, and presented in Table 8.1, at 0.5 µM Msp4capC the 
stoichiometry is 1 copper ion binding per 4 peptide molecules, while at 5 µM peptide it 
is 1 copper ion binding per 2 Msp4capC molecules. At 0.5 µM peptide, the number of 
copper ions bound to Msp4 is 4 times that bound to Msp4capC peptide. At 5 µM 
peptide, the number of copper ions bound to Msp4 is predicted also to be 4 times that 
bound to Msp4capC peptide. Fluorescence spectrometry shows that at 5 µM peptide 
concentration the stoichiometry is 1 copper ion binding per 2 Msp4capC molecules. 
Thus, in Msp4, the stoichiometry should be 1 copper ion binding per 1/2 Msp4 
molecule, or 2 copper ions binding per one Msp4 molecule, i.e. consistent with the 
results from the ED experiments. 
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As discussed in Chapter IV, the concentration of peptide used in the experiments to 
determine the Kct, is much higher than the Kct itself, resulting in low accuracy of the Kd 
determination, but high accuracy of the stoichiometry determination (Bagshaw and 
Harris, 1987). However, despite a very large error, the Kct values, which are in the nM 
range for copper binding to marsupial PrP-repeat peptides, are much lower than most Kct 
values for copper binding to other PrP repeats (from chicken and human) reported in the 
literature (Hornshaw et al., 1995a; Brown et al., 1997; Stockel et al., 1998; Viles et al., 
1999; Whittal et al., 2000; Kramer et al., 2001). Some exceptions are Kct values of 
Garnett and Viles (2003) in the 10 µM to 10 nM range, and Jackson et al. (2001) who 
proposed a Kct in the fM range. 
Thus, while results of both ED and fluorimetry experiments show the same copper-
binding stoichiometry, the Kct value is still in dispute: the Kct from the fluorimetry 
experiments is in the nM range, while that from ED experiments is in the µM range. 
However, as the binding curves from the fluorescence experiments are measured under 
conditions of stoichiometric binding, the Kct value is determined to be much lower than 
0.5 µM (peptide concentration used in fluorimetry experiments), but will have· large 
error. 
8.3. Proposed copper-binding mode in marsupial PrP repeats 
Fluorescence titration experiments show the imino group of Pro at the N-terminus is 
very important in facilitating the binding between copper ions and the Msp peptides 
((PHPGGSNWGQ)nG, where n = 1, 2, 3, and 4), as acetylation of the N-terminus 
abolished binding between peptide and copper ion. On the other hand, replacement of 
the His residue with Ala caused only a 100 times increase of Kct, which means only a 
weakening of the binding. From this we can infer that the anchoring site for copper 
binding in Msp peptides is the imino group of Pro instead of the imidazole ring of the 
His residue. Once copper ion binds to the anchoring site, other ligands including the 
nitrogen atom of the imidazole ring of His complete the coordination sphere. Similar 
findings from FTIR and ESI MS experiments confirm that the imino group is the 
anchoring site for copper ion in Msp peptides. 
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However, in contrast to fluorimetry, FTIR experiments show that in the absence of the 
imino group of Pro, the binding between the N-terminally acetylated peptide and copper 
ion does occur but only at basic pH (pH>8.0). The binding occurs via the His side chain 
as the anchoring site and other ligands, including the amide nitrogen, that complete the 
coordination sphere. 
The involvement of the amide backbone in copper coordination is indicated in FTIR 
spectra. The factors that determine whether or not a particular main chain amide is 
involved in the binding are its position relative to the anchoring site and the steric 
hindrance of the side chain. Breslow (1973) reported that copper ion tends to 
coordinate with nitrogen atoms of the peptide bond, with simultaneous displacement of 
the peptide bond proton. The nearest peptide bond to the anchoring site will have the 
lowest pK and will most likely participate in copper binding, provided there is no steric 
hindrance (Breslow, 1973). 
The His side chain residue has two nitrogen atoms that can participate 1n copper 
binding, namely Nrr and N1:. The fluorimetry experiments indicate copper ion strongly 
prefers binding to the Nrr atom rather than to the N1: atom, as the affinity of copper 
binding to MsplHis(lMe)capC at pH 8.0 is shown to be much higher than that for 
Msp1His(3Me)capC. Furthermore, copper ion addition to Msp1His(3Me)capC at pH 
6.0 and 7.0 does not change the Trp fluorescence emission intensity, while addition to 
MsplHis(lMe)capC peptide does. This lack of change suggests that copper ion does 
not bind to the N1: atom of the imidazole ring of His under these fluorimetry 
experimental conditions (pH 6.0-7.0 and 0.5 µM peptide concentration). The result is in 
contrast to the FTIR experiment, which shows that addition of copper changes the 
spectrum of both peptides at all pHs studied (pH 6.0-9.0). This discrepancy is probably 
due to the difference in peptide concentration used in each method, with the FTIR 
method requiring a 1,000 times higher peptide concentration than the fluorimetry 
method. 
In order to propose a structure for the copper complex, information about the binding 
stoichiometry as well as the groups or atoms that bind to copper ion is needed. The 
difficulty is that the stoichiometry of binding is very much affected by the peptide 
concentration, as has been shown by the fluorimetry experiment. In the work presented 
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here, information on the stoichiometry is obtained from the fluorimetry experiments, 
which requires only µM concentration of the peptides. On the other hand, information 
on the binding sites is gained mostly from the FTIR experiments, which employed mM 
peptide concentration. However, the fluorimetry experiments to some extent also 
provide information about the binding sites that are in good agreement with the FTIR 
results, such as the importance of the imino group of Pro at the N-terminus and the 
imidazole side chain of His. 
Titration data to study binding from the FTIR experiments are available only for copper 
binding to Mspl. However, the shape of the binding curve (Figure 3.35.B) shows the 
binding is not under stoichiometric conditions, but under equilibrium conditions, from 
which we can extract accurate information about the Ka, but not stoichiometry. The 
stoichiometry data at high peptide concentration, therefore, are deduced from 
fluorimetry titration of copper binding to various concentrations of Msp peptides (see 
section 4.4.5 of Chapter IV) 
The data presented in Table 4.3 of Chapter IV, and discussed above in section 8.3, 
indicate an increase in the number of copper ions bound to the peptide molecule with 
increasing peptide concentration. From this data, the predicted complex that formed at 
high peptide concentration is 1: 1 copper per Msp 1, Msp 1 capC, and Msp 1 capN C 
peptide. The likelihood of 2 copper ions binding to 1 Msp 1 molecule is less as there is 
only one potential anchoring site, which is the imino group of Pro at the N-terminus. 
The complexes of Msp2, Msp3, and Msp4 are more difficult to predict. However, given 
that copper binding requires the imino group of Pro at the N-terminus, it is likely that 
the stoichiometry is also 1 copper binding per 1 Mspn (n=2, 3, and 4) molecule. 
Nonetheless, there is also a possibility that both the imino group of Pro and the 
imidazole ring of His act as copper-anchoring sites in long repeats such as Msp4 which, 
as shown in the ED experiment, binds 2 copper ions. 
8.3.1. Copper-binding mode in Mspl and MsplcapC 
As noted above, the anchoring site for peptide is the imino group of Pro. The binding of 
copper to the imino group will be accompanied by binding to the adjacent peptide bond 
nitrogen with concurrent displacement of the peptide bond proton (Breslow, 1973). 
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Therefore, in Mspl (PHPGGSNWGQG) and MsplcapC (PHPGGSNWGQ-NH2), the 
nitrogen amide of the His2 residue will join the coordination sphere. Note that the 
involvement of the amide backbone in copper coordination is apparent in FTIR spectra. 
Another nitrogen atom comes from the imidazole ring of His
2
. There are two nitrogen 
atoms of the imidazole ring with potential to be binding sites, but in this case, according 
to the FTIR spectra of copper complexes of Msp 1 and Msp 1 capC and fluorescence 
titration spectrophotometry results, it is the Nn atom that is participating. The possible 
complex is shown in Figure 8.1. Copper ion binds the nitrogen atom of the imino group 
of Pro 1, the nitrogen atom of the main chain amide of His
2
, and the nitrogen atom of the 
imidazole ring of His2. In Msp 1, the fourth ligand could be the oxygen atom of a water 
molecule or the a-carboxyl group at the C-terminus. In Msp 1 capC, the fourth ligand 
could be the oxygen atom of a water molecule. 
Figure 8.1: Copper-binding mode in (PHPGGSNWGQ)11G peptide at neutral pH. The 
Cu atoms of the first four residues were labeled. The figure shows that peptide binds 
copper ion via the nitrogen atom of the a-imino group of Pro 1, the nitrogen atom of the 
amide backbone of His2, and the nitrogen (Nn) aton1 of the imidazole ring of His
2
, 
resulting in the formation of 5- and ·6-membered rings. The fourth ligand could be the 
oxygen atom from the a-carboxyl group at the C-terminus or a water molecule. At 
basic pH, other nitrogen atoms from the main chain amide backbone participate. 
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8.3.2. Copper-binding mode in MsplcapNC 
In the absence of the a-imino group of Pro, the anchoring site for copper binding to 
marsupial PrP-repeat peptide is the imidazole ring of His. The deprotonated nitrogen 
atoms of the main chain amide will complete the coordination sphere. At the N-
terminal side of the anchoring site, the nearest amide nitrogen coming from the His 
residue itself participates in the binding. However, the binding towards the N-terminus 
cannot move further than His2, as the nitrogen atom of the main chain amide of Pro 
1 
does not have a proton to displace. 
Figure 8.2: Copper-binding mode in Ac-(PHPGGSNWGQ)nG peptide at basic pH. The 
Ca atoms of the first six residues were labeled. The figure shows that the peptide binds 
copper ion via the nitrogen (N1t) atom of the imidazole ring of His2, and 3 nitrogen 
atoms of the main chain amide backbone of Gly4, Gly
5
, and Ser6 resulting in the 
formation of one 10- and two 5-membered rings. 
Consequently the binding should move towards the C-terminus (forward binding). But, 
the fact that the third residue is Pro, for which the nitrogen amide cannot participate in 
coordination, the forward binding is blocked. Participation of the amide nitrogen 
further along towards the C-terminus is possible only at high pH. As mentioned above, 
the closer the peptide backbone to the anchoring site, the lower the pK for proton 
displacement, and vice versa (Breslow, 1973). As a consequence, the binding occurs 
only at basic pH (see Figure 3.6 of Chapter III), where the coordination of the imidazole 
ring of His2 can be supported by coordination of the nitrogen atoms of main chain 
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amides of residues further towards the C-terminus, for instance Gly
4 and Gly5 . The fact 
that the binding occurs only at basic pH also indicates copper ion prefers binding to the 
nitrogen atom of the peptide bond rather than to the carbonyl oxygen atoms of the Pro
1 
or Pro3 residues. 
The proposed binding site in Msp 1 capNC at basic pH is, therefore: the N1e atom of His
2 
and nitrogen atoms of the main chain amides of Gly4, Gly
5
, and possibly Ser6 as the pH 
is increased. The binding results in the formation of one 10-membered and two 5-
membered rings (Figure 8.2). 
8.3.3. Copper-binding mode in MsplP3GcapNC 
The sequence of the first half part of this peptide (1PHGGGSNWGQG11) is similar to 
that of the first half part of human PrP repeats (1PHGGGWGQG9). FTIR assignments 
have revealed that copper-binding sites in MsplP3GcapNC will be the imidazole ring of 
His2 (the anchoring site) and three nitrogen atoms of the main chain amide of Gly3, 
Gly4, and Gly5, as shown in Figure 8.3. The participation of the nitrogen amide of Gly
3 
is inferred from large FTIR spectral changes that occur upon addition of copper ion to 
MsplP3GcapNC. Note that in wild-type peptide (MsplcapNC), where the third residue 
is Pro, the spectral changes upon copper ion addition are minimal. 
The binding site proposed in Figure 8.3 is fairly similar to the proposed binding site for 
human PrP octarepeat according to the X-ray crystal structure of Bums et al. (2002) and 
the proposed model of Luczkowski et al. (2002). As mentioned in Chapter I, both 
papers proposed that copper ion binds to the N1e atom of His
2 and two nitrogen atoms of 
the main chain amide of Gly3 and Gly4 (Bums et al., 2002; Luczkowski et al., 2002). In 
addition to that, the XRD data show copper ion also binds to the peptidic oxygen atom 
of Gly4 (Burns et al., 2002). 
As shown in Figure 8.3, in MsplP3GcapNC (1PHGGGSNWGQG11 ) copper ion binds to 
the N1e atom of the imidazole side chain of His2 residue and 3 nitrogen atoms of the 
main chain amide backbone of Gly3, Gly4, and Gly5. It is possible that the Gly
5 
residue 
is not the ligand for copper, but that the amide backbone participation comes from the 
oxygen atom ( of Gly4) rather than the nitrogen atom ( of Gly5). However, there are no 
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data to support the involvement of the oxygen carbonyl in the copper coordination 
sphere. 
Figure 8.3: Copper-binding mode in MsplP3GcapNC (Ac-PHGGGSNWGQG-NH2) 
peptide at neutral and slightly basic pH. The Ca atoms of the first five residues were 
labeled. The figure shows the peptide binds copper ion via the nitrogen (Nn) atom of the 
imidazole ring of His2, and 3 nitrogen atoms of the main chain amide backbone of Gly
3
, 
Gly4, and Gly5 resulting in the formation of one 7- and two 5-membered· rings. 
The fact that copper ion binds this mutant peptide better than the wild type indicates the 
HGGG segment as a copper-binding unit at neutral and slightly basic pH. As noted, this 
cannot be replaced by HPGG because the Pro residue cannot donate its nitrogen main 
chain amide for copper coordination. Recent literature points out the specificity of this 
HGGG segment in binding of copper ion (Garnett and Viles, 2003; Luczkowski et al., 
2003). None of the marsupial (Windl et al., 1995; Premzl and Greatly, 2003, personal 
communication) or avian (Gabriel et al., 1992) PrP repeats have this segment. 
Copper binding to the tammar wallaby PrP repeats, in which the third repeat 
(PHAGGSNWGQ) contains the HAGG segment (Premzl and Greatly, 2003, personal 
communication), should be studied to establish further the copper-binding specificity of 
the HGGG segment and to provide a comparison with the properties of possum PrP 
repeats. 
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8.4. Copper-binding mode in HulcapNC 
As mentioned in the previous section, the copper-binding mode in HulcapNC would be 
similar to that of MsplP3GcapNC. The coordination involved the imidazole ring of 
His2, the three nitrogen atoms of the main chain amides coming from Gly
3
, Gly4, and 
Gly5, as shown in Figure 8.4. 
Figure 8.4: Copper-binding mode in HulcapNC (Ac-PHGGGWGQG-NH2) peptide at 
neutral and slightly basic pH. The Ca atoms of the first five residues were labeled. The 
figure shows the peptide binds copper ion via the nitrogen (N1) atom of the imidazole 
ring of His2, and 3 nitrogen atoms of the main chain amide backbone of Gly
3
, Gly4, and 
Gly5 resulting in the formation of one 8- and two 5-membered rings. 
The nitrogen of the imidazole ring of His that participates in copper coordination comes 
from the N-r rather than the Nn atom, as suggested by FTIR spectra. This is in contrast 
to the binding site proposed by Miura et al. (1999) for human repeat, in which, at pH 
8.0, copper ion binds the Nn atom of the imidazole ring of His. This difference may be 
due to the ratio of peptide and copper ion concentration in the FTIR experiments (1 :4 of 
peptide per copper ion) being much higher than in the Raman experiments [ 1: 1 (20 mM 
peptide per 20 mM copper ions]. As mentioned in Chapter III, in this FTIR experiment, 
the peptide concentration was 2.5 mM and the copper ion concentration was 10 mM. 
Thus, this phenomenon indicates that for Hul cap NC peptide the concentration ratio of 
copper influences the coordination environment. This suggestion, however, is not 
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confirmed, as there are no experimental data for this concentration ratio-dependent 
binding mode. 
8.5. Suggestion for future studies 
The work presented in this t~esis has resolved some questions regarding the copper-
binding properties of PrP repeats from species other than human, other eutherian 
mammals, or birds. But, several issues still need further investigation. The first issue is 
whether the copper-binding modes in multi-decarepeat marsupial PrP peptide will be 
the same as those for the single-decarepeat peptide. For that matter, the stoichiometry 
of copper binding to multi-decarepeats peptide needs to be clarified. A second issue is 
whether the preference of copper ion binding to the Nn or N-c atom of the imidazole ring 
of the His residue is a function of the concentration ratio of peptide and copper ion. A 
third issue is whether the copper-binding properties of the actual sequence of the 
marsupial PrP-repeat peptide are similar to the properties of the consensus-decarepeat 
peptides studied in this thesis. A fourth issue that needs to be investigated further is the 
cation-n or n-n interaction between His and Trp in PrP-repeat peptides, and the 
influence of such interactions in the folding of the repeats and the stability of the 
peptide conformation. 
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